Clinical Evaluation of Siddha herbal formulation Chitramutti Nei (Internal) in the treatment of Azhal pandu (Iron Deficiency Anaemia) by Shakila, M S
Clinical Evaluation of Siddha herbal formulation “CHITRAMUTTI NEI”           
(Internal) in the treatment of Azhal pandu (Iron Deficiency  anaemia.) 
The Dissertation Submitted by 
Dr.M.S.SHAKILA. 
PG Scholar 
Under the supervision of 
PROF .Dr.K.MANICKAVASAKAM M.D(s), 
Head of the Department of Maruthuvam& Former Director 
National Institute of Siddha. 
Chennai-47 
 
 
 
 
 
 
 
 
 
 
For the partial fulfillment of 
 
Requirements to the degree of 
 
DOCTOR OF MEDICINE (SIDDHA) 
 
(AFFLIATED TO THE TAMILNADU Dr.M.G.R.MEDICAL UNIVERSITY) 
BRANCH I – DEPARTMENT OF MARUTHUVAM 
NATIONAL INSTITUTE OF SIDDHA 
TAMBARAM SANATORIUM, CHENNAI-600 047 
OCTOBER - 2018 
 
                                    DECLARATION BY THE CANDIDATE 
 
 
I hereby declare that this dissertation entitled “Clinical Evaluation of Siddha 
herbal formulation “CHITRAMUTTI NEI” (Internal) in the treatment of Azhal 
pandu (Iron Deficiency Anaemia.) Guidance of Dr. H.Vetha Merlinkumari, M.D(s), 
Ph.D., Lecturer, Under the Department of Maruthuvam, National Institute of Siddha, 
Chennai -47, and the dissertation work has not formed the basis for the award of any 
Degree, Diploma, Fellowship or other similar title. 
 
 
 
Date:        Signature of the candidate 
Place: Chennai -47                        (Dr.M.S.SHAKILA) 
                 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 BONAFIDE CERTIFICATE 
 
Certified that I have gone through the dissertation submitted by  
Dr. M.S. SHAKILA (Registration No: 321511206) a student of Final year MD(S),Branch 
I, Department of Maruthuvam, National Institute of Siddha, Tambaram Sanatorium, 
Chennai-47 and the dissertation work has been carried out by the individual only. This 
dissertation does not represent or reproduced the dissertation submitted and approved 
earlier. 
 
        
Date   : 
Place: Chennai-47 
 
 
 
Name and Signature of the Guide   Name and Signature of the HOD 
Dr.H.VETHAMERLINKUMARI,  M.D(S), Ph.D Prof Dr.K. MANICKAVASAKAM, M.D(S) 
Lecturer/Guide     Head of the Department 
Department of Maruthuvam    Department of Maruthuvam 
National Institute of  Siddha.    National Institute of  Siddha. 
 
 
 
Forwarded by the Head of the Institute 
Prof. Dr.V.BANUMATHI,M.D(S) 
Director, 
National Institute of Siddha 
Tambaram Sanatorium,  Chennai-600 047. 
               
 
 
 
 
             CONTENTS 
 
 
 
 
 
                                                 
 
 
 
 
 
 
 
 
                                                                                                                                                             
CONTENTS 
 
S.NO TITLES PAGE.NO 
1 INTRODUCTION 1 
2 AIM AND OBJECTIVES 3 
3 REVIEW OF LITERATURE  
 A] SIDDHA ASPECT 4 
 B] MODERN ASPECT 34 
4 MATERIALS AND METHODS 58 
5  PREPARATION AND PROPERTIES OF 
DRUG 
68 
6 BIO CHEMICAL  ANALYSIS  79 
7 STANDARDIZATION REPORT 84 
8 OBSERVATION AND RESULTS 92 
9 DISCUSSION 141 
10 SUMMARY 151 
11 CONCLUSION 153 
12 ANNEXURE 154 
13 BIBLIOGRAPHY 194 
 
 
ACKNOWLEDGEMENT 
 I feel enormous wonder and colossal gratitude in my heart of hearts to GOD and 
SIDDHARS Almighty for granting me the wisdom, health and strength to undertake 
this dissertation and enabling me to its completion. 
 I take this opportunity to express my gratitude and acknowledge to the  
Vice-Chancellor, The Tamil Nadu Dr. M.G.R. Medical University, Chennai-32 
 I express my gratitude to our Director, Prof. Dr. V. Banumathi, M.D(s), National 
institute of siddha, Chennai-47. 
 I express my deep sense of thankful gratitude to our HOD,  
Prof. Dr.K. Manickavasakam, M.D(s), Former director & Head of the department, 
Department of Maruthuvam, National institute of Siddha, Chennai-47. 
 I express my grateful thanks to Lecturer, Dr. H. Vetha merlin kumari M.D(s), 
Ph.D., , Department of  Maruthuvam, National institute of Siddha,Chennai-47 for 
her excellent guidance, monitoring and constant encouragement , hopeful support 
and guidance given by her time to throughout the course of dissertation. 
 I express my sincere thanks to Dr. N. Periyasamy pandian, M.D(s), Associate 
professor, Department of Maruthuvam, National institute of Siddha, Chennai. 
 I express my sincere thanks to Dr. K. Thangadurai, M.D(s), Associate professor, 
Department of Maruthuvam, National institute of Siddha, Chennai. 
 I express my sincere thanks to Lecturer, Dr. T. Lakshmikantham M.D(S), 
Department of Maruthuvam, National Institute of Siddha,Chennai-47. 
 I express my sincere thanks to Lecturer,  Dr. H. Nalini sofia, M.D(s), Ph.D., 
Lecturer, Department of Maruthuvam, National institute of Siddha, Chennai-47. 
 I express my sincere thanks to Dr. D. Aravind, M.D(s), M.Sc [Medicinal plants], 
Assistant Professor, Medicinal Botany, National institute of Siddha, Chennai-47,for 
his identification and authentication of herbs 
 I express my sincere thanks to Dr.S.Visweswaran M.D(s), Lecturer, Hospital 
superintendent (i/c), ,Head of the Department (i/c),Department of Gunapadam, 
National of Siddha,Chennai-47,for his identification and authentication of mineral. 
 I express my sincere thanks to Dr. A. Mariappan, M.D(s), Lecturer, Department of 
Gunapadam, National institute of siddha, Chennai, for the guidance in trial drug 
preparation. 
 I express my sincere thanks to Dr. V.  Muthuvel, Asst Professor, Biochemistry.  
 I express my thanks to Mr. M. Subramanian, M.Sc. (Statistics), Senior Research 
Officer, National Institute of Siddha, for his valuable guidance in statistical 
analysis of the data.  
 Laboratory (i/c), National institute of Siddha, Chennai-47 for the support in 
Chemical analysis of trial drug.  
 I express my gratefulness to All My Colleagues for lending their helping hands 
whenever needed during the course of the study. 
 I express my thanks to each and every faculties , Library staff and lab staffs of 
National Institute of Siddha,Chennai-47, 
 Last but not the least, I would like to pay high regards to all my family members,  
my Husband, my Mother, my lovable Daughter and my Brothers for their 
sincere encouragement and inspiration throughout my research work and lifting me 
uphill this phase of life. I owe everything to them. Besides this, several people have 
knowingly and unknowingly helped me in the successful completion of this project 
and supporting me spiritually throughout my life. 
 I wish to thank the patients for their full co-operation and support. 
 
 
 
 
 
 
 
 
  
 
 
 
 
ACKNOWLEDGEMENT 
 
 
 
  
 
 
 
 
INTRODUCTION 
  
 
 
 
 
AIM AND OBJECTIVES 
  
 
 
 
 
 
REVIEW OF LITERATURE 
SIDDHA ASPECT 
 
 
 
 
 
 
 
MODERN ASPECT 
  
 
 
 
 
MATERIAL & METHODS 
PROTOCOL 
  
 
 
 
 
DRUG REVIEW  
  
 
 
 
PHYSIOCHEMICAL 
ANALYSIS 
  
 
 
 
 
BIOCHEMICAL ANALYSIS 
  
 
 
 
OBSERVATION AND 
RESULTS 
  
 
 
 
DISCUSSION 
  
 
 
 
 
STANDARDIZATION 
REPORT   
  
 
 
 
 
 
CONCLUSION 
  
 
 
 
SUMMARY 
  
 
 
 
 
REFERENCES 
  
 
 
 
ANNEXURE 
 
 
 
 
1 
 
INTRODUCTION 
The siddha system of Medicine also known as Tamil Maruthuvam, Sinthamani 
Maruthuvam, NaattuVaithiyam in Tamil Nadu, is the oldest among the Indian medicine 
System.  
Siddha System of medicine is an integrated part of  an Indian system, which  is very 
potent and unique system when compared with traditional  systems in existence. Siddha 
medicine is contributing much to the health care of human beings. 
Siddha system propounded by the Siddhars is a vast and unique system which 
defines health as a perfect  state of physical ,psychological, and social and spiritual 
wellbeing of an individual .The system not deals with medicine , but with spirituality, 
righteous way of living ,rejuvenation and its main aim is attainment of perfection no doubt 
,The siddha system of medicine is one among the foremost of all other medical  systems  of 
the world.  
The period of origin of this system is also substantiated by the extensive reference  
about the medical practice that are available in ancient tamil literature. The ancient 
tamilgrammer work Tholkappiyam, various  other works of Sangam literature and the 
Tamil vedham , Thirukkural not only mention ,but also give a better picture about this 
system.Accorting to Thiru T.V. Sambasivampillai, who compiled  the monumental work of 
siddha medical dictionary, dates the origin of the siddha system back to B.C.4,000.   
The siddhars were the greatest spiritual scientists on those days; they were the 
seekers of truth. „‟ SIDDHU‟‟ means „‟knowledge or wisdom‟‟ and „‟SIDDHI‟‟ means 
attainment of perfection‟‟. One who had attained perfection in life is called siddhars. 
Siddhars thoroughly studied human body , all kinds of plants ,minerals, metals and other 
poisonous drugs and their physical and chemical properties. 
Health is defined has physical and mental well being of an individual. 
„Sound mind in a sound body‟ is famous saying. A perfect state of health is maintained 
through regular diet, exercise and physical and mental activities  
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Disease is defined has irregularity in diet, physical and mental activities. Siddhars 
have classified disease into 4448 types. In this modem mechanical world, now a days 
people are suffering from various diseases. Especially females are the majority of sufferers 
due to their dual role both in family as well as in the society,  
Sage yugi classified „paandu‟ in his YugiVaidhyaChinthamani into 5 types. One of 
such disease is „ Azhal paandu‟  of these throws a big challenge to medical practioners of 
our siddha field and also the general medical world. Since  it affects the patients mentally, 
physically and economically, „Azhal paandu‟ is characterized by  yellowish of the body, 
generalized pallor, excessive thirst, breathlessness,  chest discomfort. Patients may also 
have a bitter  or pungent tasting sensation filling in the mouth .Giddiness always haunts the 
Azhal paandu patient its one of the haematological disease. It occurs due to diet and life 
style. In order to get rid of, this problem disease and also for its preventive aspect this is the 
main aim of the work due. 
According to siddha system of medicine, the treatment is given not only to the body 
but also to the mind, psychological changes are said to be causes for disease.  
Many formulations are available to treat Azhal Paandu in Siddha system of 
medicine, I have chosen the drug CHITRAMUTTI NEI, (Ref: Kannusamypillai, 
ChikichaRathina Deepam, Page no; 212,213) as internal Medicine. The ingredient of trial 
drug is easily available and cost effective,it has rich amount of iron. 
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AIM AND OBJECTIVES 
 
AIM 
 
Clinical evaluation of  siddha drug CHITRAMUTTI NEI (Internal) in the treatment 
of AZHAL PANDU [Iron Deficiency Anaemia]. 
 
OBJECTIVES 
 
Primary Objective: 
 
 To Study the therapeutic efficacy of siddha formulation CHITRAMUTTI NEIin the 
treatment of AZHAL PANDU (IRON DEFICIENCY ANAEMIA) for increasing the 
level of haemoglobin. 
 
Secondary Objective: 
 
 To study the siddha cofactors related to the disease such as age, sex, socio-
economicstatus, family history, occupation. 
 To study the siddha basic principles like Envagai thervu, Neerkuri, Neikuri, Udal 
thathukkal and Kaalam etc., in pitha 
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SIDDHA  ASPECT  
 
     Siddha system is said to have originated from lord siva and parvathy. Agasthiyar is 
the first disciple of siva no one could deny the fact that from hindu epic. Agathiyar is the 
mentor and pioneer to propagate this siddha system of medicine.  
 
 Siddha system of medicine declares that the human body is made up of five basic 
elements (Panchapootha).  
 
     The whole universe is also made up of five elements man  is said to be the 
microsome and  the world  as the macrosome. Because what exists in the world exists in 
man. The body will get upset or change from normal if there is any change in the world 
resulting in the development of disease.  
  
Siddha literatures deal with classification of diseases mainly by Tridosha theory that 
is Vaatham, Pitham and Kabam 
 
                  ''ÅÆí¸¢Â Å¡¾õ Á¡ò¾¢¨Ã ¦Â¡ýÈ¡¸¢ø 
                   ¾Æí¸¢Â À¢ò¾õ ¾ýÉ¢Ä Å¨ÃÅ¡º¢ 
                   «ÆíÌõ ¸Àó¾¡ É¼í¸¢§Â ¸¡§Ä¡Êø 
                   À¢Èí¸¢Â º£ÅüÌ À¢º¦¸¡ýÚ Á¢ø¨Ä§Â.'' 
                                                     -«¸ò¾¢Â÷ Ì½Å¡¸¼õ. 
 
           Pithapandu noi is caused by derangement of Pitham. Hence the basic details 
regarding Pitham are briefly explained before going into the study about Pitha pandu noi. 
 
Mukkutra Theory of Pitham: 
 
Pitham (Azhal) is one of the three vital humour (Vatham, Pitham, and Kabam). 
Among the Panchaboodhas, it is formed by the Theyu bootham.  In healthy individuals, the 
existence of the three humours are found in the following ratio of 1: ½: ¼ respectively. This 
is told as, 
              "¦ÁöÂÇ× Å¡¾¦Á¡ýÚ §Áø À¢ò¾§Á¡Ã¨ÃÂ¡õ 
               ³Âí ¸¡¦Äý§È «È¢" 
                                           -¸ñÏº¡Á¢Âõ 
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When this ratio is altered in our body, there is disturbance to Pitha thathu, which 
leads to alteration of Pitham leading to Pitha diseases. 
 
SITES OF PITHA: 
 
As per kannusaamiyam thoughts 
 
Between the heart and the naval,  
Viyarvai  :  Sweat,  
Saram   : Chyle 
Senner  : Blood, 
Irrappai  : Stomach, 
Neerpai  :  Urinary Bladder, 
Iruthayam  : Heart,  
Naavil  
Ooorukindraneer :  Salivary Secretion, 
Kan   : Eye  
Thol   : Skin. 
 
As per Yugimuni‟s thought 
 
"§À¡¦ÁýÈ À¢ò¾òÐì¸¢ÕôÀ¢¼§Á §¸Ç¡ö 
 §ÀÃ¡É ¸ñ¼ò¾¢ý £¸Æ¾¡Ìõ" 
 
General  Characteristics of Pitham: 
 
1. Veppam     :   Hot 
2. Koormai    :  Sharpness 
3. Neippu       :  Lubricative 
4. Nekizhchi   : Viscousity 
Pitham conceives the properties of the substance to which it combines. 
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Changes in Pitham by food: 
 
Some of characters of food we consume which leads to aggravation of  Pitha 
humour or neutralizing the aggravated Pitha humour, which is given as follows; 
          
  ''À¢ò¾ò¾¢ý º£÷Ì½ò¨¾ô §Àº¢Ê§Ä¡ Ã¡È¡Ìõ 
       Íò¾ôÀ¨º ¾£Ôõ ¦º¡ø¸Î¨Á - ¦Áò¾ 
¾¢ÃÅõ ÒÇ¢§Â¡Î º£÷¸¡Ã ÓüÈ¢í 
       ÌÃÁ¡ö ¿¢¨Ä¦ÀÚÁ¡ Óý.'' 
''§¾¡ýÈ¢ÅÕõ À¢ò¾ó ¦¾¡¼Ã¡ ¾¼í¸¢¼§Å 
       º¡ýÈÅÈðº¢ ÌÇ¢÷îº¢ º¡ó¾Ó¼ó - ®ýÈ¦¾¡Õ 
¦¸ðÊÔ¼§É ¸¢ÇÃ¢É¢ôÒ ¨¸ôÀ¢ §É¡Î 
           ¸¢ðÎõ ÀÃ¢¸¡Ãí §¸û.'' 
                -¸ñÏº¡Á¢Âõ 
 
Six qualities of food which aggrevate Pitham: 
 
1. Hot 
2. Acidic 
3. Mobility 
4. Liquid 
5. Aggressive 
6. Pungent 
 
Six neutralizing qualities of food for aggrevated Pitham: 

 Cold 
Sweet 
Immobility 
Solid 
Calmness 
 Bitter 
 
Qualities of aggrevated Pitham: 

1. Yellowish tinge of eyes, skin, urine and stool. 
2. Excessive thirst and appetite. 
3. Burning sensation all over the body. 
4. Decrease in sleep. 
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Qualities of reduced Pitha: 
 
1. Decrease in normal colour of the skin 
2. Loss of appetite 
3. Chillness 
4. Affecting the normal growth of Kabha humour. 
Natural Properties of Pitham: 
 
       ''Àº¢¾¡¸õ μì¦¸¡Ç¢¸ñ À¡÷¨ÅÀñ ¼òÐ 
        Õº¢¦¾Ã¢ ºò¾¢¦Åõ¨Á Å£Ãõ - ¯º¢¾ 
        Á¾¢Ü÷ò¾ Òò¾¢ÅÉô ÀÇ¢òÐì ¸¡ìÌõ 
        «¾¢¸¡Ã¢ Â¡í¸¡ ÉÆø.'' 
                                 - ¯¼ø ¾òÐÅõ 
1. Seripithal (Digestion) 
2. Vanmai (Strong) 
3. Vemmai (Hot) 
4. Menmai (Softness) 
5. Paarvai (Sight) 
6. Pasi (Hunger) 
7. Neervetkai (Thirst) 
8. Suvai (Taste) 
9. Oli (Brightness) 
10. Ninaippu (Thought) 
11. Arivu (Knowledge) 
 
Physiological Functions of Pitham: 
 
1. Increasing the body temperature. 
2. Giving red or yellow tinge to the body. 
3. Raising the body temperature during digestion and assimilation. 
4. Produces perspiration, giddiness. 
5. Raising the volume of blood and its expulsion. 
6. Gives yellow stain to skin, eye, motion and urine. 
7. Anger, irresponsible, immobile, thoughtfulness, emaciation. 
8. Feeling of irritation, excitement. 
9. All tastes are found to be sour, bitter. 
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Types of Pitham: 
 
      ''¬ì¸Éø Åñ½¦ÅÃ¢ Â¡üÈÄí¸¢ Ôû¦Ç¡Ç¢ò¾£ 
      §¿¡ì¸ÆÄ¡õ À¢ò¾¨Áó¾ á¾ÉÁ¡- Â¡ìÌ¦Á¡Æ¢ 
      À¡º¸Á¢ Ãïº¸ï º¡¾¸õ Ã¡º¸Á¡ 
      §Ä¡º¸ ¦ÁýÈ¢Î§Á¡ §Ä¡.'' 
                                             - ¯¼ø ¾òÐÅõ 
 
1. «ÉÄõ [Analam]             :  Gives appetite and helps digestion. 
2. À¢Ã¡º¸õ [Prasagam]     :  Gives complexion to the skin. 
3. þÃïº¸õ [Ranjagam]    :  Enriches the Colour of the blood. 
4. ¬§Ä¡º¸õ [Aalosagam]   :  Brightens the eye. 
5. º¡¾¸õ [Sathagam]            :  Controls the whole body. 
 
Relationship of Pitham with taste: 
 
Salt - Water + Fire 
Sour - Earth + Fire 
Pungent - Air + Fire 
 
Salt, sour and pungent tastes increase Pitham, because they are formed by fire (heat). 
So they possess Veppa Veeriyam. 
 
           "ÒÇ¢ÐÅ÷ Å¢ïÍí¸È¢ Â¡÷âÃ¢ìÌõ Å¡¾õ 
            ´Ç¢ÔÅ÷ ¨¸ô§ÀÈ¢ø À¢òÐîº£Úõ-¸¢Ç¢¦Á¡Æ¢§Â 
            ¸¡÷ôÀ¢É¢ôÒ Å¢ïº¢ü ¸ÀõÅ¢ïÍ ïºðÊÃ¾î 
            §ºÃô Ò½÷§¿¡ÂÏ¸¡§¾." 
                                  - ¸ñÏº¡Á¢Âõ. 
 
              Astringent, sweet and bitter tastes neutralize Pitham, because they do not contain 
Agni (heat).  Hence they Possess Seedha Veeriyam. 
 
Astringent  :  Earth + Air 
Sweet   :  Earth + Water 
Bitter   :  Space + Air 
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 "À¢ò¾Á¾¢ ¸Ã¢ôÀ¢ý §ÀÍõ ÀÃ¢¸¡Ãõ 
 Íò¾ò ÐÅ§Ã¡Î ¦º¡øÄ¢É¢ôÒî ºò¾¡Ìõ 
 ¨¸ôÒî Í¨Å§Â ¸ÕÐÅ¾ý Å£Ú 
 ±öôÀ¨¼Ô ¦ÁýÚ¨Ãò¾¡ Ã¢íÌ." 
     -¸ñÏº¡Á¢Âõ 
Aggravation of Pitham in daily routine: 
 
Pitham is raised at the time of 10 a.m to 2 p.m and 10 p.m to 2 a.m 
 
 
    "¸¡¨ÄÂ¢ø Å¡¾¿¡Ê ¸Ê¨¸Â¢ø Àò¾¡Ìõ 
    À¡¨ÄÂ¢ø À¢ò¾¿¡Ê À¸Õîº¢ Àò¾¡Ìõ 
    Á¡¨ÄÂ¡õ §ºòÐÁ ¿¡Ê Á¾¢ôÒ¼ý Àò¾¡Ìõ 
    Å¡¨ÄÂ¡ Á§É¡ýÁ½¢ìÌ ÅÌòÐ§Á ¦¾¡Ìò¾¾¡§Á." 
                                             - ¨Åò¾¢Â º¡Ã ºí¸¢Ã¸õ. 
Aggravation of pitham in week days: 
 
If pitha gets aggravated at morning hours of Sunday, Tuesday, Saturday and Krishna 
patcham Thursday, the vigour and vitality of body is maintained. 
 
PHYSIOLOGICAL ASPECTS OF SENNEER THATHU [BLOOD] 
 
Blood is the connective tissue of the body. It reflects the changes that occur in the 
body. The blood is the combination of various elements like Venthavalam, Senthavalam, 
Prakruthi mayai, Pranavayu and Neer. Senthavalam moves like a worm in blood. It is 
mentioned in the following verses; 
  
°Úõ ÒØÅ¢ý ´Øí§¸¡, ¿£Ã¢¨¼ 
      ¨Åò¾ ÁÄò¾¢ý Ìô¨À§Â¡, ¨ÅòÐì 
      ¸ðÊÂ ¿ÃõÀ¢ý ¸Â¢§È¡, ¯¼õÀ¢üÌû 
      À¢Ã¢Â¡ ¦¾¡ÚìÌõ À¢½¢§Â¡, ¦¾Ã¢Â¡Ð 
      þýÉÐ Â¡ý ±ýÚ «È¢§Âý ±ý¨É.'' 
                         - ÀðÊÉò¾¡÷ [¾¢ÕÅ¢¨¼ÁÕà÷ ÓõÁ½¢ì§¸¡¨Å -13] 
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Nourishment of Senneer: 
 
Among seven body constituents, Senneer is placed in second order next to saram. 
This is stated by Thirumoolar as follows, 
  ''þÃ¾ Ó¾Ä¡É ²ú¾¡Ð ãýÈ¢ý 
      ¯Ã¢Â ¾¢Éò¾¢ý ´ÕÒü ÀÉ¢§À¡ø 
      «Ã¢ÂÐÇ¢ Å¢óÐ Å¡Ì§Áú ãýÈ¢ý 
      ÁÕÅ¢Â Å¢óÐ ÅÇÕí¸¡ Âò¾¢§Ä'' 
                                      - ¾¢ÕÁó¾¢Ãõ-1897 
 
During  the process of digestion in our body formation of Raktham thathu according 
to Siddhars:  
 
As the digestion takes place in the body “Rasa thathu” is formed on the very first 
day. The second day “Raktha thathu” is formed from the Rasa thathu , Mamisam is formed 
from this Ratha thathu on third day. Kozhuppu is formed from Mamisa thathu on the fourth 
day. Enbu is formed from kozhuppu on the fifth day, “ Moolai” is formed from enbu on the 
sixth day and finally “Sukkilam” is formed from moolai on the seventh day. The nutrients 
absorbed after digestion are responsible for the metabolism and formation of   blood.  
 
PANDU NOI 
VERU PEYARKAL (SYNONYMS): 
 
 Venmai Noi 
 Veluppu Noi 
 Venpandam. 
 
IYAL (DEFINITION): 
 
          Pandu noi is a disease characterized by changing of natural colour of the body and 
pallor noticed in skin, nails and conjunctiva.  
 
In Sambasivam Pillai Tamil English Dictionary, Pandu, which means white. So 
the colour the body in pale or white colour. In the text Agasthiyar gunavagadam, 
it is quoted as follows, 
 "§¾¸ò¾¢ø þÃò¾õ ÅüÈ¢ò 
           ¾£í¸¡É Å¢ó¾ §¿¡ö ¸¡ÏÁôÀ¡." 
                          -«¸ò¾¢Â÷ Ì½Å¡¸¼õ. 
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In Uyir Kaakum Siddha Maruthuvam, 
 
            The Characters of Pandu noi are natural colour of the body will be pale and glowing, 
Oedema in face, Eyes in blue and dark yellow colour urination. 
 
In Agathiyar vaithiya pillai tamil, In Pandu, Red blood cells are reduced in blood and the 
skin is pale in colour. 
 
NOI VARUM VAZHI (ETIOLOGY): 
 
According to Yugimuni the causes of Pandu are as follows; 
 
"«È¢óÐ§Á ¯üÀò¾¢ ¦º¡øÄì §¸Ç¡ö 
«¾¢º¡Ã ÁÄÁ¢Ç¸¢ ¦Âó§¿ Ãó¾¡ý 
À¢È¢óÐ§Á ÒÇ¢ÔôÒ ¦ÀÕò¾Ä¡Öõ 
     ¦Àò¾Á¡ Áì¸¢É¢ Â¢Õò¾ Ä¡Öõ 
Á¢È¢óÐ¾¡õ âÄÁ¢¸ «Õó¾ Ä¡Öõ 
     Á£È¢§Â ÁÐì¸¨Çò¾¡ý Òº¢ò¾Ä¡Öõ 
ÀÈ¢óÐ§ÁÀ¸ø ¿¢ò¾¢¨Ã§Â ¦ºö¾ Ä¡Öõ 
     À¡ñÎ ÅóÐ À¡Ã¢Öû§Ç¡÷ ÀÎõÀ¡ ¼¡§Á." 
                                - ä¸¢¨Åò¾¢Â º¢ó¾¡Á½¢ 
 
From the above mentioned lines, it is clear that frequent attacks of diarrhoea, 
Excessive intake of salt and sour food,  Living in hot surroundings,  Excessive chewing of 
pawn and nuts,  Excessive intake of alcohol, Day time sleep are some of the factors causing 
Pandu noi. 
 
According to Thanvathiri vaithyam, 
 
"¾¢Õó¾¢Îõ À¡ñÎ §Ã¡¸ï §º÷ó¾¢Îí Ì½ò¨¾ì §¸Ç¡ö 
           þÕó¾¢Îõ Å¡¾À¢ò¾î º¢§ÄüÀÉ Á¢¨Å¾¡ý Á¡Úõ 
      ÒÃ¢óÐ¾¡ ¦É¡ý§È¡¦¼¡ýÚ ¦À¡ÕóÐÅ¾¡Ö Áñ§½¡ 
           ¼ÕóÐÅ¾¡Öõ À¡ñÎ Å¨½ó¾¢Î ¦ÁýÉÄ¡§Á" 
      ¬¸¢Â ãÄó ¾ýÉ¢¨Ä¨½ó¾ ×ð¼½ò¾¢½¡Öó 
           §¾¡¨¸Â÷ §Á¸ò¾¡Öõ ÐÂ÷Á¢Ì §Ã¡¸ò¾¡Öõ 
      §¾¸ §À¡„¨½ Ôû§Ç¡÷ìÌò ¾Ã¢ò¾¢Ãï §º÷¾Ä¡Öõ 
           §Å¸Á¡ó ¾¢Ã¢§¾¡„í¸û Á¢ïº¢Â À¡ñÎ Å¡§Á." 
                                             - ¾ýÅó¾¢Ã¢ ¨Åò¾¢Âõ 
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Imbalance between the three thathus [Vatham, Pitham, and Kabam], perversion of 
Appetite such as eating mud, excessive heat accumulation due to altered Abana vayu, 
Excessive Sorrow, and psychosocial factors are some of the causes of Pandu noi. 
According to Theraiyar vagadam; 
"¾¡¸ ÓÚõ Àº¢Â¡ø ¾¡Óñ½¡ Ã¡Á¡¸¢ø 
§¸¡¾Õ¿£÷ ¾¡¸ò¾¡ü ¦¸¡ûÇ¡Ã¡ö-§À¡¾ 
Á¢Ãò¾ó ¾¨ÉìÌÊìÌõ Á¢ýÀÅ¢¼¡ö §À¡ìÌõ 
ÀÕò¾ Å¢Æ¢ÌÕ¼¡õ À¡÷." 
                         -§¾¨ÃÂ÷ Å¡¸¼õ 
 
It is mentioned that negligence of food and water causes Pandu noi. According to 
Agathiyar kanmakandam kouvmathi, 
“ ¿¡¦Á¡ýÚ ¦º¡øÖ¸¢§È¡õ À¡ñÎ Åó¾ 
¿ÄÁ¡É ¸ÕÁÁÐ ¦º¡øÄì§¸Ù 
¾¡¦ÁýÈ ¾¡ö¾ó¨¾ ÁÉõ§¿¡¸î ¦ºö¾ø 
¾Ã½¢¾É¢ ÖûÇÅ÷ìÌõ Åõ§À ¦º¡øÄ 
¦Ä¦ÁýÈ ×ÚôÀÆ¢ò¾ø ¦ºÅ¢Í Å¡º 
ÁüÚô ¦À¡ö ¦º¡øÄ¡í¸¡Ãï ¦ºö¾ø 
§Å¦ÁýÚ ¸ÕÁÁÐ À¢ò¾ §ÁÈ¢ 
¦ÅÙòÐ¾¼¡ ¦ÅôÒÁ¢ïº¢ ¨¸¸¡§Ä¡Â§Å‛ 
 
To regret parents and others, lying and to get furious and increased pitha leads to pandu noi. 
 
According to Agathiyar gunavagadam, 
‘’¦¸¡ûÇ¼¡ «ÀìÌÅ §À¡ºÉò¾¡Öõ 
ÌÊ¦¸ÎòÐ ¦ÀÕõÀ¡Î ¸¢Ã¡½¢Â¡Öõ 
¸ûÇ¼¡ ¸ÕôÀò¾¢ý ¸¢Ãó¾¢Â¡Öõ 
¸ÉÁ¡É þÃò¾ò¾¢ý §À¡ì¸¢É¡Öõ 
«ûÇ¼¡ «¾¢ÂÁ¡É ¸ÅÉò¾¡Öõ 
«ÇÅüÈ Å¢º¡Ãó¾¡ É¨¼Ôõ §À¡Ðõ 
¦¾ûÇ§Å §¾¸ò¾¢ø þÃò¾õ ¦¸ðÎ 
¦¾Ç¢Å¡É À¡ñ¼Ð× Óñ¼¡õ À¡§Ã’’ 
Pandu noi occurs due to unfit food, menorrhagia, dysentery and other 
bleeding disorders. 
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NOI ENN (CLASSIFICATION): 
According to Yugimuni Pandu noi is classified into 5 types 
"ÜÈ§Å À¡ñÎÅ¢¼ô ¦ÀÂ¨Ãì §¸Ç¡ö 
ÌÈ¢ôÀ¡¸ ¨ÅóÐÅ¢¾ Á¡Ìõ À¡Õ 
Å¡Ã§Å Å¡¾Á¡õ À¡ñÎ §Å¡Î 
Á¡÷ì¸Á¡õ À¢ò¾ò¾¢ý À¡ñÎ Å¡Ìõ 
§¾È§Å º¢§ÄðÎÁÁ¡õ À¡ñÎ ¾¡É¡õ 
¾¢Ã¢§¾¡¼ô À¡ñ§¼¡Î Å¢¼ôÀ¡ñ ¼¡Ìõ 
¬È§Å À¡ñÎÅ¢¼ Å¡ñ¨Á ¦ÂøÄ¡õ 
       ¬Ã¡öóÐ ¦º¡øÄ§Å «È¢óÐ ¦¸¡û§Ç." 
                                       - ä¸¢ ¨Åò¾¢Â º¢ó¾¡ÁÉ¢ 
Thanvanthiri  classified Pandu into 7 types 
"ÀÂ¢ò¾¢Â À¡ñÎ Å¡¾À¡ñÎ§Å º¢§ÄòÐÁ À¡ñÎ 
Å¢Âò¾¢Ã¢ §¾¡„ôÀ¡ñÎ ¦ÅÚõ À¢ò¾ º¢§ÄòÐÁ À¡ñÎ 
ÀÂ¢ò¾¢Â Å¡¾À¡ñÎ À¸÷ ºýÉ¢Å¡¾ À¡ñÎ 
¿ÂôÒÚõ À¡ñÎ §ÅÆ¢ý Ì½ò¨¾ ¿¡ý ¿Å¢ÄÖü§Èý." 
                                   - ¾ýÅó¾¢Ã¢ ¨Åò¾¢Âõ 
KURIKUNANGAL IN PANDU NOI (CLINICAL FEATURES) : 
1. Murkurikunangal (Premonitory symptoms): 
 
In Siddha Maruthuvam Pothu, Kuppusamy Mudaliar  states that, Pandu patients exhibit 
the following symptoms from their initial stage of development Itself. The patient 
experiences insidious onset of fatiguability, dyspnoea on exertion,diminished vision, 
faintness, palpitation and pallor of the skin. 
 
Theraiyar Neerkkuri illustrates that; 
 
þÂü¨¸ ¿£÷ ÍÕí¸¢Ûõ þÐ×õ ºÄô¦À¡Õû 
¦ºÂü¨¸ Â¡ÂÕó¾¢Ûõ º¢Úò¾ ¿£Ã¢Ð×õ 
À¡ñÎ §¿¡öî ºõÀÅò¨¾ò ¾ÕÁ¢¾¢ø.‛ 
 
Oliguria occurring suddenly and oliguria occurring even after excessive intake of 
water are explained as premonitory symptom of Pandu noi. 
 
14 
 
2.  POTHU KURIGUNANGAL(GENERAL SIGNS AND SYMPTOMS): 
In Siddha Maruthuvam Pothu, Kuppusamy Mudaliar states; 
 
        Inability to walk, headache, palpitation, blurring of vision, giddiness, syncope, 
dyspnoea, anorexia, vomiting, paleness of the skin, nail beds become swollen and pallor, fissured 
tongue, glossitis, hoarseness of voice are general signs and symptoms of Pandu noi. In 
female‟s scanty menstruation, sometimes menorrhagia may occur. If it occurs in children 
and elderly, it may manifest because of worm infestation and blood disorders. If it occurs in 
pitha thegi, anorexia, indigestion, burning sensation, pallor of skin, glossitis, and dysphagia, 
Vomiting with bile, bitter taste and diarrhoea occurs. If the symptoms persist for longer 
duration it results in jaundice. 
 
In Pathinen nadi sasthiram states that, 
þÕõÀÖ Á¢¨ÇôÒõ ¦¿ïº¢ø Ä¢ÊÂÐ Á¢¸×ñ¼¡Ìõ 
¦ÅÕ¸¢Â ¸¢Ú¸¢ÚôÒõ §ÁÉ¢Ôõ ¦ÅÇ¢È¢ô §À¡Ìõ 
¦ÀÕ¸¢Â À¢ò¾À¡ñÎ ¦ÂýÉ§Å §ÀºÄ¡§Á 
¸Õ¸¢Â ÀøÖõ ¿¡×í ¸¡öîºÖÁ¢¨ÇôÒ Óñ¼¡õ‛ 
 
Dyspnoea on exertion, Chest pain, Giddiness , Pallor present all over the body are 
mentioned as the sign and symptoms in Pandu noi. 
 
Agasthiyar Gunavaagadam states that, 
"¯ñ¼¡Ìõ §Å¨Ç ¾ýÉ¢ø §¾¸ §¿÷¨Á 
¯Ú¾¢Â¡öî ¦º¡øÖ¸¢¦Èý ¿ýÈ¡ö À¡Õ 
Ìñ¼¡É Ó¸õ ¸ñ¸û ¯¾Î ¿¡ìÌ 
ÌÈ¢ôÀ¡É Å¡ö §Å¸õ §¾¸ ÓüÚõ 
¦Åñ¼¡¸ §ÅÔÄ÷óÐ ¦Åñ¨Á Â¡¸¢ 
Å¢Ãø ¸¡ø¸û ÓØÅ¾¢Öõ Ãò¾õ ÅüÈ¢ 
¸ñ¼¡É ¸¡ø¸û ¾¡ý ¾½¢óÐ ¿¢üÌõ 
¸ÕÅ¡É ¿¡ÊÂÐ ¦ÁÐÅ¡ö §À¡§Á. 
‚§À¡§Á ¾¡ý ¾£ÀÉí¸û ÁðÎôÀðÎ 
¦À¡Ä¢Å¡É ¸ñÅ¢Æ¢¸û ¦ÀÕòÐò §¾¡ýÚ 
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¬§Á ¾¡ý «ºì¾¢Ô Á¡Â¡ºí ¸ñÎ 
«Å÷ ¿¨¼Ôõ ¾Ç÷óÐ ¦ÀÕãîÍ ¸ñÎ 
ã§Á¾¡ý ã÷î¨ºÔ¼ý Á¡÷ÐÊòÐ 
ÓÊÅ¡É ¸Ïì¸¡Ä¢ø Å£ì¸Óñ¼¡ö 
¾¡§Á ¾¡É¢Õ¾Âò¾¢ý Å¾Éó ¾ýÉ¢ü 
ÐÕò¾¢ ¿¢¸÷ ºò¾ÁÐ §¸ðÌõ À¡§Ã." 
                       -«¸ò¾¢Â÷ Ì½Å¡¸¼õ 
 Stomatitis, dryness of the skin, pallor of the face, eyes, lips, tongue and nails, 
Lassitude, tiredness, low volume pulse, anorexia, swelling of the eyelids, dyspnoea on 
Exertion, palpitation, oedema of the ankle joint, added heart sounds in the pericardium are 
Mentioned as the signs and symptoms of Pandu noi. 
 
SYMPTOMS OF VARIOUS TYPES OF PANDU: 
1. Vatha Pandu: 
"¦¸¡ûÇ§Å Å¡¾À¡ñÎ §Ã¡¸í §¸Ç¡ö 
Ì¼øÒÃðÊ ÂÊÅÂ¢Ú ¾¡ýÅ Ä¢ìÌõ 
¾ûÇ§Å ¾¡¸¦Á¡Î Àº¢Ô Á¢ø¨Ä 
¾ÆÄ¡É ºÃºÃô À¡¸ò ¾¡Ïõ 
¿ûÇ§Å ¿Ãõ¦ÀøÄ¡í ¸ÚôÒ Á¡Ìõ 
¿Îì¸¦Ä¡Î ¸ñº¢ÅôÒ ÁÄÀó ¾ó¾¡ý 
Å¢ûÇ§Å ¾¨ÄÅÄ¢ìÌ §ÁÉ¢ Å£íÌõ 
¦ÅÙôÀ¡Ìõ Å¡¾ò¾¢ý À¡ñÎ¾¡§É‛. 
-ä¸¢ÓÉ¢. 
 
The symptoms of Vatha Pandu are lower abdominal pain, thirst, loss of appetite, 
dryness of the skin and visible veins due to pallor of the skin, redness of the eyes, 
constipation, headache, anasarca and pallor of the skin. 
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2. Pitha Pandu: 
 
"Å¡¦ÁýÈ §ÁÉ¢¦ÂøÄ¡ Áïº Ç¢òÐ 
Á¸¡¦ÅÙôÒ ¯ñ¼¡¸¢ Áó¾ì ¸ñ½¡ó 
¾¡¦ÁýÈ ¾¡¸¦Á¡Î ã÷î¨º Â¡Ìó 
¾É¢Å¡Â¢ø Á¢ÇÌ§À¡ü È¡Û ¨ÈìÌõ 
§¿¦ÁýÈ ¦¿ïÍÓû ¾¡Û Óñ¼¡ö 
¦¿Õì¸¢Â¡ ãîÍÓð ¼Ð§Å Â¡Ìí 
§¸¡¦ÁýÈ ¸¢Ú¸¢ÚòÐ Å¡ö¨¸ô À¡Ìí 
¸¢Ç÷À¢ò¾ À¡ñÎ¦ÅÉì ÜÈÄ¡¦Á." 
                                 -ä¸¢ÓÉ¢ 
 
Yellowish colouration and pallor of the skin, diminished vision, thirst, fainting, 
pungent taste like pepper, chest pain, dyspnoea, giddiness and bitter taste. 
 
3. Kaba Pandu : 
 
"ÜÈ¢Â§¾¡÷ ¿ÃõÒ§¾¡ø Á¢¸¦ÅÙôÒ 
¸¢Ç÷¿¡× ¯ôÒ¨ÈìÌ ÁÂ¢÷Üî º¡Ìõ 
Å¡È¢Â§¾¡÷ Å¡ó¾¢Â¡í ÌÃÖí ¸õÓõ 
¦Á¸ò¾¡É ÐõÁÖ¼ý §¸¡¨Æ Â¡Ìõ 
®È¢Â§¾¡÷ þÕÁ§Ä¡Î ÁÂì¸ Óñ¼¡õ 
þÎôÀº¾¢ þó¾¢Ã¢Â ¿‰¼ Á¡Ìõ 
º£È¢Â§¾¡÷ §º¡À¦Á¡Î ¾¡À Á¡Ìï 
º¢§ÄðÎÁò¾¢ý À¡ñ¦¼Éî ¦ºôÀÄ¡§Á." 
                                - ä¸¢ÓÉ¢ 
 
                 Pallor of the skin, salty taste, pilo erection of the skin, vomiting, husky voice, 
Sneezing, cough with expectoration, fainting, lassitude, ejaculation of semen, anasarca and 
thirst. 
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4. Mukkutra Pandu: 
"¦ºôÀ§Å ÂÕº¢¦Â¡Î §º¡À ¾¡¸ï 
¦ºÂÄ¡ÉÍÅ¡º¦Á¡Î þ¨ÇôÒ Á¡Ìõ 
¦ÅôÀ§Å §Á¸Éò¾¢ø º¢Ú¿£÷¾¡ý Å£Øõ 
Á¢Îì¸¡É ÀÄÅ£É Á¡÷À¢ Êò¾ø 
ÐôÀ§Å Ýð§¼¡Î ¾¢Âì¸ Á¡Ìó 
ÐõÁÄ¡ Ô¼õ¦ÀíÌ ã¾¢ì ¸¡Ïõ 
¾¢ôÀ§Å §¾¸¦ÁíÌ Áº¾¢ Â¡Ìõ 
¾¢Ã¢§¾¡¼ô À¡ñ¦¼ýÉî ¦ºôÒõ á§Ä." 
-ä¸¢ÓÉ¢ 
       Anorexia, thrist, dyspnoea, anasarca, chest pain, lassitude, sneezing, warmness of the 
skin. 
 
 
5. Vida Pandu: 
 
"áÄ¡¸ ¿Äò§¾¡ §¼Ô¼ø¦Å ÙìÌõ 
§¿¡ö¿ÃõÒ Ý¼¡Ìõ ¾¡¸ Á¡Ìõ 
¬Ä¡¸ ÂÕº¢¦Â¡Î ºò¾¢ Å¢ì¸ø 
«¾ðÊ¦Â þÕÁÖ¼ É¾¢Í Å¡ºõ 
Å¡Ä¡¸ ÅÂ¢üÈ¢¨Ãîº Ä¾¢º¡Ã §¾¡¼õ 
Á¡ÍÃÓ Óñ¼¡¾ø Á¡÷ì ¸Éò¾ø 
§ÅÄ¡¸ §ÁÉ¢¦ÂíÌ Á¢¸§Å °¾ø 
Å¢¼À¡ñÎ «º¡ò¾¢Â¦Áý§È Å¢ÇõÀÄ¡§Á." 
                                  -ä¸¢ÓÉ¢ 
Pallor of the skin, excessive thirst, anorexia, vomiting, hiccough, cough, dyspnoea, 
flatulence, diarrhoea, fever, heaviness of the chest, anasarca. 
 
THODAR NOI OF PANDU NOI (COMPLICATIONS): 
 
When the disease progresses kabam increases resulting in sobai (Oedema). 
Moreover in severe condition of Pandu noi, excessive intake of pitha diets and sexual 
intercourse lead to kamalai (jaundice). This is stated by Yugimuni as follows. 
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"Å¢ÇõÀ§Å À¡ñÎÓüÈ¢ þÕìÌõ §À¡Ð 
Á£È¢§Â À¢ò¾ÅŠÐ ¾¨ÉôÒ º¢ò¾¡ø 
ÒÇõÀ§Å Áí¨¸Ô¼ý Ò½÷îº¢ ¦ºö¾¡ø 
âñÊÎ§Á ¸¡Á¡¨Ä ¦ÂýÛõ §Ã¡¸õ." 
                              -ä¸¢ÓÉ¢ 
MUKKUTRA VERUPAADUGAL (PATHOLOGY): 
 
Udal vanmai is affected due to excessive intake of salt and sour foods, which cause 
indigestion and loss of appetite. This affects Rasam and Raththa thathus which lead to 
increase in Pitham and do not give nutrition to the body affecting Ranjagam leading to 
pallor of the skin. The increased Pitham affects both Vatham and Kabam increasing the 
pallor of the skin. Further Kabam increases producing generalized swelling of the body. 
 
PINIYARI MURAIMAI (DIAGNOSIS): 
 
Diagnostic methods in Siddha system are very unique and solely based on clinical 
acumen of the physician. 
 
1. Poriyal Arithal (or)  understanding by the fire organs of perception (Mei, Vai, Kann, 
  Mooku, Sevi) 
2. Pulanal Arithal (or)   understanding by the sense objects (Uraithal, Suvaithal, Parthal, 
  Mugarthal, Kettal). 
3. Vinadhal (or)   Interrogation. 
 
Tools used by Siddha Physicians: 
1. Kanndal (Perception) 
2. Karuthal (Inference) 
3. Oorai (The instruction of the inspired) 
                                        - (Njh.fp.M) g- 46 
 
The application of these three is very extensive in diagnosis and treatment. 
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ENNVAGAI THERVUKAL (EIGHT TOOLS OF DIAGNOSIS): 
 
Ennvagai Thervugal is a unique method of diagnosing the disease, which was 
developed by Siddhars. 
 
"¿¡ÊôÀÃ¢ºõ ¿¡¿¢Èõ ¦Á¡Æ¢Å¢Æ¢ 
      ÁÄõ ãò¾¢ÃÁ¢¨Å ÁÕòÐÅÃ¡Ô¾õ." 
      ''¦ÁöìÌÈ¢ ¿¢Èó¦¾¡É¢ Å¢Æ¢¿¡Å¢ÕÁÄõ ¨¸ìÌÈ¢'' 
                                                     - §¾¨ÃÂ÷ 
PANDU IN RELATION WITH ENNVAGAI THERVUKAL: 
 
1. Naadi (Pulse) 
¯¼Ä¢ø ¯Â¢÷ ¾Ã¢ò¾¢ÕôÀ¾üÌ ¸¡Ã½Á¡É ºì¾¢ ±Ð§Å¡ «Ð§Å ¾¡Ð «øÄÐ 
¿¡Ê ±ÉôÀÎõ.     -§¿¡ö ¿¡¼ø §¿¡ö Ó¾ø ¿¡¼ø 
 
Vatha,Pitha and Kabha naadi are in the ratio of 1:1/2:1/4 proportion in normal 
condition.This is stated as follows, 
''ÅÆí¸¢Â Å¡¾õÁ¡ò¾¢¨Ã ¦Â¡ýÈ¡¸¢ø 
      ¾Æí¸¢Â À¢ò¾ó ¾ýÉ¢Ä¨Ã Å¡º¢ 
      «ÆíÌí ¸Àó¾¡ É¼í¸¢§Â ¸¡§Ä¡Êø 
      À¢Èí¸¢Â º£Å÷ìÌô À¢º¦¸¡ýÚ Á¢ø¨Ä§Â.'' 
                                              - Ì½Å¡¸¼õ 
By combination of the above said three naadi, six thontha naadi are formed. They 
are Vathapitham, Vathakabham, Pithavatham, Pithakabham, Kabhavatham and 
Kabhapitham. This is stated as follows, 
 
      ''¾¡¦ÉýÈ Å¡¾Á¡ò ¾¢¨Ã¾¡ É¢ÃñÎ 
      ¾ôÀ¡Ð À¢ò¾ÁÐ ¾¡¦É¡ý §ÈÈ¢ø 
      §Å¦ÉýÈ Å¡¾À¢ò¾ ¦¾¡ó¾¢ôÀ¡Ìõ 
                                   -À¾¢¦Éñº¢ò¾÷ ¿¡Ê 
Naadi is responsible for the existence of life. It is a suitable diagnostic tool used by 
Siddhars. It is recognised as one of the principle means of diagnosis and prognosis of the 
disease from time immemorial. 
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A)NAADI NADAI IN PANDU NOI: 
 
1. Pitha Naadi: 
"¬§Á¾¡ý Âò¾¢ ÍÃõ À¡ñÎ §º¡¨¸ 
------------------------------------------------ 
¿¡§Á¾¡ý ¦º¡ý§É¡§Á À¢ò¾ìÜÚ 
¿Å¢ýÈ¢ð¼¡÷ Å¡ºÓÉ¢ ¿Å¢ýÈ¢ð¼¡§Ã." 
                          - «¸ò¾¢Â÷ 
2. Kaba Naadi: 
"¾¡ÉÓûÇ §ºòÐÁó ¾¡É¢Ç¸¢ø ¦ÅôÒ 
-------------------------------------------------- 
²É ÓÚí ¸¡Á¡¨Ä À¡ñÎ §º¡¨À 
²Ø ÍÃí¸û ÀÄÐì¸õ Å¢¼ Óñ¼¡§Á." 
                              - º¾¸¿¡Ê 
 
3. Vatha Kaba Naadi: 
 
"þÕìÌÁó¾ Å¡¾ò¾¢ø º£¾ï §º÷ó¾¡ø 
--------------------------------------------------- 
´Õì¸¢ýÈ ÁÄÀó¾õ ¦À¡ÕÁø Å£ì¸õ 
¯ûÅ£îÍ Ý¨Ä¦Â¡Î À¡ñÎ §Ã¡¸õ." 
- º¾¸ ¿¡Ê 
4. Kaba Vatha Naadi: 
 
"¸ñ¼¡§Â¡ º¢§ÄüÀÉò¾¢ø Å¡¾ ¿¡Ê 
------------------------------------------------ 
Å¢ñ¼¡§Ä þ¨ÇôÀ¢ÕÁø §º¡¨¸ À¡ñÎ 
Å¢¼À¡¸õ Å¢¼Ý¨Ä Àì¸Å¡¾õ." 
                   - º¾¸ ¿¡Ê 
5. Kaba Pitha Naadi: 
"þ¼Á¡É §ºòÐÁò¾¢ø À¢ò¾ ¿¡Ê 
------------------------------------------- 
Å¢¼Á¡É ¦¿ïº¨¼ôÒ ÍÅ¡ºõ Å¢ì¸ø 
¦ÅÌÍÃÓõ ¿¡ÅÈðº¢ À¡ñÎ §Ã¡¸õ." 
                               - º¾¸ ¿¡Ê 
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6. Pitha Vaatha Naadi: 
"º¢ÈôÀ¡É À¢ò¾ò¾¢ø Å¡¾ ¿¡Ê 
§ºÃ¢Öó ¾¡Ð¿ð¼Ó¾¢Ã À£¨¼ 
------------------------------------------" 
- º¾¸ ¿¡Ê 
 
2. Sparisam (Palpation): 
 
The warmth, hot, chillness, dryness, roughness of the skin, oozing, sweating, 
tenderness, fissures, swelling, ulcer and hepatosplenomegaly may be noted. In PithaPandu, 
hot sensation, dryness, roughness of the skin, sweating, swelling, hepatospleenomegaly are 
seen. 
 
3. Naa (Tongue): 
 
The colour, dry or wet, coating, texture, salivation, redness, ulceration, fissure, pallor, any 
malignant growth, predominant taste in the tongue along with the conditions of the teeth 
and gums should be noted. In PithaPandu, pallor of the tongue, dryness, ulceration, fissure, 
bitter or pungent taste of tongue, baldness and loss of taste buds are seen. 
 
4.Niram (Colour): 
 
Colour of the skin all over the body, a local region of affection, conjunctiva, tongue, nail 
bud, hair etc.  
Vatha Udal  :   Black and whitish colour 
Pitha Udal  :   Yellowish (or) Reddish colour 
Kapha udal  :   White or golden colour 
Thontha udal  :   Mix of two udal colours 
 
In Pitha Paandu, pallor of skin, conjunctiva and nail beds are noted. 
 
5. Mozhi (Sound): 
 
This includes clarity of speech, any disturbances, high or low-pitched voice, slurring and 
incoherent speech and hoarseness of voice. 
In Pitha Paandu,speech and voice normal. 
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6.Vizhi (Eyes): 
 
Hyperemia, ulceration, response of pupil, pallor, protrusion, sunken eyes, sharpness 
of vision, excessive lacrimation and accumulation of secretion at the angle of eyes, visual 
disturbance and any specific diseases of the eyes should be noted. In PithaPandu noi, 
pallor of conjuctiva and dull vision are noted. 
 
7. Malam (Faeces): 
 
Colour, consistency, quality, smell, frequency, constipation/diarrhoea, presence of mucous, 
blood and undigested food particles in the stool should be studied.  In PithaPandu noi, 
diarrhoea is noted. 
 
8. Moothiram (Urine): 
Neer Ilakkanam (Method of collection of urine): 
"«È¢óÐÁ¡È¢Ã¾Óõ «Å¢§Ã¡¾Á¾¡ö 
«·¸ø «Ä÷¾ø «¸¡Äçý ¾Å¢÷ó¾Æü 
ÌüÈÇÅÕó¾¢ ¯Èí¸¢ ¨Å¸¨È 
¬Êì¸Äºò ¾¡Å¢§Â ¸¡Ð ¦Àö 
¦¾¡Õ ÓÜ÷ò¾ì ¸¨Äì ÌðÀÎ ¿£Ã¢ý 
¿¢ÈìÌÈ¢ ¦¿öìÌÈ¢ ¿¢ÕÁ¢ò¾ø ¸¼§É." 
- §¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢. 
 
Collection of Sample Urine: 
The patient must take well cooked food in the previous day. The intake must be 
proportionate to the degree of his appetite. Food intake should be taken, at appropriate time. 
We must have sound sleep on the previous night. The urine is collected on the down of the 
next day in a glass container and closed immediately to prevent contamination. This 
specimen must be examination with in one and half hours. This procedure should be 
followed strictly to get accurate observation of Neerkuri and Neikuri. 
 
Neerkkuri: 
"Åó¾ ¿£÷ì¸Ã¢ ±¨¼ Á½õ Ñ¨Ã ±ïºÄÉ 
¨Èó¾¢ÂÖÇ¨Å Â¨ÈÌÐ Ó¨È§Â." 
- §¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢. 
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Urine has the following five characters, 
1. Niram - Colour of the Urine 
2. Edai - Specific gravity of the Urine 
3. Manam - Smell of the Urine 
4. Nurai - Frothy nature of the Urine 
5. Enjal - Quantity (Increased or decreased amount) of Urine voided 
 
Neerkkuri in Pandu noi: 
 
"þÂü¨¸ ¿£÷ ÍÕí¸¢Ûõ þÐ×õ ºÄô¦À¡Õû 
¦ºÂü¨¸ Â¡ÂÕó¾¢Ûõ º¢Úò¾ ¿£Ã¢Ð×õ 
À¡ñÎ §¿¡ö ºõÀÅò¨¾ò ¾ÕÁ¢¾¢ø 
àñÎ È¡ö §À¾¢Ôõ §º¡÷×õ À¢ÈìÌ§Á." 
- §¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢. 
 
Oliguria occurring suddenly and oliguria occurring even after excessive intake of 
water are explained as premonitory symptom of Pandu noi. 
 
Neikkuri: 
 
"¿¢ÈìÌÈ¢ì Ì¨Ãò¾ ¿¢ÕÁ¡É ¿£Ã¢ü 
º¢Èì¸ ¦Åñ¦½ö§Â¡÷ º¢ÚÐÇ¢ ¿ÎÅ¢Îò 
¦¾ýÚÈò ¾¢Èó¦¾¡Ä¢ §Â¸¡ ¾¨Áò¾¾¢ 
¿¢ýÈ¾¢Å¨Ä §À¡õ ¦¿È¢Å¢Æ¢ÂÈ¢×õ 
¦ºýÈÐ Ò¸Öï ¦ºö¾¢¨Â Ô½§Ã." 
- §¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢. 
 
          The diagnosis and prognosis of deranged Mukkutrams are studied on the basis of the 
behaviour of a drop of gingelly oil gently dropped on the surface of the urine kept in a wide 
vessel in the sunlight. 
"«Ã¦ÅÉ ¿£ñÊý·§¾ Å¡¾õ" 
"¬Æ¢§À¡ü ÀÃÅ¢ý «·§¾ À¢ò¾õ" 
"Óò¦¾¡òÐ ¿¢ü¸¢ý ¦Á¡Æ¢Å ¦¾ý ¸À§Á" 
-§¿¡ö ¿¡¼ø §¿¡ö Ó¾ø ¿¡¼ø 
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Oil spreads like a snake - Vatha neer 
Oil spreads like a ring - Pitha neer 
Oil remaining and floating like a pearl - Kaba neer 
 
Neikkuri in Pandu noi: 
"Å¢¨Ã×¼ý ¸¾¢÷§À¡ø ¿£ñÎ §ÅüÚ¨Áì Ì½í¸û ¸ñ¼¡ø 
ÌÕ¾¢¾¡ý ¦¸ðÎ ¿¡ºõ ÌýÈ¢ Ì½Á¦¾ý§É" 
-§¿¡ö ¿¡¼ø §¿¡ö Ó¾ø ¿¡¼ø 
If the oil spreads like a kathir (ray) it indicates Pandu noi. 
 
ROLE OF MUKKUTRAM IN PANDU: 
Vatham : Its mathirai alavu is 1 mathirai. 
Location of vatham in the body: Vatham is located in the abanan, faeces, idakalai, 
spermatic cord, pelvic bone, skin, nerves, joints, hair and muscles. 
 
Ten forms of Vatham: 
 
1. Pranan (Uyirkaal) : It resides in the heart and legs to nose and controls knowledge, 
mind and five objects of sense, useful for breathing. In PithaPandu noi, dysnoea is present, 
if pranan is affected. 
 
2. Abanan (Keezh nokkukaal) : 
It is located in the lower abdomen and extremities. It is responsible for excretion of 
urine, stools, ejaculation of sperm and menstrual flow. In PithaPandunoi, diarrhoea, 
oliguria, ammenorohoea or oligomennorohoea are present, when abanan is affected. 
 
3. Viyanan (Paravukaal) : 
It resides mainly at the heart and responsible for movements of the body and 
sensation. In PithaPandu noi, swelling of the body, pallor of eyes and lips, numbness 
are present due to the affection of viyanan. 
 
4. Samanan (Nadukkaal) : 
It is located in the stomach, helps for proper digestion and balances the above four 
vaayus in equillibirium. In PithaPandu noi, anorexia and any of the above four vaayus 
affection are present when samanan is affected. 
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5. Uthanan (Melnokkukaal) : 
It is located in the chest and responsible for vomiting, cough and sneezing reflexes. 
In PithaPandu noi, excessive thirst is present due to the affection of uthanan. 
 
6. Naagan : 
It resides in the eyes and is responsible for opening and closing of the eyelids and 
intelligence. 
 
7. Koorman : 
 
 It is located in the eyes. It causes wrinkling of the eyelids, yawning and closure of 
mouth. It gives strength and helps to visualize things and causes lacrimal secretion. In 
PithaPandu noi, blurred vision is present when koorman is affected. 
 
8. Kirukaran : 
It is located in the throat and responsible for salivation, nasal secretion and appetite. In 
PithaPandu, anorexia and dryness of mouth are present when kirukaran is affected. 
 
9. Devathathan : 
Its location is at eruvai and karuvai. It is responsible for laziness, sleep and anger. 
In PithaPandu, fatigue and insomnia are present when devathathan is affected. 
 
10. Dhananjeyan : 
It resides in the nose and escapes on the third day after death by bursting out of the 
cranium. 
 
Pitham : 
Its mathirai alavu is ½mathirai 
 
Five forms of pitham: 
1. Anala pitham :  
This gives appetite and helps for digestion. In Pitha Pandu, loss of appetite is present when 
it is affected. 
 
2. Ranjagam : 
It gives colour to the blood. In Pitha Pandu, pallor of conjunctiva and skin are 
present when it is affected. 
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3. Saathagam :  
It controls the entire body functions responsible for the activities of the body In Pithapandu, 
inability to do the works properly and  sluggishness are presentwhen it is affected. 
 
4. Alosagam : 
This gives brightness to the eyes. 
In Pitha Pandu, dull vision is present if alosagam is affected. 
 
5. Prasagam : 
It gives complexion to the skin. 
In Pitha pandu, altered skin lusture is presentwhen it is affected. 
 
Kabam : 
Its mathirai alavu is ¼mathirai. 
 
Location of Kabam in the body: 
Kabam is located in Samanavayu, Sperm, Head, Tongue, Vulva, Fat tissue, Bone 
marrow, Blood, Nose, Chest, Nerve, Bone, Brain, Eyes and Joints. 
 
Five forms of Kabam: 
1. Avalambagam : 
It controls heart, lungs and supports other forms of kabam 
In PithaPandu, dyspnoea is present when it is affected. 
 
2. Kilethagam : 
It makes the food wet and helps for digestion. 
In Pitha Pandu, indigestionis present when it is affected. 
 
3. Pothagam : 
It is responsible for taste. 
In Pitha Pandu, bitter or pungent taste is presentwhen it is affected. 
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4. Tharpagam : 
It keeps the eyes cool. 
In PithaPandu, burning sensation of eye is present when it is affected. 
 
5. Santhigam : 
It is responsible for the lubrication and aids free movements of joints. 
 
Paruvakaalam (Season): 
The whole year is divided into six seasons, they are as follows; 
1. Kaar kaalam - Avani and Puratasi   -  Aug 16 to Oct 15 
2. Koothir kaalam - Ayppasi and Karthigai  -  Oct 16 to Dec 15 
3. Munpani kaalam - Markazhi and Thai  -  Dec 16 to Feb 15 
4. Pinpani kaalam - Maasi and Panguni  -  Feb 16 to Apr 15 
5. Ilavenil kaalam - Chithirai and Vaigasi  -  Apr 16 to June15 
6. Mudhuvenil kaalam - Aani and Aadi  -  June 16 toAug15 
 
Seasonal influence of earth, Water bodies, Flora and Fauna will have its impact in 
human beings,  physiology inturn make them susceptible to certain specific diseases which 
are common in that season. 
 
Physiological alterations of Mukkutram; 
 
 
 
Thannilai Valarchi: 
Definition : 
Provoked kutram in its own locations is called Thannilai Valarchi.It can be 
perceived byhatefulness of the things, which are causing Thannilai Valarchi and likeliness 
of the things which are possessing opposite properties. 
 
Mukkutram Thannilai valarchi Vetrunilai valarchi Thannilai Adaithal 
Vatham Muthuvenil kalam Kaarkaalam Koothirkalam 
Pitham Kaarkaalam Koothirkaalam Munpani kaalam 
Kabam Pinpani kaalam Ilavenil kaalam Muthuvenil kaalam 
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Season: 
 Pitham gets Thannilai Valarchi during Kaarkaalam . 
 
Vetrunilai Valarchi: 
Definition :  
Provoked kutram to other locations is called Vetrunilai Valarchi.It can be perceived bysigns 
and symptoms of the affected kutram and the pathological conditions of the udal thathukkal. 
 
Season : 
Pitham gets Vetrunilai Valarchi during Koothirkaalam . 
 
Thannilai Adaithal: 
Definition:  
Provoked kutram neutralizing its own property is called Thannilai adaithal. 
 
Season: Provoked pitham neutralizes during Munpani kaalam . 
 
Nilam: 
1. Kurinji  -  Hill region and its surroundings 
2. Mullai  -  Forest region and its surroundings 
3. Marutham  -  Cultivating region and its surroundings 
4. Neithal  -  Coastal region and its surroundings 
5. Palai  -  Desert region and its surroundings increased chance to acquire Pithapandu  
      noi. 
Udal Kattugal: 
Our body consists of seven udal kattugal. It gives strength to the body 
1. Saaram  -  It gives strength to the body and mind. 
2. Senneer  -  It is responsible for knowledge, strength, boldness and healthy 
      complexion. 
3. Oon  -  Gives structure and shape to the body and is responsible for the movement 
      of the body. 
4. Kozhuppu  -  Lubricates the organs and proceeds on its own works. 
5. Enbu  -  Protects vital organs and is useful for movements. 
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6. Moolai  -   Present inside the bones and it gives strength and maintains the normal  
         conditions of the bone. 
7. Venneer  -  Responsible for the propagation of species. 
 
In PithaPandu, 
 
 If Saaram is affected , fatigue, dyspnoea and tiredness are present. 
 If Senneer is affected ,pallor of skin and conjunctiva are present. 
 If Oon is affected, swelling of the body is present. 
 If Suronitham is affected , ammenorrhoea / oligomenorrhoea is present. 
 If Sukkilam is affected, sluggishness in sexual life is present. 
 
PROGNOSIS OF PANDU: 
Curable and Incurable Types: 
 
According to Siddha Maruthuvam,  
The possibilities of cure for Nanju Veluppu noi are rare. 
All other types of Veluppunoi are curable. 
Eventhough, if any of the following symptoms or diseases like vomiting, diarrhoea, 
odema, thirst, diabetes, tuberculosis gets associated in the above said four Veluppu 
noi, then it is not curable easily. 
 
Kannusamiyam states that; 
           "¦ÅôÒ À¢½¢Â¾É¢ø ¦Åõ §Á¸ò¾¡ø ÅÕó¾¢ý 
            ¾ôÒ Á¢¨¸ ¿£§Ã ¾¡É¢Èí¸¢ó ¦ºôÒõ 
            ¸¢Ã¡½¢Â¢ü À¡ñÊø¸¢Ç÷ ¿£÷ÍÕí¸¢ü 
            À¢Ã¡½ý À¢Ã¢Ô¦ÁÉ §ÀÍ." 
            "À¡ñÎ À¢Ã§Á¸õ ÀýÅ¡¾ Ý¨Ä ÌýÁõ 
            §Åñ¼¡ ºÂïºýÉ¢ ¦Åñ§º¡¨À-¿£ñ¼ 
            «¾¢¿£§Ã ¸¡Á¡¨Ä Â¡ÉÀ¢½¢ ¾õÓ 
            Ç¾¢ º¡ÃÁ¡ ¸¡¾È¢." 
            "¦º¡øÖ À¢ò¾¾¢ü §º¡¨À §º¡¨À¾É¢ø Å¡Ô ¦¾¡ó¾õ 
             ÅøÄÅ¾¢ü À¡ñÎÅý À¡ñÊø - ¿øÄ 
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             ÅÂ¢üÚì ¸ÎôÒ ÅÇ÷ ¸ÎôÀ¢ü º£¾õ 
             ÀÂ¢Ä¢ü ¦¸Î¾¢ ¦ÂÉôÀÉ" 
                              - ¸ñÏº¡Á¢Âõ. 
According to Sarabendrar Vaidhya Muraigal: 
 
a) The Pandu noi, which is chronic in nature, is not treatable. 
a) b) In acute stage, odema with yellowish discolouration,which is not curable. 
b) Constipation or greenish dysentery, if occurs also is not curable. 
c) Extreme pallorness of teeth, nail and eyes and the vision to every object seems to be 
d) whitish is not curable. 
e) Emaciation of the Pandu noi persons, with odema present in head, upperlimb and 
f) lower limb, swelling of the external genetalia, inguinal region, frequent fainting, 
g) diarrhoea and fever in pandu noi is not curable. 
 
According to Sadhaga Naadi, 
                ¾¡É¡É À¢Ã§Á¸õ Å¡¾ Ý¨Ä 
                º¡÷Å¡É ¿£Ã¢Æ¢× ÌýÁ§Ã¡¸õ 
                Á¡É¡É ºÂ§Ã¡¸í ºýÉ¢§¾¡¼õ 
                ÂÎò¾ Å¢¼í¸¡Á¡¨Ä À¡ñÎ §º¡¨¸ 
                Á¡§É §¸û ¸À§Ã¡¸ Áó¾¢Ã Å¢Â¡¾¢ 
                Áïºû §¿¡ö Ì¨Ä§¿¡× ÀÂ¢ò¾¢Â§Ã¡¸õ 
                °É¡Ìõ ÅÕÁ¢¼ò¾¢ø Â¾¢º¡Ãí¸û 
                ¯ñ¼¡¸¢Â º¡ò¾¢ÂÁ¡ ÓÚ¾¢ ¾¡§É." 
            - º¾¸ ¿¡Ê 
 
According to Agathiya Vaithiya Pillai Tamil, 
In pandu noi persons, edema, laziness, thrist, anorexia, vomiting, hiccough, cough, diarrhea 
are the symptoms appears and after that the vision to every object to be yellow is not 
curable. 
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According to Agathiyar gunavagadam, 
                  ¾¡É¡É «º¡ò¾¢Âò¾¢ý À¡ñÊ §É÷¨Á 
                  ¾¡ÉÈ¢Âî ¦º¡øÖ¸¢§Èý ¾Ã½¢ §Â¡÷ìÌ 
                  °É¡É §¾¸ò¾¢ø þÕÁø §À¾¢ 
                  ¯Ú¾¢Â¡ö Å¡ó¾¢Ô¼ý Å¢ì¸ø ¸¡Ïõ 
                  §¾É¡É §¾¡üÈÁ¼¡ Áïºû ¸¡ðÎõ 
                  ¦¾Ç¢Å¡É ¿¸ì¸ñ¸Ù Áïº Ç¡¸¢ 
                  Å£½¡¸ô §À¡ÌÁ¼¡ ÁÕóÐ ¦ºö¾¡ø 
                  Å¢ñÏÄ¸¢ü ¦ºø¦ÅýÀ¡÷ Å¢¾¢¾£÷ó ¾¡§É‛ 
Cough, Vomiting, Diarrhoea and yellow colour appear in eyes, nails and all over the 
body in pandu noi is not curable 
 
NOI NEEKKAM (TREATMENT): 
 
The speciality of Siddha treatment emphasise not only for complete healing but also 
for the prevention and rejuvenation. This is said as follows, 
 
Kappu  (Prevention) 
Neekkam  (Treatment) 
Niraivu  (Restoration) 
 
Siddha system has stated that even during the time of conception, some defects 
creep into the fertilized embryo. These defects form the basis of the manifestation of certain 
constitutional disease later on during the existence of the individual. Diseases are produced 
by the unequillibrium of three thathus, which may be due to various causes like diet, life 
style pattern, mental and physical activities. When treating the disease the following 
principles must be noted. 
 
          "§¿¡ö ¿¡Ê §¿¡öÓ¾ø ¿¡ÊÂÐ ¾½¢ìÌõ 
           Å¡ö¿¡Ê ÅöôÀî ¦ºÂø" 
          "¯üÈ¡ ÉÇ×õ À¢½¢ÂÇ×õ ¸¡ÄÓõ 
           ¸üÈ¡ý ¸Õ¾¢ ¦ºÂø" 
                                     - ¾¢ÕìÌÈû 
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So, it is essential to know about the disease and the Cause for the onset of disease, body 
constituent of the patient, severity and chronicity of the illness, the season and the time 
of onset of the disease must be observed. 
 
Line of Treatment of Pandu: 
The aim is to normalize the vitiated Mukkutram, Vayus and the affected Saram and Senneer 
thathu. Before starting the actual treatment, the presence of toxins in the body produced due 
to derangement of three thathus should be controlled. This is explained as follows. 
 
             "ºò¾¢Â¡ø À¢ò¾ó ¾¡Øõ" 
             "§À¾¢Â¡ø Å¡¾ó ¾¡Øõ" 
             "«ïºÉò¾¡ø ¸Àó ¾¡Øõ" 
-º¢ò¾ ÁÕòÐÅ¡í ¸ ÍÕì¸õ 
  
Usually for pitha diseases, emetics are given to restorethe deranged Pitham. But 
there are some exceptions to this rule. For instance, in Pandu noi, since the patient is already 
weak and drowsy, the administration of emetic medicine is excluded from the line of 
treatment. As per Siddha Maruthuvam, the line of treatment includes: 
 
1. Mild laxatives can be administrated to neutralize the deranged thaathus. 
2. To improve haemoglobin content of blood, iron preparations are used. 
3. Pathiyam ie, diet restrictions are advised to normalize the affected thathu. 
 
TREATMENT: 
Agasthiyar Kuzhambu in 200 mg  was administered at early morning in empty 
stomach for one day only before the start of the treatment, for mild laxative purpose 
and for normalizing the deranged Pitha thaathu. 
From next day onwards, the trial drug Chitramutti  Nei (4ml)  was administered twice a 
day with milk, before food for Pitha pandu. 
 
DIET : 
           "Á¡ÚÀ¡ ÊøÄ¡ ¯ñÊ ÁÚòÐñ½¢ý 
            °ÚÀ¡ Êø¨ÄÔ Â¢÷ìÌ" 
                              -¾¢ÕìÌÈû. 
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Diet regimen for Pandu Noi : 
Diet should be of 
 
1. Stimulating appetite 
2. Strengthening the body 
3. Easily digestable should be taken. 
 
 For Pandu noi, the following food items are advised. Easily digestible foods like 
porridge, mutton soup, and bone soup must be given in acute stages of Pandu noi. 
 Tender brinjal, tender country bean, pepper, garlic, anise seed, ginger, onion green 
Peas, bengal gram, vegetable soups are advised to consume in diet. 
 After the normal appetite is restored properly, prepared meat of Kaadai[quail], 
Udumbu[Monitor] can also be given. They tone up the deblitated system and also help 
 in rejuvenation. 
 Tamarind, tea, coffee, betel chewing, tobacco chewing and alcohol are advised to avoid 
as they prevent absoption of the drug. 
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MODERN ASPECT 
 
The blood is the most precious fluid in the body. It is also considered as fluid of 
growth, fluid of health. Blood is one of the extracellular body fluids. Blood contains iron in 
the form of Haemoglobin and also as cytochromes etc. Any form of iron deficiency cause 
anaemia. 
 
BLOOD:  
Blood is a complex fluid which circulates rapidly in the vascular system. 
 
Composition of Blood: 
Blood consist of a solid portion and a fluid portion. The solid portion constitutes the 
blood cells namely RBC, WBC, and platelets and the fluid portion is plasma. The cells form 
45% and the plasma forms 55% of the total volume of the blood. 
 
FUNCTIONS OF BLOOD 
 
1) Transport of hormones and enzymes: 
 The hormones and some of the enzymes arecarried by blood to different parts of the 
body from the source of secretion. 
 
2) Excretory Function:  
Waste products formed during various metabolic reactions in the tissues are 
removed by the blood and carried to the excretory organs like kidney, skin, liver etc., 
 
3)Nutrient Function:  
Nutritive substances like glucose, amino acids, lipids and vitamins derived from digested 
food are absorbed from gastro intestinal tract and carried by blood to different parts of the 
body for growth and production of energy.  
 
4) Regulation of body temperature: 
 
  Because of high specific heat of blood, it is responsible for maintaining the 
hermoregulatory mechanism in the body i.e., the balance between heat loss and heat gain in 
the body. 
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5) Respiratory Function: 
 Transport of respiratory gases is done by the blood. Blood conveys oxygen from the 
alveoli of lungs to the tissues for the oxidation of food and production of energy. The 
carbon-di-oxide formed in the tissues as a result of this process is carried to the lungs, 
where it is exhaled. 
 
6) Defensive Function:  
 
Blood has WBCs, Gamma globulins which have phagocytic action. They also 
transport protective subtances such has anti-bodies, anti-toxins and lysins. 
 
7) Storage Function:  
 
Water and some important substances like protein, glucose, sodium and potassium 
are constantly required by the tissue. Blood serves as a readymade source for these 
substances and these substances are taken from the blood during conditions like starvation, 
fluid loss, and electrolyte loss. 
 
8) Regulation of acid – base balance:  
The plasma proteins and haemoglobin acts as buffer and helps in the regulation of acid-base 
balance. 
9) Regulation of water balance: 
 
 Blood maintains the water content of the tissues and helps in the regulation of fluid 
in different compartments of the body. 
 
10)  Regulation of osmotic pressure:  
The plasma proteins play the major role in regulating the osmotic pressure of tissue 
fluids. 
 
11) Defensive Function: 
  Blood has WBCs, Gamma globulins which have phagocytic action. They also 
transport protective subtances such has anti-bodies, anti-toxins and lysins. 
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12) Storage Function:  
 
Water and some important substances like protein, glucose, sodium and potassium 
are constantly required by the tissue. Blood serves as a readymade source for these 
substances and these substances are taken from the blood during conditions like starvation, 
fluid loss, and electrolyte loss. 
 
Erythropoiesis: 
 
 
  
Erythropoiesis is the process by which the origin, development and maturation of 
erythrocytes occur. In the bone marrow, there are cells called uncommitted pluripotent 
hemopoietic stem cells because these cells are not designed to form a particular type of 
blood cell. When these cells are designed to form a particular type, the stem cells are called 
committed pluripotent hemopoietic stem cells.  
 
Sites of Erythropoiesis 
In the early few weeks of embryonic life - yolk sac 
 During the middle trimester of gestation - Liver, Spleen, lymphoid organ 
 Later part of gestation and after birth - Red bone marrow and liver 
 Up to the age of 5 - Red bone marrow of all the bones 
 After the age of 5 to adult - Red bone marrow of long bones and flat bones 
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Stages of Erythropoiesis 
 
Stage I – Pro erythroblast (Megaloblast)  
 
This early cell is large (15-20) µ. The cytoplasm is basophilic staining with a deep 
violet blue and there is a pale-staining crescent near the nucleus and the cell contains no 
haemoglobin. The nucleus is about 12µ and occupies about three quarters of the cell volume 
and the chromatin forms a fine stippled reticulum. 
 
Stage II – EarlyNormoblast (Early erythroblast) 
 
This cell is smaller than pro erythroblast diameter 15µ. It shows active mitosis. The 
nucleoli have disappeared. Condensation of chromatin network occurs. The cytoplasm is 
basophilic. So this cell is also called basophilic erythroblast. 
 
Stage III – IntermediateNormoblast (Late erythroblast) 
 
This cell is smaller (10-15) µ and shows active mitosis. Nucleus is still present. 
Chromatin network shows further condensation. Haemoglobin begins to appear and its 
eosinophilicstaining give the cytoplasm a polychromatic appearance. 
 
 
Stage IV – LateNormoblast (Normoblast)  
 
Mitosis has now ceased and the diameter of the cell is 8 – 10 µ. The nucleus becomes 
very smaller and the condensed chromatin assumes a “cart wheel” appearance or ink spot 
and finally becomes deeply stained in a uniform manner. Quantity of haemoglobin 
increases. Cytoplasm becomes almost acidophilic. So the cell is called Orthochromic 
erythroblast. In this cell, the nucleus disintegrates and disappears. The process is called 
pyknosis. 
 
Stage V – Reticulocyte  
 
It is slightly larger than matured red blood cells. Cytoplasm contains reticular network. 
It is basophilic in nature. During this stage, the cells enter the blood through the capillary 
membrane by means of a process called diapedesis. 
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Matured Erythrocyte 
 
Reticular network disappears. Matured red blood cell is biconcave; smaller in size; 
diameter of 7.2 microns. It is with haemoglobin and without nucleus. It takes 5 days for the 
development of reticulocyte from proerythroblast. The reticulocyte takes two more days to 
become matured red blood cells. 
 
FACTORS NECESSARY FOR ERYTHROPOIESIS: 
 
I.General factors 
ii.Maturation factors 
iii.Factors necessary for haemoglobin formation 
 
I.GENERAL FACTORS: 
 
a ) Erythropoietin: 
 
The most important general factor for erythropoiesis is the hormone erythropoietin . It 
is also called haemopoietin or erythrocyte stimulating factor. 
 
Source of Secretion: 
Erythropoietin is secreted by peritubular capillaries of kidney. 
 
Stimulant for Secretion: 
 Hypoxia is the stimulant for the secretion of erythropoietin.  
 
Actions of Erythropoietin : 
 
 Erythropoietin causes formation and release of new RBCs into circulation.After 
secretion ,it takes 4 to 5 days to show the action.  
i. Production of proerythroblasts from the stem cells in CFU-E of bone marrow. 
ii. Developmentofproerythroblasts into matured RBCs.  
iii. Release of matured erythrocytes into blood. 
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b) Thyroxine: 
 
 General metabolic hormone thyroxine accelerates the process of erythropoiesis at 
many levels. 
 
c)  Haemopoietic Growth Factors: 
 Haemopoietic growth factors are the interleukins.This factors induce the proliferation 
of pluripotent stem cells. 
 
d ) Vitamins: 
  
Vitamins are necessary for erythropoiesis ;Which is vitamin B,C,D,E. 
 
HAEMOGLOBIN: 
1) Haemoglobin is the colouring matter of red blood cell. It is a chromoprotein forming 
95% of dry weight of red blood cell and 30 to 34% of wet weight.  
2) The function of haemoglobin is to carry the respiratory gases,oxygen and carbon 
dioxide. 
3) The molecular weight of haemoglobin is 68,000. 
 
STRUCTURE OF HAEMOGLOBIN: 
 
Haemoglobin is a conjugated protein. It consist of a protein combined with an iron 
containing pigment. The protein part is globin and the iron containing pigment is heme. 
 
 IRON:  
It is present in ferrous (fe++) form. It is in unstable or loose form. Under certain 
conditions, the iron may be present in ferric (fe++) state,which is a stable form. 
 
PORPHYRIN: 
 
 The pigment part is called porphrin.This is formed by four pyrrole rings called I, II, 
III and IV.Thesepyrrole rings are attached to one another by methane (ch4)bridges. The iron 
is attached to N-of each pyrrole ring and N-of globin molecule. 41 
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GLOBIN:  
This contains four polypeptide chains. Among the four polypeptide chains,two are alpha 
chains and two are beta chains. 
 
Varieties of haemoglobin:  
Haemoglobin is of two types namely. 1. Adult haemoglobin – HbA 2. Fetal 
haemoglobin – HbF 
 
Blood Indices: 
 
Blood indices are specifically meant for erythrocytes. The number, shape, volume 
and colour of the red blood cells indicate the quality of blood. So these features are named 
as blood indices. 
 
Importance of Blood indices:  
Blood indices have got diagnostic value in determining the type of anaemia. 
 
 
Different Blood Indices: 
1. Mean corpuscular Volume (MCV)  
2. Mean corpuscular haemoglobin (MCH)  
3. Mean corpuscular haemoglobin concentration (MCHC) 
 4. Colour Index (CI)  
 
1. Mean corpuscular Volume (MCV):  
Mean corpuscular Volume is the average volume of single red blood cells and it is 
expressed in cubic microns (cu.µ).  
 
2. Mean corpuscular haemoglobin (MCH): 
 Mean corpuscular haemoglobin is the quantity or amount of haemoglobin present in one 
red blood cell. It is expressed in micro gram or pico gram (pg). 
 
3. Mean corpuscular haemoglobin concentration (MCHC): This is the concentration of 
haemoglobin in one red blood cell. It is the amount of haemoglobin expressed in relation to 
volume of one red blood cell. So the unit of expression is percentage. 
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4. Colour Index (CI): 
This is the ratio between the percentage of the haemoglobin and the percentage of 
red blood cells in the blood.  All the above mentioned blood indices are reduced in iron 
deficiency anaemia. 
 
Normal values: 
   PCV:Women 35 - 48%; Men 36 - 51% 
   MCV: 78-98 fl 
   MCH: 26-34 picograms 
   MCHC: 31 -37 gm /dl  
 
IRON:  
Iron is an essential constituent of haemoglobin, myoglobin, cytochromes and other 
components of respiratory enzymes like cytochrome oxidase, catalase and peroxidase. The 
main functions of iron are, Transport of oxygen to the tissues.  Iron is necessary for electron 
transport oxidative phosphorylation.  Peroxidase,lysosomal enzyme is required for 
phagocytosis and killing of bacteria by neutrophils. Iron is associated with effective 
immune competence of the body. 
 
Daily Iron Requirements in different age groups: 
 
Pregnant and lactating female   - 40 mg/day 
Females 11 years to 30 years   - 18 mg/day  
Adult‟s male     - 10 mg/day 
 Males 11 years to 17 years   - 12 mg/day  
Upto 10 years (M/F)    - 10 mg/day 
 
Iron sources: 
Rich Sources:  
 
Muscle meat (Red more than white), Organ meat (Liver, heart, kidney),  Beef 
liver,Red meat not only supplies a good amount of iron it also increases absorption of iron 
from other food sources 
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Good Source:  
Greens,  Leafyvegetables,  Nuts, Cereals, Wheatgerms, Fish, Shellfish, Poultry, Egg, 
Apples and dry fruits, Jaggery, Yeast, Molasses, Oysters, Spinach, Banana, Pomegrannate. 
 
Poor Sources:  
Wheat and Polished rice. 
 
Distribution of iron in the body: 
 
Total quantity of iron in the body averages 4 - 5 gm of total body weight.  
Iron is distributed in the body as follows;  
 
 Haemoglobin – present in red cells contain most of the body iron (65%)  
 Myoglobin – comprises a small amount of iron in the muscles (4%)  
 Haem and non-haem enzymes – eg cytochrome catalase, peroxidase, succinic 
dehydrogenase and flavoproteins constitute a fraction of total body iron (0.5%)  
 Transferrin bound iron – circulates in the plasma and constitutes another fraction of 
total body iron (0.5%). (All these forms of iron are in functional form) 
 Ferritin and haemosiderin – are the storage form of excess iron (30%). They are stored 
in the mononuclear phagocytic cells of the spleen, liver,bone marrow and in 
parenchymal cells of the liver. 
 
Factors affecting iron Absorption: 
 
  Acidity, ascorbic acid and cysteine enhance iron absorption. 
  In Iron deficiency anaemia iron absorption is increased to 2 to 10 times that of Normal. 
  Small peptides and amino acids favour iron absorption.Phytate and oxalate (found in      
      leafy vegetables) interfere with iron absorption. 
  Food additives (EDTA) and antacids reduce iron absorption. 
  A diet with high phosphate which are found in soft drinks, beer, ice cream, Candy bar   
     decreases iron absorption 
 Smoking and alcohol interferes with iron absorption. 
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 Impaired absorption of iron is observed in malabsorption syndrome such as Steatorrhoea. 
 In patients with partial or total surgical removal of stomach, iron absorption is Severely      
     impaired. 
 
Blood iron buffer as well as iron storage medium. Hemosiderin is another iron storage 
protein and this is insoluble form.  
 
ANAEMIA 
 
 
DEFINITION:  
Anaemia is defined as a reduction of the red blood cell volume or haemoglobin 
concentration below the range of values occurring in healthy persons. 
 
WHO criteria for diagnosis of Anaemia  
Adult women   11-15gms% 
 Adult men   14-18gms% 
Children   6 years-14 years  
Children 6 months  6 years Less than 11gms% 
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CLASSIFICATION: 
A. Based on Production/destruction of RBC 
1)   Decreased or ineffective production of red blood cells or haemoglobin.  
2)   Increased destruction or loss of red blood cells. 
 
1) Anaemia resulting primarily from inadequate production: 
i.  Marrow failure 
   Aplastic anaemia: Congenital,Acquired. 
    Decreased number of red blood cell precursor: Congenital,Acquired. 
    Marrow replacement:Malignancies,Osteopetrosis,Storage disorders.  
 
ii. Deficiency of Specific Factors 
a. Megaloblastic anaemia: 
   Folic acid deficiency or malabsorption. 
    B12 deficiency or malabsorption. 
 
b. Microcytic anaemia: 
  Iron deficiency. 
 Copper deficiency. 
  Lead poisoning 
 
iii. Impaired Erythropoietin Production 
  Chronic renal disease. 
  Hypothyroidism, Hypopituitarism. 
  Chronic inflammation, infection. 
  Malignancy. 
  Protein malnutrition 
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2) Anaemia resulting primarily from rapid destruction: 
I. Blood Loss: Acute haemorrhage, chronic haemorrhage. 
 
II. Haemolytic Anaemia 
a. Intrinsic Defects [Intrinsic abnormalities] 
  Membrane Defects : Hereditary spherocytosis, Elliptocytosis. 
  Enzyme Defects: 1. Enzyme of glycolytic pathway 2. Enzyme of the pentose phosphate      
      pathway 
  Defects in synthesis of haemoglobin: Hb S, C, D, E 
 
b. Extrinsic abnormalities 
   Immunologic disorders 1. Rh iso immunization   2.A (or) B iso immunization 3. Other   
      minor Blood group incompatibilities 
  Active antibody formation  
 
B. Morphological classification : 
Based on the red cell size, haemoglobin content and red cell indices anaemia are classified 
as follows 1. Microcytic Hypochromic anaemia 
 
  Iron deficiency 
   Thalassemia 
  Haemoglobinopathies 
   Haemolytic anaemia. 
 
2. Normocytic normochromic anaemia 
  Aplastic anaemia 
 
 3. Macrocytic normochromic anaemia 
Folate and vitamin B12 deficiency 
 Hypothyroidism 
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4. Macrocytic hypochromic anaemia 
 Combined deficiency of iron and folate or Vitamin B12 
 
Microcytic anaemia :  
 
The size of red cells is smaller than normal and colour index less than one. The 
mean orpuscular volume is less than its normal range (76-96 cubic microns). 
 
Causes of Microcytic anaemia:  
Inadequate intake of iron, defective absorption of iron, idiopathic hypochromic 
anaemia, starvation, dietary deficiency, anaemia of milk fed children. Excessive need of 
iron during growth, pregnancy Chronic haemorrhages Inadequate utilization of haematinics 
– myxoedema, chronic sepsis, chronicrenal diseases. 
 
Macrocytic anaemia: 
 
The red cells are bigger than normal and the colour index is above one. The mean 
orpuscular volume is more than its normal range (76-96 cubic microns). 
 
Causes of Macrocytic anaemia: 
 Deficiency of the Extrinsic factors, Nutritional anaemias, Pellagra. Absence of Intrinsic 
factor, Total gastrectomy Cirrhosis of liver Megaloblastic anaemia,Hypoblastic anaemia. 
 
Normocytic Anaemia: 
  The size of the red cells is more or less than the normal size. The colour index is less 
than the normal range and the mean corpuscular volume is 76 to 96 cubic microns. 
 
Causes of Normocytic anaemia:  
Acute hemorrhage Haemolytic anaemias Blood destruction by metals, Protozoa, 
Haemolysis Leukemia, Hodgkin‟s disease, Drug poisoning 
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B. Based on Etiopathogenesis: 
1. Nutritional Anaemias: 
Iron deficiency anaemia, Folic acid, VitaminB12,  Vitamin C,  Pyridoxine,  Thyroxine 
deficiency anaemias. 
 
2. Haemolytic Anaemias: 
Congenital  -  Thalassemia, Sickle cell anaemia, Hereditary spherocytosis, G-6-PD  
Deficiency 
Acquired  -  Malaria, Kala azar, Rh or ABO incompatibility 
 
3. Haemorrhagic Anaemias: 
Acute   -  Trauma, Epistaxis 
Chronic -  Hookworm, Scurvy, Chronic dysentery, Oesophageal varices 
 
4.Anaemia due to Bone marrow depression: 
 
Primary  -  Hypoplasia or Aplasia, Fanconi‟s Anaemia 
Secondary  -  Infections, Irradiatio 
Congenital  -  Thalassemia, Sickle cell anaemia, Hereditary spherocytosis, G-6-PD  
   deficiency 
Acquired  -  Malaria, Kala azar, Rh or ABO incompatibility 
 
3. Haemorrhagic Anaemias: 
Acute   -  Trauma, Epistaxis 
Chronic -  Hookworm, Scurvy, Chronic dysentery, Oesophageal varices 
 
4. Anaemia due to Bone marrow depression: 
Primary  -  Hypoplasia or Aplasia, Fanconi‟s Anaemia 
Secondary  -  Infections, Irradiation  
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5. Anaemia due to Infections: 
Acute   -  Fulminating osteomyelitis, Septicaemia 
Chronic  -  Tuberculosis, Rheumatic fever, Sub acute bacterial Endocarditis  
   Wound infections, Congenital syphilis 
 
6. Other Miscellaneous Conditions:  
Chronic amoebic dysentery repeated bouts of diarrhea. 
 
CLINICAL FEATURES OF ANAEMIA: 
 The haemoglobin level at which symptoms and signs of anaemia develops depends 
upon 4 main factors. 
 
1. The Speed of onset of anaemia:  
Rapidly progressive anaemia causes more symptoms than anaemia of slow onset, as 
there is less time for physiological adaptation.  
 
2. The Severity of Anaemia:  
Mild anaemia produces no symptoms or sign, but a rapidly developing severe 
anaemia (haemoglobin below 6 gm) may produce significant clinical features 
 
3. The age of the patient: 
 The young patient due to good cardiovascular compensation tolerates anaemia quite 
well as compared to the elderly.  
 
4. The haemoglobin dissociation:  
In anaemia, the affinity of haemoglobin for oxygen is depressed. As a result oxy 
haemoglobin is dissociated more readily to release free oxygen for cellular use. 
 
IRON DEFICIENCY ANAEMIA (IDA) 
 
 Iron deficiency is the most common and widespread nutritional disorder in the 
world. Iron deficiency is the most common single cause of anemia worldwide, accounting 
for about half of all anemiacases. Globally, the World Health Organization (WHO) 
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estimates that 25% of the population (1.62 billion people) has anemia . Preschool children 
47.4% and pregnant women 41.8% have the highest prevalence overall. Africa (67.6 and 
57.1%) and Southeast Asia (65.5 and 48.2%) have the highest burden of anemia in 
preschool children and pregnant women, respectively . It is more common in women than 
men. About 20% of all women of child bearing age have iron-deficiency anemia, compared 
with only 3% of adult men. The principal cause of iron-deficiency anemia in these countries 
is blood lost during mensus in premenopausal women and not compensated by intake from 
food and supplements. Nutritional Anemia – major public health problem worldwide 
particularly in developing countries among women of reproductive age. As per National 
Family Health survey[MARCH 2015], more than half of women in India (55%) have 
anemia, including 39% with mild anemia, 15% with moderate anemia and 2% with severe 
anemia. Nearly 50 – 80% of Indian mothers suffer from anemia due to iron – deficiency in 
their diet. Maternal anemia invariable translates into anemic infants and newborns. About 
30- 40 percent of newborn suffer from low birth weight due to maternal anemia and 
malnutrition. The cause of IDA in India is due to poverty, malnutrition, untreated illness, 
hook worm infestation; socio-ecnomicproblems.Various programmes are launched by 
Indian government to eradicate iron deficiency anaemia. Iron deficiency and anaemia 
reduce the work capacity of individuals and entire populations, bringing serious economic 
consequences and obstacles to national development.  
 
STRUCTURES OF THE RED CORPUSCLES IN IRON DEFICIENCY ANEMIA: 
 
 In iron deficiency anaemia, the red blood corpuscles are decreased or normal in the 
number and haemoglobin content of the red blood corpuscles is reduced. In the blood 
smear, the red cells appear pale with a large central pale area and many of the red blood 
cells appear to be smaller than the normal. This type of anemia is called “Hypochromic and 
Microcyticanemia”. 
 
Etiology: 
The etiology varies with the age, sex, and country of residence of the patient. 
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Etiological factors in iron deficiency Anaemia:  
     Increased physiological requirements: Rapid growth in Infant and preadolescence, 
Menstruation, Pregnancy. 
 
Decreased iron assimilation: 
Iron poor diet, Iron malabsorptionSprue, non tropicalsprue, Pica ,GIsurgery,Chronic 
diarrhoea, Malnutrition. 
 
Blood Loss : 
 
  Gastro intestinal bleeding, Peptic ulcer disease, Inflammatory Boweldisease, 
Meckel‟s diverticulum, Drugs-Salicylates, antibiotics etc.,Hook worm infestation, 
Haemoglobinuria, prosthetic heartvalve, Intense exercise, Bleeding diasthesis, Repeated 
venous sampling. 
 
Increased demands: 
 
Prematurity, Adolescence, Pregnancy 
 
Iron Poor Diet: 
 Dietary inadequacy is present in more than 80 percent of cases especially in the poorer 
groups.  
 
IRON MALABSORPTION: 
 
 Iron malabsorbtion is an unusual cause of iron deficiency where malnutrition is 
rampant however both histologic and functional abnormalities of the intestine are 
common. Defective iron absorption is caused by non-tropical sprue. 
 Partial or total gastrectomy impairs iron absorption caused by reduction in gastric 
acidity and acceleration of the food through the upper portion of the small bowel. 
The absorption of both haem iron and non-haem is defective. 
 Pica or the habitual ingestion of non-food substances is common in children, and 
pregnant women. It markedly inhibits iron absorption. 
 Pancreatic enzymes may contribute to the high incidence of iron deficiency in 
patients with cystic fibrosis. 
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Gastro Intestinal bleeding: 
 
 In adult men and postmenopausal women and children, occult bleeding from the 
gastrointestinal tract is the most common cause of iron deficiency. 
 Peptic ulcer disease is a well-documented cause of occult blood loss. 
 Crohn‟s disease and ulcerative colitis also are commonly associated with iron 
deficiency. 
  Corticosteroids, Indomethacin and other non-steroidal anti-inflammatory agents 
may also induce gastrointestinal tract bleeding. 
 Hookworm infestation (Ankylostomiasis) is the most important cause of intestinal 
blood loss worldwide. The parasites Ankylostomaduodenale and Nectar americanus 
attach to the proximal portion of the small intestine and suck blood from submucosal 
vessels. 
 
Pathogenesis: 
Iron deficiency anaemia develops when the supply of iron to the bone marrow is 
insufficient for the requirements of haemoglobin synthesis. It has been pointed out that the 
body is normally in a state of positive iron balance. When a negative iron balance occurs 
either due to blood loss, increased requirements or impaired absorption, the deficit is made 
good by iron mobilized from the tissue stores and an 57 adequate supply of iron for 
haemoglobin formation is maintained. It is only when the tissue stores are exhausted and the 
supply of iron to the marrow for haemoglobin synthesis becomes inadequate, hypochromic 
anaemia develops. Thus iron deficiency may be regarded as developing in two stages. 
 
1. The progressive depletion and cultivate exhaustion of the available tissue iron stores.  
2. The development of anaemia. Iron deficiency state, which may be divided into three 
functionally distinct stage of severity 
 
Stage of Iron deficiency anaemia: 
Storage iron depletion:  
Iron reserve is small or absent and is characterized by reduced serum ferritin or 
reduced iron concentration in marrow and liver tissue. Haemoglobin serum iron, 
Transferritin concentration and saturation are within normal limits. 
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Iron limited erythropoiesis:  
 
Haemoglobin (Hb) may still be normal but serum iron is low and TIBC increased 
with a low serum ferritin and raised free erythrocyte protoporphyrin (FEP). 
 
Iron deficiency anaemia:  
 
The flow of iron to erythroid marrow is impaired to cause reduction in haemoglobin 
concentration with a progressive microcytic hypochromic anaemia associated with the 
reduced serum iron, transferrin saturation and serum ferritin level. 
 
CLINICAL FEATURES: 
 
Symptoms: 
 Anorexia, Headache, Bodyache, Giddiness, Fatigue, Lassitude, Breathlessness on 
exertion, Dimness of Vision, Dizziness, Insomnia, Inability to concentrate , Tinnitus, 
Anginal pain, Paraesthesia in fingers and toes, Palpitation, Insomnia, Anxiety, Constipation, 
Abdominal distension, Hair loss, Exercise intolerance, Restless leg syndrome, Missed 
menstrual cycle or oligomenorrhoea and Pica.  
 
Signs:  
Pallor of the skin, mucous membrane, palms, nails and conjunctiva Smooth, pale, 
glossytongue, Angularstomatitis, Glossitis and Koilonychia. 
 
Epithelial tissue changes  
 
Long standing IDA causes epithelial tissue changes in some patients. The changes 
occur in the nails (koilonychia or spoon shaped nails), tongue (atrophic glossitis), mouth 
(angular stomatitis) and oesophagus causing dysphagia from development of thin 
membranous webs at the post cricoid area (Plummer Vinson syndrome). 
 
 
53 
 
Role of iron deficiency anaemia in various systems: 
Cardiovascular system : 
 
 Dyspnoea and palpitation are common symptoms while on exertion but in very 
severe anaemia the patient may get cardiac failure and there may be dyspnoea at rest. 
Haemic murmurs are commonly heard in anaemic patients. Jugular venous pressure 
increases in severe anaemia due to the high pulse pressure, with a capillary pulsation. 
Oedema of the legs occasionally occurs in ambulant patient with severe anaemia as the 
result of venous and capillary pressure on exertion and increased capillary permeability. 
 
Central nervous system:  
 
Symptoms include faintness, giddiness and headache, roaring and banging in the 
ears, tinnitus, spots before the eyes, lack of concentration and drowsiness and with severe 
anaemia clouding of consciousness, numbness, and coldness and sometime tingling of the 
hands and feet. 
 
Reproductive system:  
 
Menstrual disturbances are commonly found. 
 
Renal system:   
 
Slight proteinuria may be present with severe anaemia. Anaemia may further reduce 
renal function to the point at which nitrogen retention develops. Correction of anaemia in 
such patient is usually followed by a fall in blood urea.  
 
Gastro Intestinal system:  
 
Anorexia is the commonest symptom, nausea, flatulence and constipation may also 
occur. Slight to moderate smooth hepatomegaly is common is severe anaemia and when 
congestive heart failure develops the liver may become tender. In certain cases of iron 
deficiency anaemia, spleen may be enlarged. 
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Pyrexia:  
Mild pyrexia may occur with severe anaemia but marked fever is due to either the 
causative disorder or to some complicating factor. 
 
Dietary Iron:  
 
The dietary iron comes from two sources, Heme and non-heme, the later being the 
major source of iron in diet and is found in varying degrees in all foods of plant origin. 
Heme iron is present in meat, fish, and poultry, but the intake of these products is generally 
low. Heme iron is better absorbed than non-heme iron and is not influenced by dietary 
factors. Good sources of iron in the diet includes, pulses, dhals, green leafy vegetables, 
dates, nuts, jaggery, meat and fish. Administration of 50 mg of vitamin C increases iron 
absorption by two folds. 
 
Complications in Iron Deficiency anaemia:  
 
Iron deficiency anaemia may be the present finding in gastro intestinal cancer. In 
patients with heart disease severe anaemia may precipitate angina pectoris or congestive 
heart failure Infections are more common in Iron deficiency anaemia, especially those of the 
respiratory, gastrointestinal and urinary tracts. Chronic iron deficiency anaemia reduces the 
efficiency in work and study 
 
Investigations required for Iron Deficiency anaemia: 
 
1. Blood Investigations : 
 
 Haemoglobin, Total Red Blood cell count, Peripheral blood smear, Packed cell 
volume, Mean corpuscular volume, Mean corpuscular haemoglobin, Mean corpuscular 
haemoglobin concentration, Total iron binding capacity, Serum iron, Serum Ferritin, 
Differential count, Erythrocyte sedimentation rate, Serum protein, Serum creatinine.  
 
2. Urine Investigations:  
Sugar, albumin, Deposits, Red blood cells, Pus cells. 
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3. Stool Investigations:  
Ova, Cyst, Occult blood, Red blood cells, Pus cells. 
 
Special Investigations occasionally required: 
 
   X-ray barium meal, X-ray Barium enema, X-ray chest 
   Endoscopy, colonoscopy, sigmoidoscopy, gastro duodenoscopy 
   Isotope studies  
 
i.   Determination of life span of red cells using 51Cr labelled erythrocytes  
ii.   Determination of absorption, utilization, and disposal of iron using Fe. 
   Skeletal survey for multiple myeloma and secondary deposits 
   Bone marrow examination 
   liver Function Test (LFT) 
  Jejunal biopsy, urography, selective angiography 
   Ultrasonography 
 
Laboratory Diagnosis: 
  In Iron deficiency anaemia the haemoglobin is less than 11 gm in women and less 
than 14 gm in men. The red cell count in rarely below 2.5 million/cubic millimeter and the 
red cells are usually microcytic and hypochromic reticulocytes and platelets are normal or 
increased. The white cell count is normal.Serum ferritin is below 30µg/L in women and 
below 100µg/L in men .Serum iron is usually below normal range (Normal is 50 - 
150µg/dl). Bone marrow haemosiderin is absent. The PCV, MCV, MCH, MCHC are all 
reduced. 
 
Differential Diagnosis :  
Iron deficiency anaemia must be differentiated from other hypochromic anaemia. 
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I.    Anaemia of infection 
II.   Pyridoxine (Vit B6) Deficiencyanaemia 
III.  SomeHaemoglobinopathies 
IV. Sideroblastic anaemia 
V.  Anaemia of lead poisoning. 
 
Diagnosis :  
Following criteria are essential to diagnose iron deficiency anaemia. History of 
inadequate intake of dietary iron and blood loss if any Typical symptoms and signs like 
easy fatiguability, pallor, pica, koilonychia, smooth tongue, cheilosis, numbness, 
palpitation, dyspnoea and dysphagia associated with general considerations. Haemoglobin 
estimation variably reduced. Hypochromic and microcytic structure of red blood cells. Low 
serum ferritin, low serum iron, increased total iron binding capacity. Reduced mean 
corpuscular volume. Platelet count is either normal or raised. Blood loss usually occult. 
Erythrocyte count may be normal or reduced less than haemoglobin level would suggest. 
 
PREVENTION OF IDA: 
Appropriate nutritional strategies are an important factor in prevention of IDA. The 
basic approaches to the prevention of IDA include . 
 
1. Dietary modification and consumption of larger amounts of habitual foods increases 
total iron consumption by 25 – 30 %. Processes like germination (Sprouting of green 
gram) consumption of green leafy vegetables would be additional long-term methods 
for prevention of IDA. 
2. Periodic de-worming with anti-helminthic drugs for hookworm infestation and 
schistosoma should be considered in endemic areas. 
3. Supplementation with medicinal iron is considered necessary to reduce the extent of 
anaemia in developing countries. 
4. Food and salt fortification with iron are evolving rapidly and would be one of the most 
effective ways to control IDA. Salt fortification with iron content of 1 mg per gram of 
salt is the most effective preparation.  
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Self care Procedures for iron deficiency anaemia: 
 
 Eat more foods that are good source of iron 
 Concentrate on green leafy vegetable, red meat, beef liver, poultry, fish, wheat 
germs, oysters, dried fruit and fortified cereals. 
 Boost iron absorption. Foods high in vitamin C like citrus fruits, tomatoes and 
strawberries help the body absorbing iron from food. 
  Red meat not only supplies a good amount of iron, it also increases absorption of 
iron from other food sources. 
  Take an iron supplement, Consult your physician for proper dosage. 
 While iron is best absorbed when taken on an empty stomach, it can upset your 
stomach. Taking iron with meals is less upsetting to the stomach 
  Avoid antacids, phosphates (which are found in soft drinks, beer, ice cream, candy 
bars, etc) and the food additive EDTA. These block iron absorption 
  Increase dietary fibre to prevent constipation. 
  Avoid aspirin and products with aspirin. 
  Eat good sources of folic acid daily.These include vegetables like asparagus, 
sprouts, spinach and lettuce 
 Black-eyed peas, orange juice, oatmeal, whole grain cereals, wheat germ, liver and 
other organ meats are excellent sources of folic acid. 
  Eat fresh uncooked fruits and vegetables often. Heat destroys folic acid 
 
 
 
 
 
 
 
 
 
 
 
 
 
58 
 
59 
 
TITLE 
        Clinical Evaluation of Siddha drug “CHITRAMUTTI NEI” (Internal) in the 
treatment of Azhal paandu (Iron Deficiency anaemia.)  
BACKGROUND: 
            Siddhars classified the diseases into 4448 and established a separate chapter which 
deals Veluppu on the basis of  vali , Azhal, Iyyam, humours, mentioned in yugi vaithiya 
chindhamani. Yugi munivar further classified pandu into 5types and Azhal pandu is one 
among them.  The signs and symptoms like pallor, Giddiness, Faint, Glossitis,  Chest 
discomfort, Breathlessness, Bitter taste, Dizziness   can be correlated well with Iron 
Deficiency Anaemia mentioned in modern science. 
 Yugi indirectly explained the etiology of  Azhal pandu, which as follows excessive  
intake  of  salt&sour  food, living in  hot surroundings,  excessive chewing of  pawn &nut,  
excessive intake of  alchol,  daytime sleep  [life style  changes]  This will be highly 
appreciated in modern science well. 
Anaemia is the most common nutrional deficiency in the world. Globally, Iron 
deficiency anaemia affects 1.62 billion people, which corresponds to 24.8% population. The 
highest prevalence is in preschool age children (47.4%) and the lowest prevalence in men 
(12%) The greatest number of individuals affected is pregnant woman (41.8%). In woman 
anaemia may become the underlying cause of maternal mortality and perinatal Mortality. 
Nearly 50% of woman of reproductive age and 26% of men in the age group of 15-59 years 
are anaemic. 
Siddhars idendified numerous numbers of herbs in treating anaemia.  One such  
siddha formulation  by  CHITRAMUTTI  NEI  mentioned in  chikicha rathna deepam 
which is said to be cost effective ,  efficacious and simple  formulation  . 
One cause for Iron deficiency anaemia is poor intake of  Iron  due to poverty and  
socioeconomic status.  The main ingrediends of the above formulation are  of nellikkai 
[Phllanthus emblica  Linn],  shows significant  antioxidant and  haematinic,  
Immunomodulatory  activities.  Nilavembu  [Andrographis paniculata  Burm ] possesses    
H epato protective activity,  Antioxidant, Anti Inflammatory,  diuretic activities. Manjal 
[Curcuma longa Linn]  possesses  Anti cancer,  Antioxidant,  Hepato protective, Anti 
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Inflammatory, Appetizer Activity. Kadukkai (Terminalia chebula (Retz), possesses 
Haematinic activity. 
Chitramutti [Pavonia zeylanica Lin (cav) possesses, Hepato protective , 
Antioxitant, Larvicidal Activity. Therefore I have selected the trial drug for clinical trial. 
AIM: 
1. PRIMARY AIM: 
To study the therapeutic efficacy of siddha formulation CHITRAMUTTI  NEI   in 
the treatment of  AZHAL PAANDU (IRON DEFICIENCY ANAEMIA). 
2. SECONDARY AIM: 
 To study the cofactors related to the disease (i.e., age, sex, socioeconomic status, 
family history, occupation.  
 To study the siddha basic principles like Envagai thervu,  Neerkkuri  and  Neikkuri, 
Udal thathukal, Uyir thathukal  and  Kaalam etc., in pitha pandu patients. 
 
STUDY DESIGN&CONDUCT OF THE STUDY: 
Study type  : An Open Clinical trial 
Study Place: 
Ayothidass Pandithar Hospital (OPD&IPD),  
National Institute of Siddha, 
Tambaram sanatorium, 
Chennai-47. 
  
Study Period   : 12 months  
Sample size            :  40 patients 
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TREATMENT: 
Drug      : CHITRAMUTTI  NEI (INT) 
Dose              : 4ml (Twice a day –before food) 
     Duration          : 45 days 
    Vehicle            :  Hot water 
    Reference book: Chikicha Rathna Deepam -page no 212-213.       
   Urai aasiriyar    : Kannusamy pillai                                                                                          
   Edition              : I (2007) 
SUBJECT SELECTION: 
           As and when patients reporting at OPD of   Ayothidass pandithar Hospital NIS with 
the symptoms of inclusion criteria was subjected to screening test and documentation was 
done by using screening proforma. 
INCLUSION CRITERIA:  
 Age: 15-55 
 Sex: both sex, 
 Hb level less than normal range, 
 For male:7-12gms/d1[13-18gms/d1] 
 For female :7-11gms /d1[11.5-16.5gms/d1]  
 Patient willing to undergo blood investigation. 
 Patient willing to sign  the informed consent stating that he/she will 
conscientiously stick to the treatment during 48days but can opt out of the trial 
of  his/her own conscious discretion. 
 EXCLUSION CRITERIA:  
 Hyper tension 
 Pregnancy and lactation 
 Presence of any associated severe systemic illness (e.g.CA, RA) 
 Endocrine disorder (Thyroid abnormality, Diabetes mellitus) 
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 Cardiac disease 
 Renal disease  
 Inherited defects (sickle cell anemia, Thalassemia, Aplastic Anemia) 
 Patient not willing to give blood sample  
 Epilepsy 
 Worm Infestation 
 
WITHDRAWAL CRITERIA: 
 Intolerance to the drug and development of adverse reactions during the drug 
trial. 
 Poor patient compliance & defaulters. 
 Patients turned unwilling to continue in the course of clinical trial. 
 Patient  who will not take medication regularly. 
 
 ASSESSMENTS AND INVESTIGATIONS: 
 a) CLINICAL ASSESSMENT 
                 Siddha  assessment 
 b) ROUTINE INVESTIGATIONS: 
                1.Modern parameters 
                2.Siddha parameters 
 
 c) SPECIFIC INVESTIGATIONS: 
              1.clinical assessment: 
 
 Pallor, Oedema of the Body, Breathlessness, 
 Palpitation, Tachycardia, Anorexia, Giddiness, 
 Numbness, Tingling sensation, Lack of concentration, 
 Amenorrhoea, Angular stomatitis,  Glossitis, Cheliosis, 
 Koilonychia, Hair fall,Lassitude,Fatigue,Pica, 
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SIDDHA ASSESSMENT:    
Pallor, Giddiness,  Faint, Glossitis,  Chest discomfort,  Breathlessness, Bitter taste, 
Dizziness 
 SIDDHA PARAMETERS: 
 Naadi (pulse perception)  
 Sparisam(palpable perception) 
 Naa(Tongue) 
 Niram(complexion)  
 Mozhi(voice) 
 Vizhi(eyes) 
 Malam(bowel habits) 
 Moothiram(urine) 
 Moothiram(urine) 
 Neerkuri 
 Neikuri 
 
 ROUTINE INVESTIGATIONS 
 Liver function test 
 Renal function test 
 Blood sugar level: 
 Fasting (mg/d1)           
 Post prandial (mg/d1) 
                      Random (mg/d1) 
 Lipid profile 
 Urine Routine 
 Motion test 
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SPECIAL INVESTIGATIONS: 
 1. Complete Blood count: 
 Hb 
  Total RBC  
   PCV 
   MCV 
   MCH 
  MCHC 
  Total WBC 
  Differential count :(%) 
          Polymorphs  
          Lymphocytes   
          Monocytes      
          Esinophils       
          Basophils 
 ESR(mm/hr) 
 Platelet count 
  Smear study 
 Bleeding time- /min 
 Clotting time- /min 
2. Serum Ferritin Level 
 
STUDY ENROLLMENT: 
 In this clinical trial, Patient reporting at  NIS, OPD with clinical symptoms of  
Pallor,  anorexia,  giddiness, odema, palpitation, numbness,fatigue etc., was 
examined clinically before enrolling  the study.  
 The patients  were informed (from IV) about the objective of the study, trial drug, 
possible outcomes in their own language and terms understandable to them. 
 After ascertaining the patient‟s willingness, Informed consent was obtained them in 
the consent form (Form VI). 
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 All these patients were given unique registration card in which patient‟s Registration 
number of the study, Address, phone number and Doctors phone number etc, were 
given, so as to report easily,  if any complications arise. All these patients were 
given unique registration card in which patient‟s Registration number of the study, 
Address, phone number and Doctors phone number etc. Were given, so as to report 
easily, if any complications arise. 
 Complete clinical history, complaints and duration, examination findings- all were 
recorded in the prescribed proform in the clinical research form. Screening Form-I 
was filled up; Form – II and Form – III were used for recording the patient‟s history, 
clinical examination of symptoms and signs and laboratory investigations 
respectively. 
CONDUCT OF THE STUDY: 
 Patients who had satisfied inclusion and exclusion criteria were recruited for the 
study. 
 As per Sidhha literature, before starting the treatment for AZHAL PANDU, 
purgative drug  Agathiar Kulambu 130mg od with 15 ml of Pepper powder 
[Milagu thool] at early morning in empty sto mach for one day was given. 
 Then the trial drug “ CHITRAMUTTI NEI‟‟ was given at a dose of 4ml twice a 
day with hot water continuously for 45days,  patients visited the hospital once in 9 
days. At each clinical visit clinical assessment was done and prognosis was  noted. 
Laboratory investigations were done on 0
th
 day and 46
th
 day of the trial.  
 After the end of the treatment ,the patient was advised to visit the OPD for another 2 
Months for follow up without trial medicine.   
 DATA MANAGEMENT: 
 After enrolling the patient in the study, a separate file for each patient was opened 
and all forms were filed in the file. Study No. and Patient Number was entered on 
the top of file for easy identification.  Whenever the study patient visits OPD during 
the study period, the respective patient‟s file was taken and necessary recordings 
were made at the assessment form or other suitable forms. 
 The screening forms were filed separately. 
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 The Data recordings were monitored for completion by Guide (HOD, Dept. of 
Maruthuvam), SRO (Statistics).All forms were further scrutinized in presence of 
Investigator by Sr. Research Officer (Statistics) for logical errors and 
incompleteness of data to avoid any bias.  
 
OUTCOME 
 PRIMARY OUTCOME: 
Primary outcome was mainly assessed by comparing the pre and post treatment 
Hemoglobin level,  of the trial patient. 
 SECONDARY OUTCOME: 
Secondary outcome was assessed by comparing the following parameters,before and 
after the treatment. 
 
1.Reduction of clinical symptoms 
2.changes in complete blood count 
3.changes in serum ferritin level 
Adverse Effect and serious effect Management  
 No Cases were reported with adverse reactions to during the study period  
STATISTICAL ANALYSIS: 
 All data was entered into computer using MS Access software  for logical errors and 
manually cross checked for data entry error. Then the data was explored to STATA/SPSS 
software for univariate/multivariate analysis. Student „t‟ test and Mantel-Haenszel chi-
square test was  performed for determining the significance of a particular effect variable.  
ETHICAL ISSUES:  
 The data collected from the patient will be kept confidentially. The patient will be 
informed about the diagnosis, treatment and follow up. 
 Informed consent will be obtained from the patients after explaining about the 
clinical trial in an understandable language. 
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 After getting the consent of the patient (through consent form) they will be enrolled 
in the study. 
 Treatment will be provided free of cost. 
 No other medicines will be used except the trial drug. 
 To prevent any infection, while collecting blood sample from the patient, only 
Disposable syringes, disposable gloves, with proper sterilization of lab equipments 
will be used.  
 The patients who are excluded (as per the exclusion criteria) are given proper 
treatment with full care at OPD. 
 In conditions of treatment failure, adverse reactions patients will be given alternative 
treatmentat the OPD with full care through the end. .  
 
DATA COLLECTION FORMS: 
Required information was collected from each patient by using the following forms 
FORM l  : Screening & Selection Prof  
FORM ll     : Case Record form 
FORM lll       : Laboratory Investigation form 
FORM IV       : Drug compliance form 
FORM V         : Patient Information Sheet 
FORM VI        :Informed Consent Form  
FORM VII  : Withdrawal Form/ Adverse drug reaction form (Pharmacovigilance  
    form) 
FORM VIII      :  Dietary advice Form 
 
68 
 
RAW DRUGS, PURIFICATIN & DRUG PREPARATION: 
INGREDIENTS: 
     1. Chitramutti[ Pavonia  zeylanica .Linn]             - 8palam(280grams) 
2. Kari manjal   [Curcuma longa   .Linn]  - 8palam(280grams) 
3. Kadukkai      [Terminalia chebula .Retz] -  8palam(280grams) 
4. Nellikai         [Phyllanthus emblica  .Linn] -  8palam(280grams) 
5. Thandri         [Terminalia bellarica .Gaertn]  -  8palam(280grams) 
6. Nilavembu    [Andrographis paniculata .Burm]- 8palam(280grams) 
7. Eluppai         [Madhuca longifolia.Koening]     - 8palam(280grams) 
8.Neer                                                                     - 4marakkal(21.48liters) 
9. Cow‟s milk                                                        - 4padi(5.36 liters) 
10. Cow‟s ghee                                                      -   1padi(1.34 liters) 
SOURCE OF RAW DRUGS; 
 The  required raw drugs for preparation  of CHITRAMUTTI  NEI  was  purchased 
from a well reputed country shop at Chennai. 
 The raw drugs was authenticated by the  Assistant Professor, Medicinal   botany, 
NIS. 
    The raw drugs was purified and medicine was prepared at Gunapadam lab of   
National Institute of siddha. 
 METHOD OF PURIFICATION: 
1. Chitramutti      -      Pavonia zeylanica .Linn  
             Cleaned with water & wipe it with a clean cloth. 
2. Kari manjal     -       Curcuma longa .Linn 
                     Remove the outer skin. 
3. Kadukkai        -     Terminalia chebula.Retz 
                      Discard the seed and collect the rinds alone for use. 
4. Nellikai        -       Phyllanthus emblica. Linn 
 Boil it with milk, remove the seed and dry. 
69 
 
    5.  Thaantrikkai    -      Terminalia bellarica.Gaertn 
                  Discard the seed and collect the rinds alone  
      for use. 
    6.   Nilavembu(whole plant)     -      Andrographi spaniculata .Burm 
                 Dry it in sunlight. 
    7. Eluppaiverpattai    -    Madhuca longifolia (Koening) 
                  Wash the root in running water and dry it.  
METHOD OF PREPARATION: 
Ref :    “ChikichaRathnaDeepam” page no  212-213, Edition I  2007 
STEP 1 
The raw drugs were crushed and mixed in 21.48 liters of water. 
STEP 2 
   Then the mixture was allowed to boil till reduced to 1.34 liter. 
STEP 3 
To the above mixture 5.36 liters of cow‟s milk and 1.34 liter cow‟s ghee were 
added. 
STEP 4 
Then it was boiled till it reached ghee consistency. 
 DRUG STORAGE: 
            The trial drug CHITRAMUTTI NEI was stored in a clean  and dry wide Mouth  
glass bottles. 
 DISPENSING:                                                                                                                           
  The prepared medicine, Chitramutti  Nei (68ml) was given to the patients in a 
container. At each visit (once in 9 days for 45 days) the patients was given the above drug 
package for 9 days of treatment. At each visit the patients were advised to bring back the 
unconsumed drugs if any and return to the Investigator. 
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REVIEW OF TRIAL DRUGS 
 
1.   NELLIVATRAL 
Botanical name :   Phyllanthus emblica. Linn. 
Family               :    Euphorbiaceae 
Synonyms         :    Aamalagam ,Aalagam , Aambal , Aamarigam, Korangam , Miruthupala, 
         Meethunthu, Dhathri, Dhaththari, 
Taste                  :    Sour ,Astringent , Sweet  
Potency              :     Coolent 
Division             :     Sweet. 
Actions               :    Coolant  ,Diuretic, Laxative 
 
General character : 
 nghJFzk; 
 ey;yney;yp Ks;spaJ ehf;Ff; FUrpjUk; 
 my;yy;tpup gpj;jk; mfw;Wkiu-nky;yj; 
 jiy KOff; fz;FspUe; jhTgpj;j the;jp 
 ,iyapopNk fq;fSk; Nghk; vz;. 
- Fzg;ghlk; %ypif tFg;G 
 
Properties and its medicinal uses: It is used for giddiness, thirst, oliguria, vomiting, 
Anaemia, edema, burning sensation of the body and dryness.  The fruits are rich source of 
Vitamin C and also contain Ellagic acid, Phyllembin, Phyllantidine ,Phyllantine. It is an 
anti-oxidant and haematinic.  It helps in good absorption of iron. 
 
2.KADUKKAI: 
Botonical Name :   Terminalia chebula.Retz 
Family                :   Combretaceae 
Synonyms          :   Amutham, Arithagi,Amrutha, Aliyan, Magam, 
   Nanthiri,  Nechi, Pathiyam,Parium, Jeevanthi,   
   Jeevapriya, Sethagi, Varikkai, Vanadurkki, Vijayadevan. 
Taste                 :      Mainly Astrigent, Small amount of Sweet, Sour, pungent and  Bitter. 
Potency             :  Hot 
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Division            :  Sweet 
Actions             :   Stomachic , Digestive 
  
General character : 
fLf;fhAe; jhAq; fUjpnyhd;nwd; whYk; 
 fLf;fha;j; jha;f;fjpfq; fhz;eP–fLf;fhq;Neha; 
 xl;bAlw;Nww;Wk; cw;wtd;idNahRitfs; 
 Cl;bAlw;Nww; Kte;J. 
- mfj;jpah; Fzthflk; 
Properties and its medicinal uses: 
 It contains Astrin,Chebulinic acid, Tannic acid and gallic acid.  It induces appetite 
and helps in digestion. It is useful in anemia 
3.THANDRIKKAI 
 
Botanical Name  :  Terminalia bellirica .Roxb 
Family                 :  Combretaceae 
Synonyms           :  Aksham, Akkantham, Akkaathan, Amutham, Ambalathi,  Amutham, 
 Aaramam , Boothavasagam,   Erikatpalam ,Kanthakatpalam,  
 Sathagam, Thabamari, Vanthiyam, Vithiyam, ThirilingamThanikkai. 
Taste                  :  Astringent  
 Potency            :  Hot   
Division             :  Sweet. 
Actions               : Astringent , Laxative ,Tonic 
General character :  
rpye;jptplk; fhkpag;Gz; rPohdNkfq; 
 fye;JtUk; thjgpj;jq; fhNyh-lyh;e;Jlypy; 
 Cd;wpf;fha;g; ntg;gKjputpj; Jq;fuf;Fe; 
 jhd;wpf;fha; ifapnyLjjhy;. 
- Fzghlk; %ypiftFg;G 
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Properties and its medicinal uses: 
 It cures the disease of Vatha and Pitha and neutralizes three doshas. 
 Gallic acid, Ellagicacid ,Chebulagic acid, β Sitoserol are isolated from fruits. 
 It is useful  to induce appetite and relieve abdominal flatulence. 
 It boosts the immunity and enhances the body resistance against the disease. 
4. CHITRAMUTTI  
Botanical name   : Pavonia zeylanica Cav. 
Family                  : Malvaceae 
 
Properties and its medicinal uses : 
 It cures Pitha diseases. 
 It is also a hepatoprotective and antioxidative 
 
Synonyms             :  Sirunththotti, Sirunthottai, Sirukurunththotti. 
Taste                      :  Astringent  
Potency                  : Coolent 
Division                 :  Sweet. 
Actions                  :  Emollient, Vermifuge 
General character : 
             mj;jpRuKjy; mde;jRuk; gpj;jKk; Nghk; 
 nkj;jtpopf;nfhspahk; tPWjap–yj;jpw;fhk; 
 ew;whkiuj;jpUTehLnkope;epUNt! 
 rpw;whKl; bj;Jiur; nrg;G 
- Fzghlk; %ypiftFg;G 
 
5.ILUPPAI 
Botanical name  : Madhuca longifolia.Koenig 
English name     :  The narrow lived Mohua 
Synonyms         : Irupai,Kulikam,Madhugam 
Taste                 : Astringent, Potency,Coolent 
Division           : Sour 
Action              : Demulcent, Refrigent, Stimulant, Tonic, Astrigent. 
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General character:  
“Fd;whtpYg;igapd;G+ $h;kJuk; thriiahe; 
 jpd;whw; gapj;jpaKe; NrUq;fhz; - kd;wY}We; 
 jhh;FoNy! gpj;jRuk; jhfe; jzpe;JtpLk; 
 thh;jaf;fnka;Jk; tOj;J” 
- Fzghlk; %ypif 
Properties and its Medicinal uses: 
 Palmitic, Arachiticacid, LinoleicAcid,  Sapanin,Albumin. 
 
 Bitter, Asringent, Emollient, Anti-Inflammmatory, Anthelmintic. 
 
6.NILAVEMBU 
Botanical name  : Andrographis paniculata 
English name      : Greenchiretta 
Synonyms           : Kiriyath, Kaandagam, Chiratkuchi,Chiretta 
Taste                    : Bitter, Potency, hot  
Division               : Hot 
Division: Stomachic, Tonic, Alterative, Stimulant 
GENERAL CHARACTER; 
nghJFzk; 
 thjRuk; ePNuw;wk; khw;We; RuNjhl 
 fhjnkd Xlf; fbAq;fhz; - khjuNr! 
 gpj;j kaf;fWf;Fk; gpd;Gnjsp itf; nfhLf;Fk; 
 Rj;jepy Ntk;gpd; njhopy;. 
- Fzg;ghlk; %ypif tFg;G 
 
 Properties and Uses: 
 Contains bitter Glicosides, Andrographolide, Neoandrographolide, panicalin, 
Apigenin-7-4-dimethyl ether. 
 Plants are bitter, Acrid, cooling, laxative, anti-inflammatory, Anthelmentic, 
Digestive. 
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7.KARIMANJAL 
Botanical name : Curcuma longa.Linn 
Family  : Zingiberaceae   
Synonyms  : Arisanam, Kaansani, Nisi, Peetham 
Taste   : Pungent, Bitter 
Potency  : Hot 
Division  : Pungent 
Action   : Carminative, Stimulant, Hepatoprotective 
 
General character: 
      nghd;dpwkhk; NkdpGydhw;wKk;NghFk; 
 kd;DGUltrpakhk; - gpd;dpnaOk; 
 the;jpgpj;jNjhlikak; thjk;Nghe; jPgdkh 
 $h;e;jkQ;rspd; fpoq;Ff;F  
- mfj;jpah; Fzthflk; 
Properties and Medicinal uses: 
 It stimulates Appetite, cure oedema, diseases of Vatha and Pittha. 
 It contains      curcumin, Curcuminoides, Arturmerone, Turmerone, Zingiberone, 
Ascorbicacid, Copper and Calcium. 
 Curcumin has been shown to exhibit hepatoprotective,Anti-oxidant,Anti-
inflammatory,Anti-viral,Anti-bacterial,Anti-fungal and Anti-cancer activity.  
COW‟S GHEE 
jhfKo iyRl;fk; the;jp gpj;jk; thAgu 
Nkfk; tapw;nwupT tpf;fyoy; - khfhrq; 
Fd;kk; twl;rp Flw;Gul;l y];jpRl;fQ; 
nrhd;%yk; Nghf;Fepiwj;Jg;G 
- Fzg;ghlk; jhJrPt tFg;G 
 
General character Properties and its medicinal uses : 
 Cow‟s ghee reduces pitha and kapha. 
 Ghee is rich in the oil soluble Vitmin A&E. 
 Ghee stimulates the secretion of gastric acid, thus aiding in the digestive process. So it is excellent 
in increasing appetite. 
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 It detoxifies the body. 
 It strengthens immune system and vitality. 
 Ghee is used as a carrier for herbs and bhasmas because of its supreme penetrating 
qualities and the ability to carry the substances deep into dhathus or tissues. 
Ghee is rich with antioxidants and act as an aid in the absorption of vitamins and minerals 
from other food , serving to strengthing the immune system. 
 It cures constipation. 
 Ghee is used preferentially for diseases caused by Pitha dosha. 
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Raw Drugs 
NILABEMBU                                        CHITRAMUTTI 
 
 
 
KARI MANJAL                                                        THANDRIKKAI 
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  NELLIKKI  VATRAL                             ILUPAI VERPATTAI 
 
 
  
KADUKKAI                                                  NEI 
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PAAL 
 
 
CHITRAMUTTI NEI 
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CHEMICAL ANALYSIS OF CHITRAMUTTI NEI 
 
The chemical analysis of  chitramutti nei  was carried out in Bio chemistry lab, National 
Institute of Siddha. 
 
S.No 
EXPERIMENT OBSERVATION INFERENCE 
1.  Physical Appearance of extract 
Straw colour  
2. Test for Silicate 
     A 500mg of the sample was shaken 
well with distilled water. Sparingly soluble presence of silicate 
3. Action of Heat: 
   A 500mg of the sample was taken in 
a dry test tube and heated gently at 
first and then strong. 
 
No White fumes 
evolved. 
 
Absence of 
Carbonate 
 
 
 4. Flame Test: 
  A 500mg of the sample was made 
into a paste with Con. HCl in a watch 
glass and introduced into non-
luminous part of the Bunsen flame. 
 
No bluish green 
flame 
Absence  of copper 
 
5. Ash Test: 
A filter paper was soaked into a 
mixture of extract and dil. cobalt 
nitrate solution and introduced into the 
Bunsen flame and ignited. 
 
Appearance of yellow 
color flame 
 
 
 
 
 
flame 
 
 
 
flame 
Absence of sodium 
 
 
Preparation of Extract: 
5gm of sample was taken in a 250ml clean beaker and added with 50ml of distilled 
water. Then it was boiled well for about 10 minutes. Then it was cooled and filtered in a 
100ml volumetric flask and made up to 100ml with distilled water. This preparation was 
used for the qualitative analysis of acidic/basic radicals and biochemical constituents in it. 
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S.No EXPERIMENT OBSERVATION INFERENCE 
 I. Test For Acid Radicals   
1. Test For Sulphate: 
2ml of the above prepared extract was taken in 
a test tube to this added 2ml of 4% dil 
ammonium  oxalate solution 
No cloudy 
appearance 
Presence of 
sulphate 
 
2. Test For Chloride: 
2ml of the above prepared extract was added 
with 2ml of dil-HCl until the effervescence 
ceases off. 
No Cloudy 
appearance was 
formed 
 
Absence of 
Chloride 
3. Test For Phosphate: 
2ml of the extract was  treated with 2ml of 
dil.ammonium molybdate solution and 2ml of 
Con.HNo3 
 Cloudy yellow 
appearance 
present 
Absence of 
phosphate 
4. Test For Carbonate: 
2ml of the extract was treated with 2ml dil. 
magnesium sulphate solution. 
No Cloudy 
appearance was 
evolved. 
  Presence of 
carbonate 
5. Test For Nitrate: 
1gm of the extract was heated with copper 
turning and concentrated H2So4 and viewed 
the test tube vertically down. 
No Brown gas 
was evolved 
 
Absence of 
nitrate 
6. Test For Sulphide: 
1gm of the extract was treated with 2ml of 
Con. HCL 
No rotten egg 
smelling gas was 
evolved 
Absence of 
Sulphide 
7. Test For Fluoride & Oxalate: 
2ml of extract was added with 2ml of dil. 
Acetic acid and 2ml dil. calcium chloride 
solution and heated. 
No cloudy 
appearance. 
presence of 
fluoride and 
oxalate 
8. 
 
Test For Nitrite: 
3drops of the extract was placed on a filter 
paper, on that-2 drops of dil.acetic acid and 2 
drops of dil.Benzidine solution were placed. 
No characteristic 
changes were 
noted. 
Absence of 
nitrite 
9. 
 
 
Test For Borate: 
2 Pinches (50mg) of the extract was made into 
paste by using dil.sulphuric acid and alcohol 
(95%) and introduced into the blue flame. 
No Appearance 
of bluish green 
color. 
Absence of 
borate 
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II. Test For Basic Radicals 
1. Test For Lead: 
2ml of the extract was added with 2ml of 
dil.potassium iodine solution. 
No Yellow 
precipitate was 
obtained 
 
Absence of lead 
2. Test For Copper: 
One pinch (25mg) of extract was made into paste 
with Con. HCl in a watch glass and introduced into 
the non-luminuous part of the flame. 
 
No blue colour 
appeared 
Absence of copper 
3. Test For Aluminium: 
To the 2ml of extract dil.sodium hydroxide was 
added in 5 drops to excess. 
No yellow 
Colour  
appeared 
 
 
 
 
 
 
 
 
 
characteristic 
changes chara 
Absence of    
Aluminium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. Test For Iron: 
a. To the 2ml of extract, added 2ml of 
dil.ammonium solution 
b. To the 2ml of extract 2ml  thiocyanate solution 
and 2ml  of con HNO3 were added 
No Red colour 
appeared 
 
 
presence of  Iron 
 
 
 
5. Test For Zinc: 
To 2ml of the extract dil. sodium hydroxide 
solution was added in 5 drops to excess and dil. 
ammonium chloride was added. 
No White 
precipitate was  
formed 
 
Absence of Zinc 
 
6. Test For Calcium: 
2ml of the extract was added with 2ml of 4% 
dil.ammonium oxalate solution 
No Cloudy 
appearance and 
white 
precipitate was 
formed 
Presence 
 of calcium 
7. Test For Magnesium: 
To 2ml of extract dil. sodium hydroxide solution 
was added in 5 drops to excess. 
No  White 
precipitate was 
obtained 
Absence of 
magnesium 
8. Test For Ammonium: 
To 2ml of extract 1 ml of Nessler's reagent and 
excess of dil.sodium hydroxide solution were 
added. 
No Brown 
colour 
appeared 
Presence  of 
ammonium 
9. Test For Potassium: 
A pinch (25mg) of extract was treated with 2ml of 
dil. sodium nitrite solution and then treated with 
2ml of dil. cobalt nitrate in 30% dil. glacial acetic 
acid. 
No Yellow 
precipitate was 
obtained 
Absence of 
potassium 
10
. 
Test For Sodium: 
2 pinches (50mg) of the extract was made into 
paste by using HCl and introduced into the blue 
flame of Bunsen burner. 
No yellow 
colour flame 
evolved. 
 
 
 
 
 
 
 
 
 
Absence of sodium 
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11
. 
Test For Mercury: 
2ml of the extract was treated with 2ml of dil. 
sodium hydroxide solution. 
No Yellow 
precipitate was 
obtained 
Absence of 
Mercury 
12
. 
Test For Arsenic: 
2ml of the extract was treated with 2ml of dil. 
sodium hydroxide solution. 
No  Brownish 
red precipitate 
was obtained 
Absence of arsenic 
 
 
III. Miscellaneous 
1. 
Test For Starch: 
2ml of extract was treated with weak dil.Iodine 
solution 
No Blue colour 
developed 
presence of 
starch 
2. 
Test For Reducing Sugar: 
5ml of Benedict's qualitative solution was taken in 
a test tube and allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract and again boil it 
for 2 minutes. The colour changes were noted. 
No Brick red 
colour is 
developed 
Absence of  
reducing sugar 
3. 
Test For The Alkaloids: 
a) 2ml of the extract was treated with 2ml of 
dil.potassium lodide solution. 
b)  2ml of the extract was treated with 2ml of 
dil.picric acid. 
c)  2ml of the extract was treated with 2ml of 
dil.phosphotungstic acid. 
 
 
Yellow colour 
developed 
 
 
Presence 
of Alkaloid 
 
4 
Test For Tannic Acid: 
2ml of extract was treated with 2ml of dil. ferric 
chloride solution 
  
No Blue-black 
precipitate was 
obtained 
Absence of 
Tannic acid 
5 
Test For Unsaturated Compound: 
To the 2ml of extract, 2ml of dil. Potassium 
permanganate solution was added. 
Potassium 
permanganate 
was not 
decolourised 
Absence of 
unsaturated 
compound 
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Result; 
The chemical study of the trail drug revealed that  Iron, silicate, sulphate, 
carbonate, fluoride andoxalate,, calcium, ammonium, starch , and alkaloids. 
 
 
. 
 
6 
Test For Amino Acid: 
2 drops of the extract was placed on a filter paper 
and dried well. 20ml of Burette reagent was 
added. 
No Violet 
colour 
appeared 
 
Absence of 
amino acid 
 
 
7 
Test For Type of Compound: 
2ml of the extract was treated with 2 ml of dil. 
ferric chloride solution. 
No green and 
red colour 
developed 
 
 
 
 
 
 
No Violet 
colour 
developed 
 
 
 
No Blue colour 
developed. 
 
 
Absence of 
quinolepinephr
inepyrocatecho 
antipyrine 
 
Aliphatic 
amino acid and 
meconic acid. 
 
Apomorphine 
salicylate and 
Resorcinol 
were absent 
 
Morphine, 
Phenol cresol 
and 
hydrouinone 
were Absent. 
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PART - C: TEST PERFORMED 
Test for Aflatoxin:  
The procedures recommended for the detection of Aflatoxin as per WHO (2007).   
Instrument Details:  
 
Name of the Instrument : CAMAG (CAMAG - Automatic TLC sampler, 
   Scanner and Visualiser) 
Spray Gas : N2 
Lamp used : Mercury Lamp 
 
The samples were processed as per procedures recommended in WHO 2007 and applied for 
the Thin Layer Chromatography and High Performance Thin Layer Chromatography study with 
suitable solvent systems. After development the plate was allowed to dry in air and examined 
under 366nm.   
 
PART - D: RESULTS 
Test for Aflatoxin analysis: 
 The sample TS: Citrmutti Nei, 20µl and Standard  Std - G2, G1, B2 and B1 (15 µl) 
were applied on TLC aluminium sheet silica gel 60 F 254 (E.MERCK) and plate was 
developed using the solvent system Chloroform : acetone : water (14 : 2 : 0.2). After 
development the plate was allowed to dry in air and examined under  UV 366 nm 
  
 
 
UV-366nm 
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HPTLC Densitometric chromatogram (366nm)  
Test sample (TS) : Citramutti Nei ; Standard (S) – G2, G1, B2 & B1  
 
 
HPTLC finger print of Sample (TS) : Citramuttti Nei at 366nm  
 
Rf value of  Sample (TS) : Citrmutti Nei at 366nm  
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HPTLC finger print of Standard (S) at 366nm  
 
Rf value of Standard (S) at 366nm  
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          OBSERVATION AND RESULTS 
For this clinical study totally 130 cases were screened of which 90 cases were excluded 
and 40 cases were selected and treated in the Out-patient department of Ayothidoss 
Pandithar Hospital, National Institute of Siddha, Chennai-47. Results were observed with 
respect to the following criteria. 
1. Age distribution 
2. Sex distribution 
3. Duration of illness 
4. Treatment history 
5. Socio-ecnomic distribution 
6. Occupational distribution 
7. Educational distribution 
8. Dietary distribution 
9. Habitual distribution 
10. Marital status distribution 
11. Menopausal status distribution 
12. Reference to Thegi 
13. Reference to Thinai 
14. Reference to Season 
15. Reference to Iymporigal 
16. Reference to Iympulangal 
17. Reference to Kosangal 
18. Reference to Mukutram 
19. Reference to Ezhuudalkattugal 
20. Reference to Ennvagaithervugal 
21. Reference to Neikkuri 
22. Reference to Signs and Symptoms 
23. Reference to .Investigation Results 
24. Results after treatment 
i) Primary outcome - Hb before and after treatment. 
ii) Secondary outcome - Results from Complete Blood Count 
i. Results from Iron supply studies 
ii. Results from clinical signs and symptoms 
25. Statistical Analysis 
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AGE DISTRIBUTION 
 
 
 
 
Observation and Inference: Among the 40 cases treated 1(2.5%) cases belonged to 
15-20 years, 16(40%) cases belonged to 21-40 years and 23(57.5%) cases belonged to 41- 
55 years. The percentage is more in the age group of 41-55years. 
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AGE DISTRIBUTION
AGE DISTRIBUTION
S. No Age No of cases Percentage 
1 15-20 1 2.5 % 
2 21-40 16 40 % 
3 41-55 23 57.5 % 
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 SEX DISTRIBUTION 
 
Observation and Inference:  
Among the 130 cases screened, Patients who satisfied the inclusion criteria were all females 
38 (32%) were included in the trial. 68 (52.3%) of female cases and 22(16.9%) cases of 
male cases presented with anaemia were under exclusion criteria. 
S No Sex 
No of cases under 
inclusion 
criteria 
[Percentage%] 
No of case under 
exclusion 
criteria [Percentage 
%] 
1 Female 38 (95%) 68 (52.3%) 
2 Male 2 (5%) 22 (16.9%) 
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DURATION OF ILLNESS: 
S.NO YEAR NO. OF CASES PERCENTAGE 
1 0-1 30 75% 
2 1-2 7 17.5% 
3 2-3 3 7.5% 
 
 
Observation and inference: 
 out of 40 cases,30 cases(75%) were 0-1 year duration, 7 cases were (17.55) were 1-2 years 
of duration, 3 cases (7.5%) were 2-3 years. 
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TREATMENT HISTORY: 
TREATMENT HISTORY NO. OF CASES PERCENTAGE 
Allopathy 20 50% 
Siddha 7 17.5% 
Ayurvedha 5 12.5% 
Homeopathy 0 0 
No treatment history 8 20% 
 
 
Observation and inference:   
Among 40 cases, 50% of patients had allopathic treatment for aneamia, 
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OCCUPATIONAL DISTRIBUTION 
 
 
 
 
Observation and Inference:  
Of the 40 cases, 1(2.5%) were students, 20(50%) were Working women and 19(47.5.5%) 
were house wives. The percentage is more in house wives. 
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percentage
S.No Occupational status No of cases Percentage% 
1 Student 1 2.5 
2 working 20 50 
3 House wives 19 47.5 
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EDUCATIONAL DISTRIBUTION 
 
 
 
Observation and Inference:  
Out of 40 cases, 32(80%) cases were literate, and 8(20%) were illiterates 
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EDUCATIONAL STATUS
S.No Educational Status No of cases Percentage % 
1 Literate 32 80 
2 Illiterate 8 20 
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DIETARY DISTRIBUTION 
 
 
 
 
Observation and Inference:  
Among 40 cases, 36 cases (90 %) belonged to nonvegetarian dietary habit and 4cases (10%) 
belonged to vegetarian dietary habit. 
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S.No Diet No of cases Percentage% 
1 Vegetarian 4 10 
2 Non-vegetarian 36 90 
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MARITAL STATUS DISTRIBUTION 
 
 
Observation and Inference:  
Of the 40 cases, 1(2.5%) cases were in unmarried status, 39 (97.5%) cases were in married 
status. The percentage was more in married status 
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97.50%
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unmarried married
MARITAL STATUS
MARITAL STATUS
S.No Marital Status No of cases Percentage% 
1 Unmarried 1 2.5 
2 Married 39 97.5 
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REFERENCE TO THEGI (BODY CONSTITUTION) 
 
 
 
Observation and Inference:  
Of the 40 cases, 9(22.5%) cases were in pitha body constitution, 30(75%) cases were in 
thontham body constitution and no cases were in kabam and 1(2.5%)cases vatham body 
constitution.The percentage was more in pitham type of body constitution 
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BODY CONSTITUTION
BODY CONSTITUTION
S. No Thegi No of cases Percentage% 
1 Vatham 1 2.5 
2 Pitham 9 22.5 
3 Kabam 0 0 
4 Thontham 30 75 
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REFERENCE TO SEASON 
 
 
 
Observation and Inference:  
Among the 40 cases, 1 case (2.5%)  was affected during Munpani and 31 cases (77.5%) 
were affected in Pinpani kalam.8 cases (20%) were affected during Elavenilkalam.  
 
0 0
2.50%
77.50%
20%
00
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
Kaar koothir munpani pinpani elavenil mudhuvenil
SEASON
SEASON
S. No Paruvakaalam No of cases Percentage% 
1 Kaar (Aug 16-Oct15) 0 0 
2 Koothir(Oct 16-Dec 15) 0 0 
3 Munpani(Dec 16-Feb 15) 1 2.5% 
4 Pinpani(Feb 16-Apr 15) 31 77.5% 
5 Elavenil(Apr 16-June 16) 8 20% 
6 Mudhuvenil(June16-Aug 15) 0 0 
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REFERENCE TO IYMPORIGAL 
 
 
Observation and Inference: 
 
       Of the 40 cases, Mei [skin] was affected noted as pallor, numbness, dryness, in 
38(95%) cases and 32 (80%) cases improved after the treatment. Of the 40 cases, 
vaai[buccal cavity] was affected noted as glossitis, angular stomatitis, bitter or pungent 
taste, dryness, pallor, fissured and coated tongue in 25(62.5%) cases and all the patients 
were improved after the treatment. Of the 40 cases, Kan[eye] was affected noted as pallor, 
blurred vision in 37 (92.5%) cases and 35(87.5%) cases improved after the treatment. 
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Iymporigal 
No of 
cases 
affected 
 
before 
treatment 
[Percentage%] 
No of 
 cases 
improved 
after 
treatment 
[Percentage%] 
1 Mei [skin] 38 95% 32 80% 
2 Vaai [Buccalcavity] 25 62.5% 25 62.5% 
3 Kan [Eyes] 37 92.5% 35 87.5% 
4 Mooku[Nose] 0 0 0 0 
5 Sevi [Ear] 0 0 0 0 
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REFERENCE TO IYMPULANGAL 
S.No Iympulangal 
No of cases 
affected 
before 
treatment 
[Percentage%] 
No of 
cases 
improved 
after 
treatment 
[Percentage%] 
1 Kai [upper limb] 38 95% 35 87.5% 
2 Kaal [lower limb] 35 87.5% 34 85% 
3 Vaai[Buccalcavity] 25 62.5% 23 57.5% 
4 Eruvai[Anus] 25 62.5% 23 57.5% 
5 Karuvai[Genital organ] 3 7.5% 2 5% 
 
 
 
Observation and Inference: 
                   Out Of the 40 cases, Kai [upper limb] was affected noted as numbness, pain in 
38 (95%) and 35 (87.5%) cases were improved after the treatment. Kaal[lower limb] was 
affected noted as numbness, pain, paedaledema in 35(87.5%),and 34(85%) cases were 
improved after the treatment Vaai[buccal cavity] was affected noted as glossitis, angular 
stomatitis, bitter orpungent taste, dryness, pallor, fissured and coated tongue in 25 (62.5%) 
cases and 23 (57.5%) cases were improved after the treatment Eruvai [Anus]was affected 
noted as constipation 25 (62.5%) cases and  23 (57.5%) cases were improved after the 
treatment Of the 40 cases, Karuvai[genital organ] was affected in 3(7.5%) cases noted as 
ammennorhoea and 2(5%) cases  were improved after the treatment. 
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REFERENCE TO KOSANGAL 
S.No Kosam 
No of 
cases 
affected 
before 
treatment 
[Percentage%] 
No of 
cases 
improved 
after 
treatment 
[Percentage%] 
1 Annamayakosam 35 87.5% 33 82.5% 
2 Pranamayakosam 34 85% 32 80% 
3 Manomayakosam 29 72.5% 24 60% 
4 Vinganamayakosam 36 90% 34 85% 
5 Anandamayakosam 27 67.5% 25 62.5% 
 
 
Observation and Inference: 
        Of the 40 cases, Annamaya kosam was affected, noted as loss of appetite in 35 
(87.5%) cases, Manomaya kosam was affected, noted as palpitation in 29 (72.5%) cases, 
Vinganamaya kosam was affected, noted as pain, numbness and tingling sensation in 
36(90%) cases and all the patients were improved after the treatment. Of the 40 cases, 
Pranamaya kosam was affected, noted as breathlessness in 34(85%) cases and 32(80%) of 
the patients were improved after the treatment. Of the 40 cases, Anandamaya kosam was 
affected, noted as ammenorrhoea, oligomenorrhoea and constipation in 27(67.5%) cases 
and 25 (62.5%) cases were improved after the treatment. 
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EFERENCE TO MUKKUTRAM 
VATHAM: 
S.No Vatham 
No of 
cases 
affected 
 
before 
treatment 
[Percentage%] 
No of 
cases 
Improved 
 
After 
treatment[Percentage%] 
1 Pranan 35 87.5% 31 77.5% 
2 Abanan 25 62.5% 23 57.5% 
3 Viyanan 38 95% 35 87.5% 
4 Uthanan 29 72.5% 24 60% 
5 Samanan 35 87.5% 33 82.5% 
6 Naagan 15 37.5% 12 30% 
7 Koormam 10 25% 8 20% 
8 Kirukaran 35 87.5% 33 82.5% 
9 Devathathan 25 62.5% 23 57.5% 
10 Dhananjeyan Not 
applicable 
0 Not 
applicable 
0 
 
Observation and Inference: 
Of the 40 cases, Pranan was affected, noted as breathlessness in 35(87.5%) cases and 31 
(77.5%) were improved after the treatment. Abanan was affected, noted as flattulence, 
constipation, ammenorrhoea and oligomenorrhoea in 25 (62.5%) cases and 23 (57.5%) were 
improved after the treatment Uthanan was affected, noted asbreathlessness in 29 
72.5%)cases before the treatment and 24 (60%) were improved after the treatment. Of the 
40 cases,Viyanan was affected noted as pain, numbness, and tingling sensation in 38 (95%) 
cases and 35 (87.5%) were improved after the treatment.Samanan was affected noted as 
loss of appetite,pain, numbness and breathlessness in 35 (87.5%) cases and 33 
(82.5%)Koorman was affected notedas blurred vision in 10 (25%) cases and 8 (20%) were 
improved after the treatment Kirukaran was affected noted as loss of appetite, dryness of 
mouth in 35 (87.5%) cases and 33 (82.5%) were improved after the treatment, 
Devadhathan was affected noted afatigue in 25 (62.5%) of the cases and 23 (57.5%) were 
improved after the treatment. 
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PITHAM: 
S.No Pitham 
No of 
cases 
affected 
 
before 
treatment 
[Percentage%] 
No of 
cases 
Improved 
 
After 
treatment[Percentage%] 
1 Analam 35 87.5% 33 82.5% 
2 Ranjagam 37 92.5% 35 87.5% 
3 Prasagam 37 92.5% 35 87.5% 
4 Alosagam 8 20% 6 15% 
5 Sathagam 38 95% 36 90% 
 
 
Observation and Inference: 
Of the 40 cases, Analam was affected noted as loss of appetite in35(87.5%) cases and 33 
(82.5%) were improved after the treatment, Alosagam was affected noted as dull vision in 
8(20%) cases and 6 (15%)were improved after the treatment , Sathagam was affected noted 
as fatigue in 38(95%) cases and 36 (90%) were improved after the treatment. 
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KABHAM: 
S.No Kabam 
No of 
cases 
affected 
before 
treatment 
[Percentage%] 
No of 
cases 
Improved 
 
After 
treatment[Percentage%] 
1 Avalambagam 35 87.5% 33 82.5% 
2 Kilethagam 35 87.5% 33 82.5% 
3 Pothagam 18 45% 16 40% 
4 Tharpagam 7 17.5% 5 12.5% 
5 Santhigam 37 92.5% 35 87.5% 
 
 
 
Observation and Inference: 
Of  the 40 cases, Avalambagam was affected noted as breathlessness in 35(87.5%) cases 
before the treatment and 33(82.5%) cases were improved after the treatment. 
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REFERENCE TO EZHU UDALKATTUGAL 
S.No Udalkattugal 
No of 
cases 
affected 
 
before 
treatment 
[Percentage%] 
No of 
cases 
Improved 
 
after 
treatment[Percentage%] 
1 Saaram 40 100% 38 95% 
2 Senneer 36 90% 33 82.5% 
3 Oon 20 50% 18 45% 
4 Kozhuppu 5 12.5% 3 7.5% 
5 Enbu 25 62.5% 23 57.5% 
6 Moolai 0 0 0 0 
7 Suronitham 2 5% 2 5% 
 
 
Observation and Inference: 
Regarding seven Udalkattugal, Saaram [noted as fatigue] and Senneer[noted as pallor, 
reduction of Hemoglobin level] were affected in all 40 patients (100%) before the treatment 
and 38(95%) patients of saaram were improved and 33 (82.5%) patients of senneer were 
improved after the treatment. Oon was affected noted as paedaledema in 20 (50%) cases, 
before the treatment and 18 (45%) were improved  after the treatment. Suronithamwas 
affected in  2(5%) patients noted as ammennorhoea in 2 patients before the treatment and 2 
(5%) were improved after the treatment. 
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REFERENCE TO THINAI 
S.No Thinai No of cases Percentage% 
1 Kurinji (Hill area) 0 0 
2 Mullai (Forest area) 0 0 
3 Marutham (Fertile area) 1 2.5 
4 Neithal (Coastal area) 39 97.5 
5 Paalai (Desert area) 0 0 
 
Observation and Inference: Among the 40 cases, 1(2.5 %) belonged to Marutham 
nilam, 39(97.5 %) belonged to Neithalnilam 
REFERENCE TO ENVAGAI THERVUGAL 
S.No 
Envagai 
Thervugal 
 
Affected 
cases 
before 
treatment 
[percentage%] 
 
Improved 
cases, 
after 
treatment 
[percentage%] 
1 Naadi: 
Pithavatham 
Kabapitham 
kabavatham 
 
15 
13 
12 
 
37.5% 
32.5% 
30% 
 
13 
12 
10 
 
32.5% 
30% 
25% 
2 Sparisam 25 62.5% 23 57.5% 
3 Naa 38 95% 37 92.5% 
4 Niram 38 95% 37 92.5% 
5 Mozhi 0 0 0 0 
6 Vizhi 38 95% 37 92.5% 
7 Malam 20 50% 18 45% 
8 Moothiram 0 0 0 0 
 
Observation and Inference: 
Among the Ennvagai Thervugal, Naa[pallor, coated, glossitis, angular stomatitis, baldness, 
fissure, dryness, pungent or bitter taste, decreased salivation] Niram [pallor] andVizhi 
[pallor] were affected in all the 38cases (95%) and 37 (92.5%), 37(92.5%) and37(92.5%) 
111 
 
cases were improved from the affection after the treatment. 25(62.5%) and 20 (50%) cases 
were affected from Sparisam [noted as dryness, hot orcold sensation, excessive sweat] and 
Malam [noted as constipation] before the treatment and 15 (37.5%),13 (32.5%), 12 (30%) 
were observed in Pithavatham, Kabapitham, kabavathamnaadibefore the treatment and 13 
(32.5%), 12 (30%), 10 (25%)were improved in the above said naadirespectively. 
 
REFERENCE TO NEIKKURI 
1 Ring form-Pithaneer 25 (62.5%) 
2. Serpentineform-Vathaneer 18 [45%] 
3.pearl form – kabaneer 13 (32.5%) 
 
REFERENCE TO NEIKKURI 
 
 
 
 
Observation and Inference: Of the 40 patients, 25 (62.5%) cases were observed in 
Pithaneer and remaining 18 (45%) cases were observed in Vathaneer before the treatment 
And 13 (32.5%) were observed in kabaneer.  
 
S.No Neikkuri No of cases observed [percentage%] 
1 Vathaneer 18 45% 
2 Pithaneer 25 62.5% 
3 kabanee 13 32.5% 
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REFERENCE TO SIGNS AND SYMPTOMS 
S.No 
Signs and 
symptoms 
No of 
cases 
affected 
before 
treatment 
[Percentage%] 
No of cases 
Improved 
 
After 
treatment 
[Percentage%] 
1 Pallor 38 95% 36 90% 
2 Anorexia 25 62.5% 23 57.5% 
3 Fatigue 30 75% 28 70% 
4 Tachycardia 32 80% 32 80% 
5 Palpitation 35 87.5% 34 85% 
6 Giddiness 20 50% 18 45% 
7 Breathlessness 38 95% 35 87.5% 
8 Pungent taste of 
tongue or 
Bitter taste of 
tongue 
22 55% 20 50% 
9 Angular stomatitis 23 57.5% 22 55% 
10 Glossitis 18 45% 15 37.5% 
11 Lack of 
concentration 
8 20% 6 15% 
12 Hairfall 35 87.5% 33 82.5% 
13 Numbness 37 92.5% 35 87.5% 
14 Tingling sensation 10 25% 8 20% 
15 Ammenorrhoea 2 5% 2 5% 
16 Oligomenorrhoea 0 0 0 0 
17 Odema 12 30% 10 25% 
18 Koilonychia 0 0 0 0 
 
Out of 40 cases, Pallor and Fatigue was noted in  38 [95%] and 30 (75%) cases before the 
treatment. Of which, 36 (90%) cases in Pallor and 28 (70%) cases in Fatigue showed 
improvement after the treatment. Out of 40 cases, Anorexia was noted in 25 (62.5%) cases, 
Tachycardia was noted in 32 (80%) cases, Palpitation was noted in 35 (87.5%) cases, 
Giddiness was noted in 20 (50%) cases, Breathlessness was noted in 38 (95%) cases, 
Angular stomatitis was noted in 23 (57.5%) cases, Glossitiswas noted in 18 (45%) cases, 
Numbness was noted in 37 (92.5%) cases, Tingling sensation was noted in 10 (25%) 
cases, Odemawas noted in 12 (30%)cases and before the treatment and all the cases showed 
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improvement after the treatment. Out of 40 cases, Lack of concentration was noted in 8 
(20%) cases before the treatment and 6 (15%) showed improvement after the treatment. 
Out of 40 cases, Hairfallwas noted in 35 (87.5%) cases before the treatment and 33 (82.5%) 
showed improvement after the treatment. Out of 40 cases, Ammenorrhoeawas noted in 2 
[5%] cases before the treatment and 2  (5%) shows improvement after the treatment. 
 
RESULTS AFTER TREATMENT 
1 J93019 Pallor,anorexia,fatigue,tachycardia,palpitation,giddi
ness,breathlessness,angular stomatitis,lack of 
concentration, hairfall ,numbness ,tinglingsensation, 
ammennorhoea, 
Good improvement 
2 J19960 Pallor,anorexia,fatigue,tachycardia,palpitation,breat
hlessness,hairfall 
Moderate improvement 
3 J65728 Pallor,fatigue,tachycardia,palpitation,giddiness,brea
thlessness,hairfall,numbness,tingling, sensation, 
Good improvement 
4 J43406 Pallor,fatigue,giddiness,hairfall,numbness,tingling 
sensation. 
Good improvement 
5 J72309 Pallor,pungent taste of the tongue, fatigue, 
palpitation, giddiness, breathlessness, 
angularstomatitis, glossitis, lack of concentration, 
numbness, tinglingsensation, paedalodema, 
Moderate improvement 
6 J67762 Pallor,anorexia,fatigue,tachycardia,palpitation,giddi
ness,breathlessness,glossitis,hairfall,numbness, 
Tingling, sensation,paedalodema. 
Good improvement 
7 H94602 Pallor,anorexia,fatigue,tachycardia,palpitation,breat
hlessness, glossitis, hairfall, numbness, tingling 
sensation,paedalodema. 
Good improvement 
8 J79501 Pallor,anorexia,pungent taste of the tongue, fatigue, 
breathlessness, glossitis, hairfall, 
Good improvement 
9 I18133 Pallor,fatigue,tachycardia,palpitation,breathlessness
,numbness,tinglingsensation,pungent taste of 
the tongue. 
Good improvement 
10 I71774 Pallor, fatigue, giddiness,hairfall,numbness,tingling 
sensation  
Good improvement 
11 J47615 Pallor,anorexia, fatigue, hairfall, numbness, 
tinglingsensation, ammennorhoea . 
Good improvement 
12 D082569 Pallor,anorexia, fatigue, breathlessness, glossitis, 
numbness, 
Good improvement 
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13 C71989 Pallor,anorexia,bitter taste of the tongue, fatigue, 
tachycardia, palpitation, giddiness, breathlessness, 
angularstomatitis, 
gossitis,hairfall,numbness,tingling sensation,  
Good improvement 
14 J00382 Pallor, bitter taste of the tongue, fatigue, giddiness, 
breathlessness, hairfall, numbness, 
Good improvement 
15 J90991 Pallor, anorexia,fatigue, tachycardia, palpitation, 
giddiness, hairfall, numbness . 
Good improvement 
16 E012177
1 
Pallor, anorexia, pungent taste of the tongue,fatigue, 
tachycardia, palpitation, giddiness, breathlessness, 
angular stomatitis, lack of concentration, hairfall, 
numbness, tinglingsensation, ammennorhoea 
Good improvement 
17 I54947 Pallor,anorexia,fatigue,palpitation,giddiness,breathl
essness, hairfall, numbness, 
Moderate improvement 
18 E004118 Pallor,anorexia, fatigue, tachycardia, breathlessness, 
hairfall, numbness 
Moderate improvement 
19 J76500 Pallor, anorexia, bitter taste of the tongue, fatigue, 
palpitation, giddiness, breathlessness, hairfall, 
numbness. 
mild improvement 
20 K30418 Pallor,anorexia,fatigue,tachycardia,palpitation,giddi
ness,breathlessness,angular 
stomatitis,hairfall,numbness,paedalodema. 
Good improvement 
21 K30539 Pallor,fatigue, tachycardia, palpitation, giddiness, 
breathlessness, angularstomatitis, glossitis,lack of 
concentration, hairfall. 
Mild improvement 
22 J93972 Pallor,anorexia,bitter taste of tongue, fatigue, 
tachycardia, palpitation, breathlessness, hairfall, 
numbness, tinglingsensation, oligomennorhoea, 
paedalodemaPallor, anorexia,bitter taste of the 
tongue, fatigue, tachycardia, palpitation, giddiness, 
breathlessness, hairfall. 
Good improvement 
23 K01685 Pallor,anorexia,fatigue,tachycardia,palpitation,giddi
ness,breathlessness,angular stomatitis, glossitis, 
lack of concentration,  hairfall, numbness, 
tinglingsensation, paedalodema, 
Good improvement 
24 J36738 Pallor,anorexia,bitter taste of the tongue, fatigue, 
tachycardia, palpitation, giddiness, breathlessness, 
hairfall. 
Moderate improvement 
25 F95887 Pallor, anorexia, fatigue, palpitation, breathlessness, 
angularstomatitis, glossitis, hairfall. 
Good improvement 
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26 K15251 Pallor, anorexia, fatigue, tachycardia, giddiness, 
glossitis, lack of concentration, hairfall. 
Good improvement 
27 J74373 Pallor, anorexia, fatigue, tachycardia, palpitation, 
giddiness, breathlessness, lack of concentration, 
hairfall, numbness. 
Good improvement 
28 I45243 Pallor, pungent taste of the tongue, fatigue, 
breathlessness, glossitis, hairfall, numbness, tingling 
sensation. 
Good improvement 
29 J79782 Pallor, anorexia, bitter taste of the tongue, fatigue, 
tachycardia, palpitation, giddiness, breathlessness, 
angular stomatitis, glossitis, lack of concentration, 
hairfall, numbness, tingling sensation, 
Good improvement 
30 K19272 Pallor, anorexia, fatigue, giddiness, breathlessness, 
hairfall, numbness, tingling sensation, 
Good improvement 
31 K19930 Pallor, anorexia, bitter taste of the tongue, fatigue, 
tachycardia, palpitation, giddiness, breathlessness. 
Good improvement 
32 J35113 Pallor,anorexia,fatigue,palpitation,giddiness,breathl
essness,hairfall,numbness,paedalodema. 
Good improvement 
33 J83931 Pallor, anorexia, bitter taste of the tongue, fatigue, 
palpitation, breathlessness, lack of concentration, 
hairfall. 
Good improvement 
34 K17392 Pallor, anorexia, pungent taste of the tongue, 
fatigue, tachycardia, palpitation, giddiness, 
breathlessness, glossitis, hairfall, numbness, 
tinglingsensation, 
Good improvement 
35 H53441 Pallor, anorexia, bitter taste of the tongue, fatigue, 
palpitation, giddiness, breathlessness, glossitis, lack 
of concentration, hairfall, numbness, paedalodema. 
Good improvement 
36 H67371 Pallor,anorexia,fatigue,palpitation,giddiness,breathl
essness,hairfall. 
Good improvement 
37 K14057 Pallor, anorexia, bitter taste of the tongue, fatigue, 
tachycardia, palpitation, giddiness, breathlessness, 
lack of concentration, hairfall, numbness, 
tinglingsensation, 
Moderate improvement 
38 J37178 Pallor,anorexia, bitter taste of the tongue, fatigue, 
palpitation, giddiness, breathlessness,lack of 
concentration, hairfall, numbness, 
Good improvement 
39 K11911 Pallor, anorexia, bitter taste of the tongue, 
palpitation, giddiness, breathlessness ,hairfall, 
numbness, paedalodema 
Good improvement 
40 H59413 Pallor, anorexia, fatigue, palpitation, breathlessness, 
lack of concentration, hairfall, numbness . 
Good improvement 
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RESULTS AFTER TREATMENT: 
Results were observed on the basis of two main criteria. 
 
Primary Outcome: 
Primary Outcome is mainly assessed by comparing the pre and post treatmental 
Hemoglobin level, of the trial patient. 
 
Secondary Outcome: 
Secondary outcome is assessed by comparing the following parameters, before and 
after the treatment. 
1) Reduction of Clinical symptoms 
2) Changes in Complete Blood Count 
3) Changes in Iron supply studies 
 
HEMOGLOBIN CHART BEFORE AND AFTER TREATMENT 
S.No OPD/IPD NO HB BEFORE TMT HB AFTER TMT 
1 J93019 9.4mg/dl 10mg/dl 
2 J19960 7.3 8 
3 J65728 9.4 10.3 
4 J43406 10 11.1 
5 J72309 7.6 8 
6 J67762 10.3 11.4 
7 H94602 10 10.5 
8 J79501 11.1 12 
9 I18133 10.2 12 
10 I71774 9.1 9.8 
11 J47615 10 10.8 
12 D082569 8..3 9 
13 C71989 10.9 11.5 
14 J00382 10.3 11.8 
15 J90991 8.9 10.8 
16 E0121771 10.2 11.1 
17 I54947 7.3 8.4 
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18 E004118 7.0 8.6 
19 J76500 8.4 9.6 
20 K30418 8.6 9.9 
10 K30539 10.3 10 
22 J93972 8.0 8 
23 K01685 8.3 10.3 
24 J36738 7.6 11.1 
25 F95887 10.3 8 
26 K15251 7.8 11.4 
27 J74373 8.4 10.5 
28 I45243 9.4 12 
29 J79782 10.7 12 
30 K19272 9.1 9.8 
31 K19930 8.9 10.8 
32 J35113 9.3 10.6 
33 J83931 10.3 12.2 
34 K17392 9.1 10.4 
35 H53441 9.8 11.0 
36 H67371 10.1 11.6 
37 K14057 7.5 8.4 
38 J37178 9.1 10.5 
39 K11911 9.0 10.3 
40 H59413 10.5 11.3 
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PRIMARY OUTCOME: 
Results derived from the Hemoglobin 
S. NO Hemoglobin No of 
cases 
[Percentage %] 
1 1- 5 gms increase from its base 
level 
25 62.5% 
2 0.1-0.9 gms increase from its 
base level 
10 25% 
3 0.1-1.5 gms decrease from its 
base level 
5 12.5% 
 
 
Among the 40 cases, 25(62.5%) cases showed increase of 1 to 5 grams in the hemoglobin 
level and10(25%) cases showed increase of 0.1-0.9 grams in the hemoglobin level.5() cases 
showed no improvement in the Hemoglobin level. 
 
62.50%
25%
12.50%
HEMOGLOBIN
1-5 gms increase from its base 
level
0.1-0.9 gms increase from its 
base level
0.1-1.5 gms decrease from its 
base level
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ii) SECONDARY OUTCOME: 
1. Results from clinical improvement: 
Good, moderate and mild improvements were assessed on the basis as follows, 
 
Good improvement 
Reduction of pallor, hairfall. Restoration of regular menstrual cycle. Relief of signs 
and symptoms such as fatigue, palpitation, tachycardia, pungent or bitter taste of the tongue, 
giddiness, breathlessness, paedal edema,numbness,tingling sensation and koilonychia. 
Improvement in appetite. Absence of angular stomatitis, glossitis. 
 
Moderate improvement 
No reduction in pallor, hairfall. Presence of oligomenorrhoea and amenorrhoea. 
Reduction of signs and symptoms such as fatigue, palpitation, tachycardia, pungent or bitter 
taste of the tongue, giddiness, breathlessness,paedal edema,numbness,tingling sensation and 
koilonychia. Little improvement in appetite. Mild improvement in angular stomatitis, 
glossitis. 
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Mild improvement 
No reduction of pallor, hairfall. Presence of oligomenorrhoea and amenorrhoea. 
Reduction of signs and symptoms such as fatigue, palpitation, tachycardia, pungent or bitter 
taste of the tongue, giddiness, breathlessness,paedal edema,numbness,tingling sensation and 
koilonychia. No improvement in appetite. Presence of angular stomatitis, glossitis. 
 
S. NO Signs and symptoms No of 
cases 
[Percentage %] 
1 Good 32 80% 
2 Moderate 6 15% 
3 Mild 2 5% 
 
 
 
 
 
 
 
 
 
 
 
 
Among the 40 cases, 32(80%) cases assessed as good improvement, 6(15%) cases 
assessed as moderate improvement and 2 (5%) cases showed mild improvement. 
 
80%
15%
5%
SIGNS AND SYMPTOMS
good
moderate
mild
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2. Results from Complete Blood Count: 
Results from RBC: 
S. NO RBC No of cases [Percentage %] 
1 Increased from its base level 31 77.5% 
2 No change from its base level 5 12.5% 
3 Reduced from its base level 4 10% 
 
 
 
Regarding RBC of the 40 cases, 31 cases (77.5%) increased from its base level, 5 cases 
(12.5%) did not show any change from its base level and 4 cases (10%) showed 
reduction from its base level. 
 
77.50%
12.50%
10%
RBC
Increased from its base level
No change from its base level
Reduced from its base level
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Results from PCV: 
 
S. NO PCV No of cases [Percentage %] 
1 Increased from its base level 30 75% 
2 No change from its base level 6 15% 
3 Reduced from its base level 4 10% 
 
 
 
 
Regarding PCV of the 40 cases, 30(75%) showed increase from its base level, 6[15%] 
showed did not change from its base level and 4 (10%) showed reduction from its base 
level. 
 
75%
15%
10%
PCV
Increased from its base level
No change from its base level
Reduced from its base level
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Results from MCV: 
 
S. NO MCV No of cases [Percentage %] 
1 Increased from its base level 30 75% 
2 No change from its base level 8 20% 
3 Reduced from its base level 2 5% 
 
 
Regarding MCV of the 40 cases, 30(75%) showed increase from its base level ,8 
[20%] showed did not change from its base level and 2 (5%) showed reduction from its 
base level. 
 
 
 
75%
20%
5%
MCV
Increased from its base level
No change from its base level
Reduced from its base level
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Results from MCHC: 
 
S. NO MCHC No of cases [Percentage %] 
1 Increased from its base level 31 77.5% 
2 No change in its base level 7 17.5% 
3 Reduced from its base level 2 5% 
 
 
Regarding MCHC of the 40 cases, 31 (77.5%) showed increase from its base level and 7 
(17.5%) showed no change in the base level, 2(5%) cases reduction from its base level. 
 
 
 
77.50%
17.50%
5%
MCHC
Increased from its base level
No change in its base level
Reduced from its base level
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Results from MCH: 
 
S. NO MCH No of cases [Percentage 
%] 
1 Increased from its base level 32 80% 
2 No change from its base level 6 15% 
3 Reduced from its base level 2 5% 
 
 
 
Regarding MCH of the 40 cases, 32(80%) showed increase from its base level, 6 
(15%) did not show any change in its base level and 2 (5%) showed reduction from its 
base level. 
 
80%
15%
5%
MCH
Increased from its base level
No change from its base level
Reduced from its base level
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Results from Serum Ferritin: 
 
S. NO Serum Ferritin No of cases [Percentage %] 
1 Increase from its base level 34 85% 
2 Did not show any change 2 5% 
3 Decrease from its base level 4 10% 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regarding Serum Ferritin, Out of 40 cases, 34 (85%) cases showed increase from its base 
level, and 2 (5%)  cases did not any change, 4(10%) cases showed reduction from its base 
level. 
 
85%
5% 10%
SERUM FERRITIN
Increase from its base 
level
Did not show any change
Decrease from its base 
level
127 
 
 
 
S.NO OP NO 
AGE 
/SEX 
HAEMATOLOGY 
Haemoglobin (gm/dl) 
Red blood 
cells(mill/cu.mm) 
Serum Ferritin 
(ug/L) 
Before After  Before After Before After 
1 J93019 43/F 9.4 10 4.4 4.5 5.5 6.3 
2 J19960 46/M 7.3 8 4.8 4.8 0.9 1.0 
3 J65728 44/F 9.4 10.3 3.7 4.0 9.2 10 
4 J43406 33/F 10 11.1 4.3 4.5 6.6 7.5 
5 J72309 45/F 7.6 8 4.6 4.8 0.9 10.0 
6 J67762 55/F 10.3 11.4 4.1 4.2 4.0 4.2 
7 H94602 49/F 10 10.5 3.8 4.0 3.6 6.5 
8 J79501 30/F 11.1 12 4.2 4.1 14.5 16.0 
9 I18133 35/F 10.2 12 3.7 3.9 6.2 15.0 
10 I71774 26/F 9.1 9.8 4.8 4.7 2.2 2.5 
11 J47615 45/F 10 10.8 4.6 4.7 11 12.3 
12 D082569 44/F 8..3 9 4.1 4.4 12.8 13 
13 C71989 33/F 10.9 11.5 4.7 4.9 5.8 6.2 
14 J00382 45/F 10.3 11.8 4.4 4.7 2.3 3.5 
15 J90991 28/F 8.9 10.8 4.2 4.5 4.9 8.0 
16 E0121771 38/F 10.2 11.1 4.0 4.2 3.0 4.5 
17 I54947 40/F 7.3 8.4 3.8 4.0 0.80 1.2 
18 E004118 48/F 7.0 8.6 4.0 4.3 0.70 1.2 
19 J76500 41/F 8.4 9.6 4.3 4.3 0.80 1.4 
20 K30418 36/F 8.6 9.9 4.1 4.1 1.0 3.3 
21 K30539 46/F 10.3 11.2 4.1 5.0 12.5 13.9 
22 J93972 48/F 8.0 9 4.2 4.5 0.90 1.2 
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23 K01685 41/F 8.3 8.8 3.5 3.8 0.70 0.90 
24 J36738 45/F 7.6 8.9 3.5 3.6 3.4 4.4 
25 F95887 45/F 10.3 11.6 4.1 4.1 12.8 15.0 
26 K15251 16/M 7.8 8.9 5.4 5.5 2.9 3.5 
27 J74373 32/F 8.4 9.4 4.5 4.7 6.9 8.1 
28 I45243 35/F 9.4 10.3 4.3 4.4 11.1 12.0 
29 J79782 46/F 10.7 11.5 4.9 4.9 13.8 14.50 
30 K19272 47/F 9.1 10.3 4.3 4.6 15.8 17.10 
31 K19930 42/F 8.9 10.6 4.2 4.5 0.90 2.3 
32 J35113 42/F 9.3 10.6 3.9 4.0 14.8 16.0 
33 J83931 45/F 10.3 12.2 4.4 4.5 16.3 18.4 
34 K17392 42/F 9.1 10.4 4.1 4.1 15.3 16.4 
35 H53441 49/F 9.8 11.0 3.5 3.9 12.5 13.9 
36 H67371 44/F 10.1 11.6 4.3 4.4 0.90 1.2 
37 K14057 38/F 7.5 8.4 4.6 4.6 0.70 0.90 
38 J37178 43/F 9.1 10.5 4.3 4.4 3.4 4.4 
39 K11911 36/F 9.0 10.3 4.1 4.2 12.8 15.0 
40 H59413 41/F 10.5 11.3 4.0 4.3 2.9 3.5 
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S.NO OP NO 
AGE 
/SEX 
HAEMATOLOGY 
PCV(%) MCV (fl) MCH (pg) MCHC (%) 
Before After Before After Before After Before After 
1 J93019 43/F 30.4 32.2 71.7 72.7 20.9 21.9 29.2 30.3 
2 J19960 46/M 28.5 29.5 58.9 59 18 19 25.6 25.9 
3 J65728 44/F 29.4 32.0 78 79.8 24.9 25.7 32 32.2 
4 J43406 33/F 31.3 23.4 72 73 72 73 23 24 
5 J72309 45/F 29.5 30.3 63 63 16 70 25.8 28.8 
6 J67762 55/F 33.6 34 80.4 81.8 25.8 27 29.2 33.5 
7 H94602 49/F 31.3 32 81.1 83 27.2 29 33.3 34 
8 J79501 30/F 34 32.9 80.4 80 26.2 25.8 32.6 32.2 
9 I18133 35/F 30.7 32 82.3 84 27.3 29 27.3 28 
10 I71774 26/F 31.7 30.9 65.2 65.6 18.8 19.1 28.9 29.1 
11 J47615 45/F 22.5 32.8 70 68.6 22.4 22 32 32 
12 D082569 44/F 28.4 29 68.8 69 20.1 72 29.2 29.2 
13 C71989 33/F 36.1 33.5 75.7 78 24.1 26 31.1 33 
14 J00382 45/F 31.1 32.7 69.3 72 22.9 24 33.1 33.8 
15 J90991 28/F 29.9 34.9 70.7 76.7 21 23.6 29.8 30.9 
16 E0121771 38/F 31.5 33 77.2 81 25 22 32.4 34 
17 I54947 40/F 28.7 34.0 58.6 60.0 14.9 16.0 25.4 26 
18 E004118 48/F 25.2 29.9 61.8 65.7 17.2 19.6 27.8 29.4 
19 J76500 41/F 29.5 32.6 67.2 69.2 19.8 21.6 29.5 31.3 
20 K30418 36/F 28.2 33.3 68.0 74.2 20.7 26 30.5 36 
21 K30539 46/F 32.5 37.0 72.9 78.0 22.0 25.0 30.3 32.7 
22 J93972 48/F 28.1 28.6 65.5 68 19.6 20 29.9 31 
23 K01685 41/F 26.4 28 75 77 23.6 25 31.4 32 
24 J36738 45/F 26.4 28.4 73.5 76.2 22.7 24 29.5 31.1 
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25 F95887 45/F 32.5 36.8 78.9 80 25 27.3 31.7 33.6 
26 K15251 16/M 31.6 33.5 58.4 60.1 14.4 16.4 24.7 28 
27 J74373 32/F 30.4 31.6 66.2 67.1 19.4 20.3 29.3 30.1 
28 I45243 35/F 30.6 33.5 70.6 74.2 21.5 23.5 30.7 32.9 
29 J79782 46/F 34.3 36.5 69.2 71 21.6 23.0 31.2 33 
30 K19272 47/F 30.3 36.5 69.1 72 21 23.2 30.3 33.4 
31 K19930 42/F 29.9 34.9 70.7 76.2 21 23.6 29.9 31.9 
32 J35113 42/F 30.5 32.0 78.2 80 23.8 25.6 30.5 32.6 
33 J83931 45/F 36.0 38.2 81.0 83.4 29.0 26.6 29.9 31.9 
34 K17392 42/F 29.9 32.0 72.6 76.4 22.1 24.5 22.4 33.0 
35 H53441 49/F 31.0 33.2 80.2 83.4 25.0 27.6 30.1 33.1 
36 H67371 44/F 33.2 34.3 76.3 79.2 23.2 24.2 30.2 34.2 
37 K14057 38/F 28.0 29.4 60.5 61.9 16.2 18.2 26.8 29 
38 J37178 43/F 30.7 34.0 70.2 72.7 20.0 29.9 29.6 22.0 
39 K11911 36/F 30.1 33.2 71.8 73.4 21.5 24 29.9 32.4 
40 H59413 41/F 32.9 34.0 82.3 84.6 26.3 28.4 31.9 34 
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S.NO OP NO 
AGE 
/SEX 
HAEMATOLOGY 
Total wbc cells/ul 
Differential count 
%before.treatment 
Differential count % 
After treatment 
Before After P                L            E P             L             E 
1 J93019 43/F 8200 9100 66 32 2 65 33 2 
2 J19960 46/M 8200 8900 60 32 8 60 35 5 
3 J65728 44/F 7100 7500 62 35 3 62 35 3 
4 J43406 33/F 7000 7200 56 42 2 58 40 2 
5 J72309 45/F 7500 7700 65 33 2 65 33 2 
6 J67762 55/F 6900 7800 61 35 4 68 29 3 
7 H94602 49/F 8100 8200 62 36 2 60 38 2 
8 J79501 30/F 7300 6400 68 29 3 55 41 4 
9 I18133 35/F 6500 6800 57 39 4 60 36 4 
10 I71774 26/F 6000 7100 59 38 3 55 41 4 
11 J47615 45/F 8400 9700 55 42 3 59 38 3 
12 D082569 44/F 10500 10000 62 35 3 61 36 3 
13 C71989 33/F 6800 7000 59 39 2 62 36 2 
14 J00382 45/F 5600 6000 66 31 3 59 38 3 
15 J90991 28/F 8400 9200 59 39 2 60 36 4 
16 E0121771 38/F 6300 6800 68 30 2 66 30 4 
17 I54947 40/F 7600 8000 65 33 2 63 35 2 
18 E004118 48/F 6800 7500 59 38 3 59 39 2 
19 J76500 41/F 7000 8400 60 36 4 63 35 2 
20 K30418 36/F 7200 9000 65 33 2 64 34 2 
21 K30539 46/F 8800 10600 59 39 2 54 33 1 
22 J93972 48/F 10700 10800 59 36 3 60 37 3 
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23 K01685 41/F 5600 6000 54 42 3 56 40 3 
24 J36738 45/F 6600 9100 66 34 5 60 30 3 
25 F95887 45/F 8700 9800 60 37 3 60 38 2 
26 K15251 16/M 4800 6200 62 36 2 36 54 3 
27 J74373 32/F 8900 8700 69 27 4 60 38 2 
28 I45243 35/F 5500 6200 54 44 2 59 40 1 
29 J79782 46/F 8000 8600 65 32 3 63 35 2 
30 K19272 47/F 6400 7900 71 27 2 66 32 2 
31 K19930 42/F 8400 9200 59 39 2 60 36 4 
32 J35113 42/F 6900 7400 71 27 2 68 30 2 
33 J83931 45/F 8100 9200 66 33 1 63 34 3 
34 K17392 42/F 6700 7200 63 35 2 69 30 1 
35 H53441 49/F 6400 6900 65 31 4 59 39 2 
36 H67371 44/F 6600 7200 70 27 3 65 34 1 
37 K14057 38/F 6500 6800 59 39 2 60 36 4 
38 J37178 43/F 7600 8100 68 30 2 66 33 1 
39 K11911 36/F 9300 9700 71 26 3 65 33 2 
40 H59413 41/F 4700 5600 62 35 3 58 30 2 
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S.NO OP NO AGE 
/SEX 
HAEMATOLOGY 
ESR- ½ hr-1hr Clotting time /min Bleeding time/min 
before after before after before after 
1 J93019 43/F 20 42 4min30sec 4min35sec 2min5sec 2min5sec 
2 J19960 46/M 16 32 2min50sec 2min50sec 1min45sec 1min45sec 
3 J65728 44/F 10 22 3min50sec 3min 1min 1min 
4 J43406 33/F 12 24 3min 2min15sec 2min 1mjn.50s 
5 J72309 45/F 8 16 2min 2min15sec 3min 2min 
6 J67762 55/F 34 70 2min 3min 1min45sec 1min45sec 
7 H94602 49/F 36 54 3min 2min 2min 1min50s 
8 J79501 30/F 10 22 2min 1min30sec 1min15sec 1min15sec 
9 I18133 35/F 44 90 3min 1min45sec 2min 1min 
50sec 
10 I71774 26/F 11 22 1min 2min 1min 1min 
11 J47615 45/F 2 6 2min 1min 1min 1min 
12 D082569 44/F 40 82 1min 1min45sec 3min 2min 
13 C71989 33/F 20 42 1min 3min50sec 3min 2min 
50sec 
14 J00382 45/F 10 22 2min 3min20sec 3min 2min 
40sec 
15 J90991 28/F 12 24 3min 2min 2min 1min 
45sec 
16 E0121771 38/F 30 62 3min50sec 2min15sec 1min45sec 1min 
40sec 
17 I54947 40/F 10 22 2min50sec 2min50sec 1min50sec 1min 
30sec 
18 E004118 48/F 40 82 3min50sec 3min 2min50sec 1min 
45sec 
19 J76500 41/F 12 24 2min50sec 2min50sec 1min50sec 1min 
45sec 
20 K30418 36/F 10 22 3min50sec 2min45sec 1min30sec 1min 
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21 K30539 46/F 8 10 3 2min 45sec 2min 45sec 1min 
45sec 
22 J93972 48/F 10 22 3 1min45sec 1min45sec 2min30sec 
23 K01685 41/F 16 34 3min45sec 2min30sec 2min30sec 1min30sec 
24 J36738 45/F 20 31 4min55sec 3min 3min 1min45sec 
25 F95887 45/F 12 24 3min 2min45sec 2min45sec 1min45sec 
26 K15251 16/M 10 22 3min 2min45sec 2min45sec 1min45sec 
27 J74373 32/F 16 22 3min 2min50sec 2min50sec 1min45sec 
28 I45243 35/F 14 28 3min45sec 3min 3min 1min30sec 
29 J79782 46/F 16 34 3min 2min 2min 1min45sec 
30 K19272 47/F 12 24 3min30sec 3min 1min15sec 1min 
31 K19930 42/F 12 24 3min 2min45sec 1min45sec 1min 
32 J35113 42/F 16 22 2min45sec 2min 1min45sec 1min30sec 
33 J83931 45/F 20 42 3min50sec 3min 1min15sec 1min 
34 K17392 42/F 16 24 3min15sec 3min 2min5sec 2min 
35 H53441 49/F 32 40 3min50sec 3mn 1min15sec 1min 
36 H67371 44/F 16 22 1min50sec 1min40sec 2min30sec 2min 
37 K14057 38/F 22 34 3min 2min45sec 2min 1min50sec 
38 J37178 43/F 16 22 2min30sec 2min 1min50sec 1min30sec 
39 K11911 36/F 20 40 3min50sec 3min 2min 1min50sec 
40 H59413 41/F 36 54 2min45sec 2min15sec 1min15sec 1min 
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S.NO OP NO AGE 
/SEX 
Lipid profile 
Fasting blood 
sugar   gm/dl 
pp blood sugar 
gm/dl 
Total 
cholesterol  
gm/dl 
HDL gm/dl 
Before After Before After Before After before after 
1 J93019 43/F 95 98 119 129 149 159 49 51 
2 J19960 46/M 102 101 139 140 121 121 52 44 
3 J65728 44/F 83 94 150 111 231 227 62 60 
4 J43406 33/F 86 101 84 108 151 160 50 52 
5 J72309 45/F 102 100 133 120 138 135 62 65 
6 J67762 55/F 78 82 141 143 189 188 40 42 
7 H94602 49/F 98 102 106 113 159 154 49 51 
8 J79501 30/F 93 99 92 136 105 108 39 56 
9 I18133 35/F 88 97 88 95 110 115 47 48 
10 I71774 26/F 84 95 95 97 157 165 39 36 
11 J47615 45/F 118 135 124 142 168 170 54 56 
12 D082569 44/F 95 110 100 108 191 195 40 48 
13 C71989 33/F 98 102 130 141 226 220 67 65 
14 J00382 45/F 98 105 112 116 167 163 39 42 
15 J90991 28/F 94 100 120 128 125 146 46 48 
16 E0121771 38/F 84 90 92 97 217 220 53 60 
17 I54947 40/F 107 104 128 110 125 127 44 43 
18 E004118 48/F 95 104 150 118 188 185 76 69 
19 J76500 41/F 84 89 152 121 164 165 54 51 
20 K30418 36/F 114 102 140 141 158 156 55 52 
21 K30539 46/F 114 109 109 126 195 197 47 50 
22 J93972 48/F 60 71 127 132 190 191 57 50 
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23 K01685 41/F 110 109 140 150 142 145 34 55 
24 J36738 45/F 102 110 133 137 161 174 43 36 
25 F95887 45/F 100 108 136 140 178 174 45 55 
26 K15251 16/M 100 103 110 114 131 139 40 42 
27 J74373 32/F 90 94 102 114 184 189 43 46 
28 I45243 35/F 76 81 100 10 133 140 42 47 
29 J79782 46/F 98 102 110 118 159 163 40 49 
30 K19272 47/F 70 74 99 110 172 174 45 44 
31 K19930 42/F 94 100 120 128 125 146 46 46 
32 J35113 42/F 84 90 93 112 139 142 42 48 
33 J83931 45/F 86 90 134 139 146 152 40 46 
34 K17392 42/F 111 115 117 128 169 171 50 46 
35 H53441 49/F 96 110 127 131 175 173 38 53 
36 H67371 44/F 113 116 134 144 196 200 52 37 
37 K14057 38/F 93 95 79 97 142 149 52 56 
38 J37178 43/F 88 92 108 116 127 135 56 60 
39 K11911 36/F 98 102 126 134 128 131 40 42 
40 H59413 41/F 97 100 129 134 114 118 35 37 
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S.NO OP NO AGE 
/SEX 
                   Lipid profile Renal function test 
LDL   gm/dl TGL  gm/dl Uriagm/dl Creatininegm/dl 
Before After  Before After Before After before after 
1 J93019 43/F 87 87 143 125 15 16 0.8 0.9 
2 J19960 46/M 63 59 61 64 12 12 0.9 1 
3 J65728 44/F 129 128 103 114 16 19 0.9 0.8 
4 J43406 33/F 76 70 86 90 26 29 0.8 1.6 
5 J72309 45/F 79 73 50 62 15 18 0.8 1.5 
6 J67762 55/F 106 106 146 140 17 20 0.8 0.7 
7 H94602 49/F 74 75 79 78 22 10 1 0.8 
8 J79501 30/F 59 78 52 93 07 21 0.8 0.9 
9 I18133 35/F 58 59 44 45 16 19 0.7 0.8 
10 I71774 26/F 97 97 84 70 21 25 1 0.9 
11 J47615 45/F 105 93 91 103 18 25 0.9 0.9 
12 D082569 44/F 120 122 82 88 16 16 0.9 0.8 
13 C71989 33/F 118 117 115 118 17 17 1 0.7 
14 J00382 45/F 94 95 72 74 17 20 0.9 0.8 
15 J90991 28/F 53 66 41 59 24 18 0.8 0.9 
16 E0121771 38/F 127 129 124 127 14 20 0.8 0.8 
17 I54947 40/F 77 67 103 93 18 20 0.8 0.8 
18 E004118 48/F 90 94 96 84 22 21 0.9 0.9 
19 J76500 41/F 89 86 85 99 16 16 0.9 0.8 
20 K30418 36/F 83 80 53 50 11 10 0.9 0.8 
21 K30539 46/F 116 120 88 90 24 24 1.0 1.1 
22 J93972 48/F 106 105 88 63 27 18 0.8 0.9 
23 K01685 41/F 95 97 161 80 13 24 0.8 0.8 
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24 J36738 45/F 91 101 113 98 18 11 0.9 .08 
25 F95887 45/F 103 98 71 102 25 21 0.8 0.8 
26 K15251 16/M 68 73 64 69 24 24 0.8 0.8 
27 J74373 32/F 106 109 125 127 23 24 0.7 0.8 
28 I45243 35/F 80 86 49 51 20 20 0.8 0.8 
29 J79782 46/F 109 112 82 86 15 16 0.8 0.9 
30 K19272 47/F 98 100 114 111 16 17 1.0 0.9 
31 K19930 42/F 53 66 41 67 24 18 0.8 0.9 
32 J35113 42/F 75 79 110 116 16 16 0.8 0.9 
33 J83931 45/F 69 73 69 67 21 20 0.9 0.9 
34 K17392 42/F 93 97 69 71 17 18 0.7 0.8 
35 H53441 49/F 100 98 88 86 27 21 0.8 0.8 
36 H67371 44/F 112 118 150 156 12 13 0.8 0.9 
37 K14057 38/F 75 81 51 56 19 18 0.8 0.9 
38 J37178 43/F 62 69 38 41 18 19 0.9 0.8 
39 K11911 36/F 69 71 57 60 23 21 1.0 0.9 
40 H59413 41/F 61 64 228 229 16 16 0.9 0.9 
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STASTICAL ANALYSIS 
  All collected data were entered into MS Excel software using different columns as 
variables and rows as patients. SPSS software was used to perform statistical analysis. Basic 
descriptive statistics include frequency distributions and cross-tabulations were performed. 
The quantity variables were expressed as Mean ± Standard Deviation and qualitative data as 
percentage. A probability value of <0.05 was considered to indicate as statistical 
significance. Paired „t‟ test was performed for determining the significance between before 
and after treatment. 
Paired „t‟ test for Haemoglobin before and after treatment 
 
group Mean std „t‟ value P value 
Before 
treatment 
9.22 1.112 3.469 <o.ooo1 
After treatment 10.05 1.712 
 
Haemoglobin before treatment is 9.22 and after treatment is 10.05 which is statistically 
significant (p<0.0001). 
Paired „t‟ test for RBC before and after treatment 
group Mean std „t‟ value P value 
Before 
treatment 
4.37 4.38 0.096 0.4618 
After treatment 1.08 0.37 
RBC before treatment is 4.37 and after treatment is 4.38 which is statisticallynonsignificant 
(p0.4618). 
Paired „t; test for PCV before and after treatment 
group Mean std „t‟ value P value 
Before treatment 30.65 2.388 7.025 <o.ooo1 
After treatment 32.73 2.421 
PCV before treatment is 30.65 and after treatment is 32.73 which is statistically significant 
(p<0.0001). 
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Paired  „t‟ test for MCV before and after treatment 
group Mean std „t‟ value P value 
Before treatment 71.58 6.85 5.141 <o.ooo1 
After treatment 74.26 7.29 
 
MCV before treatment is 71.58 and after treatment is 74.26 which is statistically significant 
(p<0.0001). 
 
Paired „t‟ test for Serum ferritin before and after treatment 
group Mean std „t‟ value P value 
Before 
treatment 
7.51 6.136 5.767 <o.ooo1 
After treatment 8.82 6.52 
 
Serum ferritin before treatment is 7.51 and after treatment is 8.82 which is statistically 
significant (p<0.0001). 
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DISCUSSION 
 In Siddha Science, Azhal pandu is caused due to derangement of Pitham. The signs 
and symptoms of Azhal pandu such as pallor, anorexia, dyspnoea, palpitation, 
blurred vision, pungent taste of tongue etc., are related with Iron Deficiency 
Anaemia in Modern Science. 
 
 Azhal pandu [Iron Deficiency Anaemia] is one of the global diseases affecting 
1.62 billion people all over the world and nearly 50% of women of reproductive age 
in India are affected. 
 
 Hence the Principal Investigator focused to treat Azhal pandu [IDA].The aim of the 
study was to find the theurapeutic efficacy of the Siddha formulation 
CHITRAMUTTI  NEI (INT)  [Ref: “: Chikicha Rathna Deepam -page no 212-213] 
in Azhal pandu.  
 
 Before the initiation of the study, Institutional Ethical Committee approval [Reg No: 
F.No.NIS/6-20/IEC/15-16] was obtained by submitting well defined protocol, at 
NIS.  
 
 The raw herbs were authenticated by Assistant professor of Medicinal Botany, NIS, 
Chennai. 
 
 The Siddha formulation Chitramutti nei was prepared by following the standard 
operating procedure in Gunapadam labarotary, NIS. 
 
 The HPTLC of Chitramutti nei was evaluated at captain srinivasamurthy regional 
ayurvedha drug development institute, Arumbakkam, Chennai showed the 
fingerprint at UV 254 nm showed highest peak in 8th peak ( max44.76%  area 
63.80% ) which could serve as a marker and it is responsible for biological action. 
 
QUALITATIVE ANALYSIS: 
The Qualitative study was done in Department of Biochemistry, NIS and the results 
are as follows,  Presence of Iron, sulphate, Calcium, fluoride and oxalate, Ammonium, 
starch, Alkaloids,  Carbonate, Silicate, etc., which are essential to fulfill the therapeutic 
need. 
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CLINICAL STUDIES: 
 
 The clinical study was conducted in OPD of NIS.  
 The patients with the complaints of pallor, anorexia, glossitis, breathlessness, 
palpitation, numbness etc., were screened using screening proforma, for Azhal 
pandu.  
 Out of 130 patients screened, 106 were females and 24 were males of which 40 of 
the patients who satisfied the inclusion and exclusion criteria were recruited for the 
trial.  
 Before the start of the trial, Informed Consent was obtained from the patients.  
 Out of 40 patients  All cases were treated in OPD  
 .  The treatment aim was to regulate the deranged Pithadosha and to improve the 
Hemoglobin level. 
  The patient was advised to consume 200mg. of agasthiyar kuzhambu with ginger 
juice once a day at early morning for one day only before the start of the treatment to 
regulate the Pitha dosha. From the next day, the drug Chitramutti nei was advised to 
consume 4 ml, twice a day before meals with hot water for 45 days continuously. 
 Specific diet restrictions such as tobacco, betel chewing, tea, coffee and alcohol were 
advised to avoid, during the trial period. 
 For OPD patients, the drug was provided for 9 days and clinical assessment was 
done using assessment forms once in 9 days. 
 Labarotary investigations were done on 0th, and 45th day for the assessment of 
safety of the patients and efficacy of the drug. 
 After completion of the trial, patients were followed up for the next 2 months in the 
OPD. 
 After the completion of treatment with the trial drug in 40 cases, highly encouraging 
results were observed in the following Haematological, Stastical and Clinical 
parameters as follows, 
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RESULTS FROM HAEMATOLOGICAL PARAMETERS: 
1.Hemoglobin:  Out of 40 cases,  
 32 [80%] cases showed improvement, of which 6 cases reached normal level. 
 i)  Increase of 1 to 5 grams of HB – 25 (62.5%) 
 ii) Increase of 0.1- 0.9 grams of HB – 10 (25%)  
 Remaining 5 [12.5%] cases showed no improvement. 
 
2. RBC:  Out of 40 cases, 31cases (77.5%) increased from its base level, 5 cases (12.5%) 
did not show any change from its base level and 4 cases (10%) showed reduction from its 
base level. 
 
3. MCV:  Out of 40 cases, 30cases (75%) showed increase from its base level,8case(20%) 
showed didnot any change from its base level and 2cases(5%) showed reduction from its 
base level. 
 
4. PCV: Out of 40 cases, 30(75%) showed increase from its base level, 6 case (15%) did not 
show any change from its basal level and 4(10%) showed reduction from its base level. 
 
 5. MCH: Of the 40 cases, 32(80%) showed increase from its base level, 6(15%) did not 
show any change and 2 (5%) showed reduction from its base level. 
 
 6.  MCHC: Of the 40 cases, 31(77.5%) showed Increase from its base level and 7(17.5%) 
did not show any change and 2(5%) showed reduction from its base level. 
 
7. Serum Ferritin: Out of 40 cases, 38 cases had undergone the investigation for Serum 
Ferritin and in that 34(85%) cases showed increase from its base level, and 4(10%) cases 
showed reduction from its base level 
 
8. Liver function tests, Renal function tests and other blood parameters were found to be in 
normal limits, during the treatmental period and after the treatment. 
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STASTICAL REPORT: The Stastical report states that the Mean ± Standard deviation for, 
i. Haemoglobin before treatment is 9.22 and after treatment is 10.05 which is 
statistically significant (p<0.0001) 
 
ii.  RBC before treatment is 4.37 and after treatment is 4.38 which is statisticallynon 
significant (p o.4618). 
 
iii. PCV before treatment is 30.65 and after treatment is 32.73 which is statistically 
significant (p<0.0001). 
 
iv. MCV before treatment is 71.58 and after treatment is 74.26 which is statistically 
significant (p<0.0001). 
 
v.  Serum ferritin before treatment is 7.51 and after treatment is 8.82 which is 
statistically significant (p<0.0001). 
 
RESULTS FROM CLINICAL PARAMETERS: 
Age incidence: 
 
The age limit for the cases taken for study ranged from 15 to 55 years. Among the 40 
cases treated 1(2.5%) cases belonged to 15-20 years, 16(40%) cases belonged to 20-40 years 
and 23(57.5%) cases belonged to 40-55 years. The percentage is more in the age group of 
20-40 years . 
 
Sex incidence: 
 
Out of 130 patients screened for the trial, 24 cases were males and all of them were 
found to be under the exclusion criteria were not included and 106 cases were females of 
which 40 of the cases, who satisfied the inclusion and exclusion criteria were included in the 
trial. The inference obtained from the study showed, the vulnerability of the female 
population towards the disease Azhal pandu [IDA]. 
 
Occupational incidence: 
 
Among the 40 cases, 1(2.5%) were students, 20(50%) were working women and 
19(47.5%) were house wives. The percentage is more in house wives. 
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Socio-ecnomic Incidence:. 
  Among the 40 cases, 5(12.5%) cases belonged to Upper middle class economic 
status, 10(25%) cases belonged to middle class people and 25(62.5%) belonged to poor 
economic status.The percentage is more in poor economic group.The inference obtained 
from the study showed, poor socio-economic status is a main predisposing factor, since the 
poor people usually consume low nutritional food. 
 
Dietary Factor: 
Among the 40 cases, 4(10%) cases were observed to have pure vegetarian diet and36 
(90%) were taken non-vegtariandiet.The incidence is high in nonvegtarians. 
 
Habitual incidence: 
Among 40 cases ,none of the cases having betelnut chewing, tobacco chewing and 
alcoholism. 
 
Marital status incidence: 
Of the 40 cases, 1(2.5%) cases were in unmarried status, 39(97.5%) cases were in 
married status. The percentage was more in married status. 
 
Menopausal incidence : 
Of the 40 cases, 4(10%) cases were in menopausal attained status, 36 (90%) cases 
were in menopausal not attained status.The percentage was more in menopausal not 
attained. 
 
Thegi [Body constitution]: 
  Of the 40 cases, 1(2.5%) cases were in vatha body constitution, 9(22.5%) cases were 
in pitham body constitution and thontham body constitution  cases 30 (75%) in vatham 
pitham,  and kabham body constitution. The percentage was more in thontham type of body 
constitution. 
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Iymporigal [Sensory organs]: of the 40 cases, 
 
 Mei [skin] was affected noted as pallor, numbness, dryness, in 38 (95%) cases and 
32 (80%) cases improved after the treatment.  
 
 Vaai [buccal cavity] was affected noted as glossitis, angular sto3matitis, bitter or 
pungent taste, dryness, pallor, fissured and coated tongue in 32 (80%) cases and all 
the patients were improved after the treatment. 
 
 
 Kan[eye] was affected noted as pallor, blurred vision in 37 (92.5%) cases and 
35(87.5%) cases improved after the treatment 
 
 Iympulangal [Motor organs]: Of the 40 cases, 
 
 Kai  [Upper limb] was affected noted as numbness, pain in 38(75%) cases 
and35(87.5) cases improved after the treatment..  
 
 Kaal [Lower limb] was affected noted as numbness, pain, paedaledema in 35 
(87.5%)  cases and 34(85)cases improved after the treatment.  
 
 Vaai  [Buccal cavity] was affected noted as glossit is, angular stomatit is, bitter or 
pungent taste, dryness, pallor, fissured and coated tongue in 25 (62.5%) cases 
andand23(57.5) cases improved after the treatment.  
 
 Eruvai [Anus] was affected noted as constipation in25 (62.5%) cases and Karuvai 
[Genital organ] was affected in 3 (30%) cases noted as ammennorhoea in 2 patients 
and oligomennorhoea in 10 patients and 10(7.5%) [1 in ammennorhoea and 9 in 
oligomennorhoea] were improved after the treatment. 
 
 Kosam: Of the 40 cases,  
 
 Annamayakosam was affected, noted as loss of appetite in 35 (87.5%) cases and 
33(82.5) cases improved after the treatment.   
 
147 
 
 Manomayakosam was , noted as palpitation in 29(72.5%) cases and 24(60) cases 
improved after the treatment 
 
 Vinganamayakosam was affected, noted as pain, numbness and tingling sensation 
in 36 (90%) cases and 25(62.5) improved after the treatment. 
 
 Pranamayakosam was affected, noted as breathlessness in 34(85%) cases and 
32(80%) of the patients were improved after the treatment.  
 
 Anandamayakosam was affected, noted as ammenorrhoea, oligomenorrhoea and 
constipation in 17 (42.5%) cases and 15(37.5%) were improved after the treatment. 
 
 Mukkutram: 
Vatham: Out of 40 cases,  
 
 Pranan was affected, noted as breathlessness in 35(87.5%) cases and 31(77%) were 
improved after the treatment.  
 
 Abanan was affected, noted as constipation, flatulence, ammenorrhoea and 
oligomenorrhoea in 25(62.5%) cases and 23(57.5%) were improved after the 
treatment.  
 Uthananwas affected, noted as breathlessness in 29(72.5%) of the cases before the 
treatment and 24(60%) of the cases were improved after the treatment. 
 
 Viyanan was affected noted as pain, numbness and tingling sensation in 35(87.5%)   
cases and 3587.5) were improved after the treatment.  
 
 Samanan was affected noted as loss of appetite, pain, numbness and breathlessness 
in 35(87.5%) cases and  33(82.5) were improved after the treatment.  
 
 Koorman was affected, noted as blurred vision in 10(25%) cases and 8(20)%were 
improved after the treatment. 
 
 Kirukaran was affected noted as loss of appetite, dryness of mouth in 35(87.5%) 
cases and all of them were improved after the treatment.  
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 Devadhathan was affected, noted as fatigue in 40(100%) of the cases and all of 
them were improved after the treatment. 
 
 Pitham: Out of 40 cases,  
 
 Ranjagam was affected in all the 37 [87.5%] cases, noted as pallor before the 
treatment and 35(87.5%) cases showed improvement after treatment.  
 
 Prasagam was affected in all the 37 [92.5%] cases, noted as pallor and 35(87.5%) 
cases showed improvement after treatment.  
 
 Analam was affected in 35 (87.5%) of the cases noted as loss of appetite before the 
treatment and  33(82.5) cases showed improvement after the treatment. 
 
 Alosagam was affected in 8(20%) of the cases noted as dull vision before the 
treatment and 6(15)%caeses showed  improved after the treatment.  
 
 Sathagam was affected noted as fatigue in 38(95%) cases and all  36(90)%  cases 
were improved from the affection after the treatment. 
 
 Kabam: Out of 40 cases, 
 
 Avalambagam was affected noted as breathlessness in 35(87.5%) cases before the 
treatment and 33(82.5%) cases were improved after the treatment.  
 
 Kilethagam was affected noted as indigestion in 35(87.5%) cases and33  (82.5) 
were improved after the treatment.  
 
 Pothagam was affected in 18(45%) cases noted as feeling of pungent or bitter taste 
of the tongue and 16 (40) were improved after the treatment.  
 
 Tharpagam was affected noted as burning sensation of eye in 7(17.5%) cases 
before the treatment and all 5 (12.5)were improved after the treatment. 
 
 UdalKattugal: Of the 40 cases,  
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 Saaram [noted as fatigue] was affected in all 40 patients (100%) before the 
treatment and 38(95%) patients were improved after the treatment.  
 
 Senneer [noted as pallor, reduction of Hemoglobin level] was affected in all 36 
patients (90%) before the treatment and 33(82.5%) patients were improved after the 
treatment. 
 Oon was affected noted as paedaledema in 20(25%) cases, before the treatment and  
18 (45) %were improved from the affection after the treatment.  
 
 Suronitham was affected in 12(30%) patients noted as ammenorrhoea in 2 of the 
cases and oligomenorrhoea in 10 cases before the treatment of which 10(25%) [9 
patients in oligomennorhoea and 1 patient in ammennorhoea] were improved after 
the treatment. 
 
 Envagai Thervugal: Out of 40 cases, 
 
 Naa [noted as pallor, coated, glossitis, angular stomatitis, baldness, fissure, dryness, 
pungent or bitter taste, decreased salivation] was affected in 38 [95%] cases before 
treatment and 38(95%) cases were improved after the treatment.  
 
 Niram [noted as pallor] was affected in 40 [100%] cases before treatment and 
37(92.5%) cases were improved from the affection after the treatment.  
 
 Vizhi [noted as pallor] was affected in all the 38 cases (95%) of which 37(92.5%) 
cases were improved from the affection after the treatment.  
 
 Sparisam was affected [noted as dryness, hot or cold sensation, excessive sweat] in 
25(62.5%) cases and 23(57.5)  were improved after the treatment 
 
 Malam was affected [noted as constipation] in 20(50%) before the treatment and 18 
(45%)  caseswere improved after the treatment.  
 
 Naadi: According to this study, among 40 cases, Pithavaatham naadi was observed 
in 15 cases, kabhavatham naadi was observed in 13 cases and kabhapitham was 
observed in 12 cases, before the treatment. After the treatment 37 cases in 
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Pithavatham naadi, 1 case in Pitham naadi and 2 case in Vathapitham naadi were 
observed. 
 
 
 Neikkuri: Of the 40 patients, 25 [62.5 %] cases were observed in Pithaneer and 
remaining 18(45 %) cases were observed in Vathaneer before the treatment and 13 
[32 %] cases were observed in Pithaneer and 25(62.5 %) cases were observed in 
Vathaneer after the treatment. 
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SUMMARY 
 
The aim of the study was clinical evaluationof the siddha drug formulation 
CHITRAMUTTI  NEI (INT) in Azhalpandu [Iron Deficiency Anaemia].   
 
Institutional Ethical Committee approval was obtained before the commencement of 
the trial by submitting the well defined protocol and proforma. [Reg No: F.No.NIS/6-
20/IEC/15-16] 
 
CTRI registration number:ctri2018/01/011179  The raw drugs were collected from 
the reputed raw drug market in Chennai. 
 
Raw herbs were authenticated at Assistant Professor, Department of Medicinal 
Botany, NIS.    
 
The medicine was prepared as per the standard operating procedure in Gunapadam 
laboratory, NIS.    
 
The Qualitative Analysis was evaluated at of Biochemistry laboratory, NIS..The 
report showed the presence of Iron and other Minerals such as sulphate, calcium, carbonate , 
etc., 
 
The HPTLC of Chitramutti nei was evaluated at captain srinivasamurthy regional 
ayurvedha drug development institute, Arumbakkam, Chennai showed the fingerprint at UV 
254 nm showed highest  peak in 8th peak ( max44.76%  area 63.80% ) which could serve as 
a marker and it is responsible for biological action. 
 
TLC&HPTLC- HPTLC- finger print of Chitramuttinei could serveas a marker and 
which is  responsible for expression of its biological and clinical actions. HPTLC was 
carried out in UV at 254nm,UV at 366nm to establish the finger printing profile and to show 
the possibly active phyto chemical constituents. The prepared medicine was subjected to 
clinical trial at OPD of NIS. 
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Among the 130 patients screened in the OPD of Department of Maruthuvam, 40 
patients who satisfied the inclusion and exclusion criteria were selected and all were 
females. 
 
Clinical diagnosis of Azhalpandu was made by Siddha and Modern methodology.  
 
After obtaining the Informed Consent from the selected patients, they were 
administered with chitramutti nei 4ml twice a day with Hotwater, before meals for 45 days 
with specific diet restrictions.  
 
  A day before the commencement of the treatment, 200mg. of Agasthiyar kuzhambu 
with ginger juice to normalize the deranged Pitha Thaathu.  
 
 All cases 40 were treated in OPD . 
 
 Assessments and required Lab Investigations were carried out as per protocol and 
the concerned data was recorded in the proforma. 
 
Followups of the patient for next 2 months in the OPD after the trial period were also 
carried out, without the trial drug.  
 
The Statistical analysis showed the datas obtained from the Hematological 
parameters were statistically significant.   
 
Both Hematological and Clinical improvement of the patient was noted. In this 
Clinical study, the efficacy of the drug in increasing the Hb level was noted in 32(80%) 
patients.  No adverse effects were reported during or after the course of treatment. 
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CONCLUSION 
 
The therapeutic dose of chitramutti nei [4ml-Neikkarandi] mentioned in Chikicha 
Rathna Deepam  is the safety dose level for clinical trial.  
 
From the Biochemical studies, chitramutti nei possesses Iron, carbonate, calcium, 
ammonium, silicate, sulphate, fluoride,  oxalate, starch and alkaloid.  
 
Adverse reaction of the drug was not observed during the course of the study.    
 
In the clinical trial, Out of 40 cases 32(80%) cases showed good improvement, 
6(15%)  cases moderate improvement , 2 (5%)cases poor improvement and some of the 
important siddha parameters are stated below. 
 
From the Stastical studies, the Mean ± Standard deviation for Haemoglobin before 
treatment is 9.22 and after treatment is 10.05 which is statistically significant (p<0.0001). 
 
From Clinical studies, it is clear that Azhal pandunoi is caused due to derangement 
of Pitham followed by derangement of Vatham and Kabam. Both objective and subjective 
improvements were observed in the sample of 40 patients.  
 
  The Siddha formulation chitramutti nei has been proved clinically to be 
haematinic(80%).  
 
Hence I conclude, the drug is found to be there peutically efficacious, and it can be 
explored in large sample size for further research in near future. 
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   MARUTHUVAM 
           A Clinical evaluation of siddha formulation  CHITRAMUTTI NEI (INT) in the 
treatment of AZHAL  PAANDU (IRON DEFICIENCY ANAEMIA)    
 
Principal Investigator:                                                               Reg. No:  
 
             FOR M I - SCREENING & SELECTION PROFORMA 
 
1. SERIAL NO :                                                    2.  OP /IP NO: -------------    
                           
3. NAME: ……………………………………     4. AGE/GENDER: ………….......   
 
5. OCCUPATION: ……………………               6. INCOME:   …………………    
 
7. CONTACT NOS;    ------------------------------------------ 
 
8. INCLUSION CRITERIA 
 
 Age15-55 of both sexes                                                                            Yes/No 
 Hb less than normal range ie.,men:7-12gms/dl,Women:7-11gms/dl        Yes/No 
 Clinical symptoms of Pallor, Breathlessness, Palpitation, Anorexia,        Yes/No 
      Giddiness, Numbness, Glossitis, lassitude, Fatigue, koilonychias, etc., 
         Patient willing to undergo blood investigations                                         Yes/No 
 Patient willingness for consent to include in the trial                                Yes/No 
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9. EXCLUSION CRITERIA:  
 
Pregnancy and  lactation Yes No Epilepsy Yes No 
Severe systemic illness (CA,RA)      Yes No Hypertension Yes No 
Inherited defects(Aplastic anemia, 
Sickle cell anemia, Thalassemia) 
Yes No Renal disease Yes No 
Hyperthyroidism/Hypothyroidism Yes No Diabetes mellitus Yes No 
Worms infestation Yes No Cardiac disease Yes No 
 
10.ADMITTED TO TRAIL 
 
YES  NO  
If Yes, OPD  IPD  
  Serial NO:  
Date:        
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                           Signature of the HOD   
 
 
           
 
 
 
 
 
156 
 
NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   MARUTHUVAM 
A Clinical evaluation of siddha formulation CHITRAMUTTI NEI (INT) in the treatment of  
AZHAL  PANDU  (IRON DEFICIENCY ANAEMIA) 
 
   Principal Investigator:                                                               Reg. No: 
 
             FORM II-CLINICAL  RECORD  FORM    
 
1.   Serial No of the case:   _______________ 
2.   Name: ________________    3. Gender:   Female/male 
4.   Age (years): ______DOB: Date                Month                   Year  
5.   Address: 
6.   Occupation: 
7.   Religion        : H /C /M / O  
8.   Income         : 
9.   Educational Status:   A) Illiterate                  B) Literate  
10. Height:         cms                11. Weight         kg 
12. Complaints and Duration:   
             ______________________________________________________________ 
              ______________________________________________________________ 
              ______________________________________________________________ 
13. HABIT OF 
  A) Smoking             . Yes          duration ________ years; number-              .No 
  B) Tobacco chewing .Yes            duration ________ years                            No                         
  C) Betel chewing      . Yes            duration ________ years                            No  
   D) Alcoholism         Yes           duration ________ years; Quantity-ml        No    
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14. DRUG HISTORY: Had the patient been treated before with Allopathic drug?  
                                      YES NO  
 
15. DIETARY STYLE:      Pure vegetarian          Non-vegetarian            Mixed diet 
 
 
16.  MARITAL STATUS:          Married    Unmarried  
 
 
                                               No of children            male:             female: 
                                             
 
17. FAMILY HISTORY: 
 
      Whether this problem runs in family?                              Yes                              No   
  
       If yes, mention the relationship of affected person(s)        ------------------------- 
 
                                                                                          ------------------------- 
                                             
18. MENSTRUAL HISTORY:               Regular    /    Irregular    /    Menopause 
 
                                               
19. BOWEL HABITS & MICTURITION:  Normal   
 
            History of habitual constipation             Yes                        No                                                       
 
            History of frequent diarrhoea                Yes                        No                                                         
 
            History of frequent dysuria                   Yes                        No                
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20. PSYCHOLOGICAL STATE: 
                   
              Normal                                                   Anxiety                          Depression 
 
21.SIDDHA SYSTEM OF EXAMINATION: 
 
 ENVAGAI THERVU:[EIGHT-FOLD EXAMINATION] 
 
 I.NAADI: [PULSE PERCEPTION] 
 0
th day 9
th
 day              18
th
  day                27
th
day         36
nd 
day 46
th
 day 
Vali       
Azhal       
Iyyam       
Vali Azhal       
Azhal vali       
Iyya vali       
Vali Iyyam       
Azhal Iyyam       
Iyya Azhal       
 
II.NAA:[TONGUE] 
 0
th day 9th day              18th  day                27th day         36th day 46th day 
Colour normal/ Red 
pale/yellow 
normal/ Red 
pale/yellow 
normal/ Red 
pale/yellow 
normal/ 
Red 
pale/yellow 
normal/ Red 
pale/yellow 
normal/ Red 
pale/yellow 
Taste Sweet/Sour/ 
Pungent/ 
Bitter/None 
Sweet/Sour/ 
Pungent/ 
Bitter/None 
Sweet/Sour/ 
Pungent/ 
Bitter/None 
Sweet/Sour
/ Pungent/ 
Bitter/None 
Sweet/Sour/ 
Pungent/ 
Bitter/None 
Sweet/Sour/ 
Pungent/ 
Bitter/None 
Coating Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Fissure Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
159 
 
Saliva Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Present/ 
Absent 
Present/ 
Absent 
Dryness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Glossitis Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Baldness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
 
 
III.NIRAM:[COMPLEXION]    
 
0
th
 day 9th day 18th day 27th day   36
th
 day 45
th
 day 
Dark/pale/ 
Yellow tinted/ 
wheatish brown 
Dark/pale/ 
Yellow tinted/ 
wheatish 
brown 
Dark/pale/ 
Yellow tinted/ 
wheatish 
brown 
Dark/pale/ 
Yellow tinted/ 
wheatish 
brown 
Dark/pale/ 
Yellow tinted/ 
wheatish 
brown 
Dark/pale/ 
Yellow tinted/ 
wheatish brown 
 
 
       IV.MOZHI:[VOICE] 
0
th
 day 9th day 18th day 27th day  36
th
 day 46
th
 day 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
                     
      V.VIZHI:[EYES] (Lower palpebral conjunctiva)     
 
0
th
 day 9th day 18th day 27th day  36
nd
 day 46
th
 day 
normal/ Red 
pale/yellow 
normal/Red 
pale/yellow 
normal/Red 
pale/yellow 
normal/ Red 
pale/yellow 
normal/ Red 
pale/yellow 
normal/ Red 
pale/yellow 
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 VI. MALAM:[BOWEL HABITS / STOOLS] 
 0
th
 day   9th 
day 
18
th
 day 27th day  36
nd
 day 46
th
 day 
Colour Dark/pale/ 
yellow/ 
Red 
Dark/pale/ 
yellow/ 
Red 
Dark/pale/ 
Yellow/ 
Red 
Dark/pale/ 
yellow/ 
Red 
Dark/pale/ 
yellow/ 
Red 
Dark/pale/ 
yellow/ 
Red 
Consistency Solid/ 
Semisolid/
Watery 
Solid/ 
Semisolid/
Watery 
Solid/ 
Semisolid/
Watery 
Solid/ 
Semisolid/W
atery 
Solid/ 
Semisolid/ 
watery 
Solid/ 
Semisolid/Water
y 
stool  bulk                          Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Constipation   Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Diaarhoea Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
 
 
       VII.MOOTHIRAM:[URINE EXAMINATION]     
Neerkkuri 0
th
 day   9th 
day 
 18th 
day 
 27
th
 day  36
nd
 day 46
th
 day 
Niram 
[Colour]   
Yellow/ 
Red/ 
White/ 
Straw 
Coloured 
Crystal clear 
Yellow/ 
Red/ 
White/ 
Straw 
coloured/ 
Crystal 
clear 
Yellow/ 
Red/ 
White/ 
Straw 
coloured/ 
Crystal 
clear 
Yellow/ 
Red/ 
White/ 
Straw 
coloured/ 
Crystal clear 
Yellow/ 
Red/ 
White/ 
Straw 
coloured/ 
Crystal clear 
Yellow/ 
Red/ 
White/ 
Straw 
coloured/ 
Crystal clear 
Manam[Odour] Present/ 
Absent 
 Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ Absent 
Nurai[Froth] Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Edai[Sp.gravity]                                Normal/ Normal/ Normal/ Normal/ Normal/ Normal/ 
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Increased/ 
Reduced  
Increased/ 
Reduced  
Increased/ 
Reduced  
Increased/ 
Reduced  
Increased/ 
Reduced 
Increased/ 
Reduced 
Enjal[Deposits] Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ Absent 
Volume   Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
                                       
Neikkuri  0th day 9th day 18th day 27th day  36nd day 46th day 
Serpentine 
fashion 
      
Annular/ 
Ringed 
fashion 
      
Pearl 
beaded 
fashion    
      
Mixed 
fashion 
      
Other 
fashion 
      
 
VIII. SPARISAM:[PALPATORY  PERCEPTION] 
0
th
 day 9th day 18th day 27th day  36nd day 46th day 
Warmth/ 
Hot/ 
cold/ Sweat 
Warmth/ 
Hot/cold/ 
Sweat 
Warmth/Hot 
/cold/ Sweat 
Warmth/Hot/ 
cold/ Sweat 
Warmth/Hot 
/cold/ Sweat 
Warmth/Hot 
/cold/ Sweat 
 
 THEGI:[ TYPE OF BODY CONSTITUTION]    
Vatham predominant  Kabam predominant  
Pitham predominant  Thondha udal  
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 NILAM: [ LAND WHERE PATIENT LIVED MOST]  
                
Kurinji               Mullai                  Marutham             Neithal              Paalai   
 
(Hilly terrain)      (Plains)                (Coastal belt)        (Aridregions)    (Forest range) 
 
 KAALAM: [SEASON] 
 
Kaarkalam   Pinpanikalam      
Koothirkalam   Ilavenil 
                  Munpanikalam                        Muthuvenil 
 
GUNAM:[CHARACTER] 
 
Sathuvam                        Rasatham                       Thamasam    
 
IYMPORIGAL:[SENSORY ORGANS] 
 
 0
th
 day 9th day 18th day 27th day  36nd day 46th day 
 Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Mei [Skin       
Vaai [Buccalcavity]
  
            
Kan [Eyes]             
Mooku[Nose]             
Sevi [ear]              
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IYMPULANGAL:[MOTOR ORGANS] 
 0
th
 day 9th day 18th day 27th day 36nd day 46th day 
 Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Kai [upperlimb]       
Kal [lowerlimb]       
Vai[Buccal cavity]       
Eruvai  
[excretory organ] 
      
Karuvai 
[Reproductive 
organ] 
      
 
KOSAM:[SHEATHS] 
 
 0
th
 day 9th day 18th day 27th day  36nd day 46th day 
 Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Annamaya kosam       
Praanamaya Kosam       
Manonmayakosam       
Vingyanamaya osam       
Anandhamaya kosam       
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MUKKUTRAM:[AFFECTION OF THREE HUMORS] 
VATHAM:                                                                          
 0
th
 day 9th day 18th day 27th day 36nd tday  46th day 
 Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Praanan       
Abaanan        
Samaanan       
Udhaanan       
Viyaanan       
Naahan       
Koorman       
Kirukaran       
Devathathan       
Dhananjeyan       
 
B) PITHAM:       
         
 0
th
 day 9th day 18th day 27th day  36nd day 46th day 
 Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Analapitham       
 Prasakam       
Ranjakam       
Aalosakam       
Saathakam       
 
165 
 
C) KABAM:                        
 0
th
 day 9th day 18th day 27th day  36nd day 46th day 
 Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Avalambagam       
Kilethagam       
Pothagam       
Tharpagam        
Santhigam       
               
 
SEVEN DHATHUS:[SEVEN SOMATIC COMPONENTS]   
                                       
 0
th
 day 9th day 18th day 27th day  36nd day 46th day 
 Normal/  
Affected       
Normal/ 
Affected 
Normal/ 
Affected 
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Saaram[chyme]       
Senneer[Blood]        
Oon[Muscle]       
Kozhuppu[Fat]       
Enbu[Bones]       
Moolai[Bonemarrow]       
Sukkilam/ 
Suronitham  
[Genital discharges] 
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SYSTEMIC EXAMINATION: 
 0
th
 day 9th day 18th day 27th day  36nd day 46th day 
CardioVascular 
System           
      
Respiratory  System           
Gastrointestinal 
System 
      
Central Nervous 
System     
      
Endocrine System       
 
GENERAL EXAMINATION: 
 
 0
th
 day 9th day 18th day 27th day  36nd day 46th day 
Height (cms)       
Weight (kg)       
Temperature(°F)          
Pulse rate (per min)       
Heart rate (per min)       
Respiratory rate(per 
min) 
      
Blood pressure(mm/Hg)       
Pallor       
Jaundice       
Cyanosis       
Lymphadenopathy       
Pedal edema       
Clubbing       
Jugular vein pulsation       
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CLINICAL SYMPTOMS: 
 0
th
 day 9th day 18th day 27th day  36nd day 46th day 
 Fatigue       
  Pallor       
  Anorexia       
  Tachycardia       
Palpitation       
Giddiness       
Breathlessness       
Pungent or bitter taste of 
tongue 
      
Angular stomatitis       
Glossitis       
Lack of concentration       
Hair fall       
Numbness       
Tingling sensation       
Amenorrhoea       
Oligomenorrhoea       
Oedema       
Koilonychia       
 
Date:                                   Station:  
Signature of the Investigator: 
 
Signature of the Lecturer:                               Signature of the HOD;                                                                                                                                                                                                                                                    
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                       NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
                                  AYOTHIDASAR PANDITHAR HOSPITAL 
                                    DEPARTMENT OF   MARUTHUVAM 
           A  Clinical evaluation of siddha formulation CHITRAMUTTI NEI (INT) in the 
treatment of  AZHAL  PAANDU  (IRON DEFICIENCY ANAEMIA)  
 
   Principal Investigator:                                                              Reg. No: 
                                                                     
FORM-III LABORATORY PARAMETERS-CHART 
1. Serial No: ________             2. Reg No:   
3. Name: ________________     4.Age:   _______ years   5.Gender: Male/Female            
BLOOD INVESTIGATION 
0th DAY 
Date: 
46th DAY 
Date: 
NORMAL VALUES 
HB ( gms%)      M:13-18 ;W:11.5- 16.5 
T.RBC(milli/cu.mm)       M:4.5-6.5;W:3.5-5.5 
ESR (mm) 
½ hr.  -             
1 hr.   M:0-10 ;W:0-20 
MCV( fl or cu.µ)   76-96 
PCV (%)       M:40-55 ;W:35-45 
MCH (pg)   27-33 
MCHC (gm/dl)(%)   31-35 
SERUM FERRITIN(µg/L)        M:20-400 ;W:8-200 
MORPHOLOGY OF RBC   Normocytic Normochromic 
T.WBC (cu.mm) 
 
DIFFERENTIAL 
COUNT (%) 
                       4000-11,000 
Polymorphs   40-75 
Lymphocytes   20-35 
Monocytes   2-10 
Eosinophils   1-6 
 Basophils   0-1 
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BT (per min)   1-3 
Clotting time   3-8 
Platelets(lak/ cubic mm)   1,50000-500000 
Blood 
glucose 
(mg/dl) 
Fasting   80-120 
PP                  <140 
Random                  <140 
Lipid 
profile 
(mg/dl) 
Serum cholesterol                  150-250 
HDL                  30-60 
LDL   Up to 130 
VLDL   40 
TGL   Up to 160 
RFT 
(mg/dl) 
Blood urea   16-50 
Serum creatinine   0.6-1.2 
Serum Uric acid    M:3-9 ;W: 2.5-7.5 
LFT 
(mg/dl) 
Total bilirubin   0.3-1 
Direct bilirubin   0.1-0.3 
Indirect bilirubin   0.2-0.8 
Serum total protein   6-8 
Serum Albumin   3.5-5.5 
Serum globulin   2-3.5 
Fibrinogen(g/dl)   0.2-0.4 
Serum calcium   9-11 
Serum phosphorous   2-5 
SGOT (IU/L)   6-18 
SGPT (IU/L)   3-26 
Alkaline 
phosphatase (kings 
Å units) 
  3-12 
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Urine 
investigation 
    Before TMT Date:      After TMT  Date: 
Neer kuri   
Niram   
Manam   
Nurai   
Edai   
Enjal   
Nei kuri   
Albumin   
 Sugar F   
Sugar PP/ R   
Deposits   
Motion test   
Ova   
Cyst   
Occult blood   
 
Date: 
 
Station: 
 
Signature of the Investigator: 
 
Signature of the Lecturer:                                                        Signature of the HOD                                                                                              
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   MARUTHUVAM 
A Clinical evaluation of siddha formulation CHITRAMUTTI NEI (INT) in the 
treatment of AZHAL PAANDU (IRON DEFICIENCY ANAEMIA) 
                                                                                                       
 
FORM IV   (DRUG COMPLIANCE FORM) 
 
Name: Reg No: Serial No: DRUG NAME:CHITRAMUTTI 
KIRUTHAM 
 
On 1
st   
 day-Date:              Drugs issued:         (Nos) /   Drugs returned:    (Nos) 
On 9
th
 day-Date:                Drugs issued:   (Nos) /   Drugs returned:    (Nos) 
On18 
th
 day-Date:              Drugs issued:   (Nos) /   Drugs returned:    (Nos) 
On 27
th
 day-Date:             Drugs issued:          (Nos) /   Drugs returned:    (Nos) 
On36 
th
 day-Date:              Drugs issued:   (Nos) /   Drugs returned:    (Nos) 
On 45
th
 day-Date:             Drugs issued:           (Nos) /   Drugs returned:    (Nos) 
 
Day Date  Morning Evening Day Date Morning Evening 
Day 1    Day25    
Day2    Day26    
Day3    Day27    
Day4    Day28    
Day5    Day29    
Day6    Day30    
Day7    Day31    
Day8    Day32    
Day9    Day33    
Day10    Day34    
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Day11    Day35    
Day12    Day36    
Day13    Day37    
Day14    Day38    
Day15    Day39    
Day16    Day40    
Day17    Day41    
Day18    Day42    
Day19    Day43    
Day20    Day44    
Day21    Day45    
Day22        
Day23        
Day24        
 
 
 
Signature of the Investigator:                                                         
 
 
Signature of the Lecturer:                                                           Signature of the HOD  
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   MARUTHUVAM 
A Clinical evaluation of siddha formulation CHITRAMUTTI  NEI (INT) in the treatment of  
AZHAL PANDU  (IRON DEFICIENCY ANAEMIA) 
                                             
FORM V – INFORMATION SHEET 
 
Name of the Principal Investigator: Dr.M.S.SHAKILA 
 
Name of the Institution                   : National Institute of Siddha, 
                                                            Tambaram Sanatorium 
                                                            Chennai- 47. 
 I, Dr.M.S.Shakila  Studying  M.D(S) in National Institute of Siddha, Chennai. The 
disease called  Azhal paandu (Iron deficiency of anaemia) symptoms, like  pallor, 
giddiness, fatigue, anorexia, hair fall. This condition is being treated is NIS with many 
siddha formulations. As a part of M.D(S) research programme and developing new 
efficacious medicine, we propose to study the Chitramutti nei formulation for treating 
the condition. This formulation has been mentioned in siddha literature and empirical 
evidence with contemporary tools is required for documentation. You can receive 
medicines free of cost Chitramutti nei 4ml BD   twice a day for 9 days in a duration of 
45 days The diagnosis tests will be carried out free of cost. We will assess the effect of 
treatment after completion of 45 days of treatment using clinical and lab parameters. 
 
 In this regard, we need to ask you few questions. We will maintain confidentiality of 
your comments and data obtained from you. There will be no risk of disclosing your 
identity and no physical, psychological or professional risk is involved by taking part in 
this study. 
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 Taking part in this study is voluntary. No compensation will be paid to you for taking 
part in this study. You can choose not to answer any specific question. There is no 
specific benefit for you if you take part in the study, but you will be under our clinical 
monitoring and specific attention will be given for your health. Taking part in the study 
may be of benefit to the community, as it may help us to develop medicine for Azhal 
paandu, In case of any adverse symptoms which is expected for few patients during the 
treatment, shall be reported to PIs and care will be taken in NIS for relief. You can 
withdraw from the study at the midst of treatment period, if you are not interested to 
continue and you will receive our usual treatment without condition. 
 The information we will collect in this study, will remain between you and the principal 
investigator. We will ask you a few questions through questionnaire. We will not write 
your name on different forms which sent to other investigation forms 
investigating/analysis sections and we will use a code instead given by the principal 
investigator. Only the principal investigator will know the key to this code which will be 
kept in safe custody. If you agree to be a participant in this study, you will be screened 
as per the study protocol.  
 
 If you wish to find out more about this study before taking part, you can ask me all the 
questions you want or contact Dr.M.S.Shakila Studying M.D(S) scholar cum principal 
investigator of this study, attached to the National Institute of Siddha, Chennai (Mobile 
phone no:8681918617). You can also contact the Chairman/Member-secretary of Ethics 
committee, National Institute of Siddha, Chennai – 600047, Tel no: 91-44-22411611, 
for rights and participation in the study. 
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§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, ¦ºý¨É 47 
«§Â¡ò¾¢¾¡º÷ ÀñÊ¾÷ ÁÕòÐÅÁ¨É 
moy; À¡ñÎ §¿¡öì¸¡É º¢ò¾ ÁÕó¾¢ý º¢üÈ¡ÓðÊ nea; 
ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É ¾¸Åø ÀÊÅõ. 
FORM V- ¾¸Åø ÀÊÅõ 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ¦ÀÂ÷ :  ÁÕ.Á£.Í.£„¸¢Ä¡ 
 ¿¢ÚÅÉò¾¢ý ¦ÀÂ÷           :  §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
                               ¾¡õÀÃõ º¡Éð§¼¡Ã¢Âõ 
                               ¦ºý¨É 47 
           ÁÕ.Á£.Í.£„¸¢Ä¡ ¬¸¢Â ¿¡ý §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø Àð¼ §ÁüÀÊôÒ 
ÀÂ¢ýÚ ÅÕ¸¢§Èý. moy; À¡ñÎ ±ýÛõ §¿¡Â¡ÉÐ º¢ò¾ ÁÕòÐÅò¾¢ø º¢ÅôÀÏì¸û 
Ì¨ÈÅ¾É¡ø ²üÀ¼ÜÊÂ §¿¡ö.  -Ð  ÀÃÅ ÜÊÂ §¿¡ö «øÄ.  þó§¿¡öìÌ §¾º¢Â 
º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø ÀÄ º¢ò¾ ÁÕóÐ¸û ÀÂýÀÎò¾ôÀðÎ ÅÕ¸¢ýÈÐ. º¢ò¾ ÁÕòÐÅ 
Àð¼ §ÁüÀÊôÀ¢ø, ¬öÅ¢ý ´Õ ÀÌ¾¢Â¡¸ Ò¾¢Â ÁÕóÐ¸¨Ç ÀÂýÀÎòÐõ §¿¡ì¸¢ø 
º¢üÈ¡ÓðÊ nea; 
ÁÕó¾¢¨É þó§¿¡öìÌ ÅÆí¸ ÀÃ¢óÐ¨Ã ¦ºö¸¢§È¡õ. þó¾ ÁÕó¾¢ý ¦ºöÓ¨È, 
«Ç×, ÁüÚõ ÁÕòÐÅ ÀÂý¸û «¨ÉòÐõ «í¸£¸Ã¢ì¸ôÀð¼ º¢ò¾ ÁÕòÐÅ áÄ¢ø 
ÜÈôÀðÎûÇÐ. ±ó¾Å¢¾ ¸ð¼½ÓÁ¢ýÈ¢ ¾¡í¸û þó¾ ÁÕó¾¢¨É ¦ÀüÚì¦¸¡ûÇÄ¡õ. 
þó¾ ¬öÅ¢ø ÁÕóÐ ¯ð¦¸¡ûÙõ ¸¡Äõ 45 ¿¡ð¸û ¬Ìõ. Å¡Ãõ ´ÕÓ¨È §¾º¢Â 
º¢ò¾ ÁÕòÐÅÁ¨ÉìÌ §¿Ã¢ø ÅóÐ 9¿¡ð¸Ùì¸¡É ÁÕó¾¢¨É ¦ÀüÚì¦¸¡ûÇ §ÅñÎõ. 
þó¾ ¬ö× ºõÀó¾Á¡É ¬öÅ¸ ÀÃ¢§º¡¾¨É¸û ¸ð¼½Á¢ýÈ¢ ¦ºöÂôÀÎõ.45¿¡ð¸û 
ÁÕóÐ ¯ð¦¸¡ûÙõ ¸¡Äõ ÓÊó¾ À¢ÈÌ §¿¡öì¸¡É ÌÈ¢Ì½í¸û ÁüÚõ ¬öÅ¸ 
ÀÃ¢§º¡¾¨É¸û þÅüÈ¢ý ÓÊ×¸Ç¢ý «ÊôÀ¨¼Â¢ø ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò¾¢Èý 
¸ñ¼È¢ÂôÀÎõ.   
þó¾ ¬ö× ºõÀó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨Ç ¾í¸Ç¢¼õ §¸ð¸ þÕì¸¢§Èý. 
¾í¸Ç¢¼Á¢ÕóÐ ¦ÀÈôÀÎõ ¸ÕòÐì¸û ÁüÚõ ÌÈ¢ôÒ¸û «¨ÉòÐõ ¿õÀ¢ì¨¸Â¡¸ À¾¢× 
¦ºöÂôÀÎõ.þó¾ ¬öÅ¢ø ¾í¸¨Ç ¯ðÀÎò¾¢ì¦¸¡ûÅ¾¢ý ãÄõ ±ó¾ Å¨¸Â¢Öõ 
À¡¾¢ôÒìÌûÇ¡¸ Á¡ðË÷¸û ±É ¯Ú¾¢ «Ç¢ì¸¢§Èý. 
  ±ó¾Å¢¾ ÅüÒÚò¾ÖÁ¢ýÈ¢, þó¾ ¬öÅ¢ø Àí§¸ü¸×õ, þó¾ ¬ö× ºõÀó¾Á¡¸ 
§¸ð¸ôÀÎõ §¸ûÅ¢¸ÙìÌ À¾¢ø ÜÈ×õ ¾í¸ÙìÌ ÓØ Í¾ó¾¢Ãõ «Ç¢ì¸ôÀÎ¸¢ÈÐ. þó¾ 
¬öÅ¢ø Àí§¸üÀ¾üÌ ±ó¾ ºýÁ¡ÉÓõ ÅÆí¸ôÀ¼Á¡ð¼¡Ð.  ¬É¡ø, ¬ö× ÓØÅÐõ 
±ÉÐ §ÁüÀ¡÷¨ÅÂ¢Öõ, ¾í¸û ¯¼ø¿Äý ÌÈ¢ò¾ ¾É¢ ¸ÅÉò¾¢Öõ ¬ö× 
§Áü¦¸¡ûÇôÀÎõ. moy; À¡ñÎ   §¿¡öì¸¡É Ò¾¢Â ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò¾¢È¨É 
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ºã¸ò¾¢üÌ ¯½÷òÐõ Å¨¸Â¢ø þó¾ ¬ö× §Áü¦¸¡ûÇôÀÎ¸¢ÈÐ.þó¾ ¬öÅ¢¨Éò 
¦¾¡¼Ã ¾í¸ÙìÌ Å¢ÕôÀõ þø¨Ä¦ÂÉ¢ø, ±ô¦À¡ØÐ §ÅñÎÁ¡ÉÖõ ¬öÅ¢ý þ¨¼Â¢ø 
Å¢Ä¸¢ì¦¸¡ûÇ×õ, þõÁÕòÐÅÁ¨ÉÂ¢ø ÅÆí¸ôÀÎõ þó§¿¡öì¸¡É ÅÆì¸Á¡É 
ÁÕóÐ¸¨Ç ¦ÀüÚì¦¸¡ûÇ×õ «È¢×Úò¾ôÀÎ¸¢È£÷¸û. 
     þó¾ ¬öÅ¢ø §º¸Ã¢ì¸ôÀÎõ Å¢ÀÃí¸û «¨ÉòÐõ ¾í¸ÙìÌõ Ó¾ý¨Á 
¬Ã¡öîº¢Â¡ÇÃ¡É ±ÉìÌõ þ¨¼Â¢ø þÃ¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ. §¸ûÅ¢ À¾¢ø ÅÊÅò¾¢ø 
¾í¸Ç¢¼õ §¸ûÅ¢¸û §¸ð¸ôÀÎõ. «¨ÉòÐô ÀÊÅí¸Ç¢Öõ ¾í¸Ç¢ý ¦ÀÂ÷ ¾Å¢÷ì¸ôÀðÎ 
¬öÅ¡ÇÃ¡ø ¾í¸Ùì¦¸É ¾É¢ì ÌÈ¢Â£Î ÅÆí¸ôÀÎõ. «ó¾ì ÌÈ¢Â£Î ¬öÅ¡ÇÕìÌ 
ÁðÎ§Á ¦¾Ã¢ó¾¾¡¸ þÕìÌõ. ¿£í¸û þó¾ ¬öÅ¢ø Àí§¸ü¸ Å¢ÕôÀôÀð¼¡ø, ¾¢ð¼ 
Å¨Ã× ÀÊ §¾÷× ¦ºöÂôÀÎÅ£÷¸û. 
¿£í¸û þó¾ ¬öÅ¢ø Àí§¸üÌõ Óý, þó¾ ¬öÅ¢¨Éô ÀüÈ¢Â §ÁÖõ Å¢ÀÃí¸û 
¦ÀÈ §ÅñÎ¦ÁÉ Å¢ÕôÀôÀð¼¡ø, þó¾ ¬öÅ¢ý Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ÁüÚõ §¾º¢Â 
º¢ò¾ ÁÕòÐÅÁ¨É, Àð¼ §ÁüÀÊôÒòÐ¨È Á¡½Å÷ ÁÕ.Á£.Í.£„¸¢Ä¡ ¬¸¢Â ±ý¨É 
8681918617 ±ýÈ ±ñ½¢ø ¦¾¡¼÷Ò ¦¸¡ûÇÄ¡õ. §ÁÖõ, ¿£í¸û þó¾ ¬öÅ¢ø, ¯í¸ÇÐ 
Àí§¸üÒ ÁüÚõ ¯Ã¢¨Á ÀüÈ¢ ¦¾Ã¢óÐ ¦¸¡ûÇ §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨É, 
¾¨ÄÅ÷/¦ºÂüìÌØ ¯ÚôÀ¢É÷ «Å÷¸¨ÇÔõ  
91-44-22511611 ±ýÈ ±ñ½¢ø ¦¾¡¼÷Ò ¦¸¡ûÇÄ¡õ.   
 
 
         
 
.   
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FORM VI A - CONSENT FORM 
Certificate by Investigator 
 
     I certify that I have disclosed all details about the study in the terms readily understood 
by the patient. 
 
Date:      Signature: 
                                                                Name:      
 
Consent by Patient 
   I have been informed to my satisfaction, by the attending physician, the purpose of 
the clinical trial, and the nature of drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my body functions. 
    I am aware of my right to opt out of the trial at any time during the course of the 
trial without having to give the reasons for doing so. 
    I, exercising my free power of choice, hereby give my consent to be included .As a 
subject in the clinical trial of Chitramuttineifor the management of 
Azhalpandu(IronDeficiencyAnaemia) 
 
Date:                        Patient   Signature: 
                                                           Patient     Name:  
 
Date:            Signature of Witness:  
                                                                              Name:  
                                                                  Relationship:  
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§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
«§Â¡ò¾¢¾¡…÷ ÀñÊ¾÷ ÁÕòÐÅÁ¨É,¦ºý¨É-47 
Àð¼§ÁüÀÊôÒ ÁÕòÐÅòÐ¨È 
IV A- ´ôÒ¾ø ÀÊÅõ 
 
   ¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸ôÀð¼Ð 
                 ¿¡ý þó¾ ¬ö¨Å ÌÈ¢ò¾ «¨ÉòÐ Å¢ÀÃí¸¨ÇÔõ §¿¡Â¡Ç¢ìÌ  ÒÃ¢Ôõ 
Å¨¸Â¢ø ±ÎòÐ¨Ãò§¾ý ±É ¯Ú¾¢ÂÇ¢ì¸¢§Èý. 
 
 §¾¾¢ :                                          ¨¸¦Â¡ôÀõ: 
 þ¼õ:                                               ¦ÀÂ÷     : 
 
                                 §¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø 
 
                ±ýÉ¢¼õ  þó¾ ÁÕòÐÅ ¬öÅ¢ý ¸¡Ã½ò¨¾Ôõ, ÁÕó¾¢ý ¾ý¨Á ÁüÚõ 
ÁÕòÐÅ ÅÆ¢Ó¨Èô ÀüÈ¢Ôõ, ¦¾¡¼÷óÐ ±ÉÐ ¯¼ø þÂì¸ò¨¾ ¸ñ¸¡½¢ì¸×õ, 
«¾¨É À¡Ð¸¡ì¸×õ ÀÂýÀÎõ ÁÕòÐÅ ¬ö×ìÜ¼ ÀÃ¢§º¡¾¨É¸û ÀüÈ¢   ¾¢Õô¾¢ 
«Ç¢ìÌõ Å¨¸Â¢ø ¬ö× ÁÕòÐÅÃ¡ø Å¢ûì¸¢ì ÜÈôÀð¼Ð.       
               ¿¡ý þó¾ ÁÕòÐÅ ¬öÅ¢ý §À¡Ð, ¸¡Ã½õ ±Ð×õ ÜÈ¡Áø, ±ô¦À¡ØÐ 
§ÅñÎÁ¡É¡Öõ þó¾ ¬öÅ¢Ä¢ÕóÐ   ±ý¨É Å¢ÎÅ¢òÐ ¦¸¡ûÙõ ¯Ã¢¨Á¨Â 
¦¾Ã¢ó¾¢Õì¸¢ý§Èý. 
               ¿¡ý ±ýÛ¨¼Â Í¾ó¾¢ÃÁ¡¸ §¾÷× ¦ºöÔõ ¯Ã¢¨Á¨Âì ¦¸¡ñÎ moy; 
À¡ñÎ §¿¡öì¸¡É º¢üÈ¡ÓðÊ nea;  ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ 
ÁÕòÐÅ ¬öÅ¢üÌ ±ý¨É ¯ðÀÎò¾ ´ôÒ¾ø «Ç¢ì¸¢§Èý. 
 
  §¾¾¢:                                                       ¨¸¦Â¡ôÀõ: 
  þ¼õ:                                                      ¦ÀÂ÷     : 
 
 
  §¾¾¢:                               º¡ðº¢ì¸¡Ã÷ ¨¸¦Â¡ôÀõ: 
  þ¼õ:                                       ¦ÀÂ÷                : 
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FORM VII - (WITHDRAWAL FORM) 
 
1) S. NO: -----------             2) OPD/ IPD NO: ---------------                 3)REG  NO:  
 
4) NAME: ------------------------------    5) AGE: ---------                     6) GENDER: M/F------ 
 
Date of trial commencement:  
 
Date of withdrawal from trial:  
 
REASONS FOR WITHDRAWAL: 
 
 Long absence at reporting :                              Yes/ No 
 Irregular treatment:                                           Yes/ No 
 Shift of locality :                                               Yes/No 
 Increase in severity of symptoms:                    Yes/No 
 Complication/Adverse reactions if any:          Yes/No 
 Poor patient compliance:                                 Yes/No 
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FORM VIII [Azhal pandu-chitramutti nei] 
Please note:  i. All consumers / patients and reporters information will remain 
confidential. 
ii. It is requested to report all suspected reactions to the concerned, even if 
it does not have complete data, as soon as possible. 
Peripheral Center code:     State:  
1. Patient / consumer identification (please complete or tick boxes below as 
appropriate) 
 
Name  Father name Patient / Record No. 
Ethnicity  Occupation 
Address  
Village / Town 
Post / Via 
District / State    
Date of Birth / Age: 
Sex:     Male / Female  
Weight : 
Degam: 
 
2. Description of the suspected Adverse Reactions (please complete boxes below) 
 
Date and time  of 
initial observation 
 Season: 
Description of 
reaction   
 Geographical area: 
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3. List of all medicines / Formulations including drugs of other systems used by the 
patient during the reporting period: 
 
Medicine Daily 
dose 
Route of 
administration 
& Vehicle – 
Adjuvant 
Date  Diagnosis for 
which medicine 
taken  Starting Stopped 
Siddha      
Any other system 
of medicines 
 
     
 
4. Brief details of the Siddha Medicine which seems to be toxic : 
 
Details Drug – 1 Drug – 2 Drug - 3 
a) Name of the medicine    
b) Manufacturing unit and 
batch No. and date 
   
c) Expiry date    
d) Purchased and obtained 
from 
   
e) Composition of the 
formulation / Part of the drug 
used 
   
 
b) Dietary Restrictions if any 
c) Whether the drug is consumed under Institutionally qualified medical supervision or used 
as self medication.  
d) Any other relevant information. 
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5. Treatment provided for adverse reaction: 
 
6. The result of the adverse reaction / side effect / untoward effects (please complete 
the boxes below) 
 
Recovered:          Not 
recovered: 
 Unknown: Fatal: If Fatal 
Date of death: 
Severe:   Yes   /   No. Reaction abated after drug stopped or dose reduced: 
Reaction reappeared after re introduction: 
Was the patient admitted to hospital? If 
yes, give name and address of hospital 
 
 
7. Any laboratory investigations done to evaluate other possibilities?  If Yes specify:  
 
8. Whether the patient is suffering with any chronic disorders? 
Hepatic    Renal    Cardiac    Diabetes    Malnutrition    
Any Others  
9. H/O previous allergies / Drug reactions:  
10. Other illness (please describe): 
11. Identification of the reporter: 
 
Type (please tick):  Nurse / Doctor / Pharmacist / Health worker / Patient / Attendant / 
Manufacturer /   Distributor / Supplier / Any others (please specify) 
Name: 
Address: 
Telephone / E – mail if any : 
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Signature of the reporter:       Date: 
Please send the completed form to:  
Name & address of the RRC-ASU / PPC-ASU 
    The Director 
    National Institute of Siddha, 
                                               (Pharmacovigilance Regional Centre For Siddha Medicine), 
                                                Tambaram, Sanatorium, Chennai-600 047. 
                                           (O) 044-22381314      Fax : 044 – 22381314 
Website : www.nischennai.org  
Email: nischennaisiddha@yahoo.co.in   
 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ** * * * *  
 
This filled-in ADR report may be sent within one month of observation / 
occurrence of ADR   
 
 
 
Date:                                                                              
Station:  
Signature of the Investigator: 
Signature of the Lecturer:                                                             
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FORM IX-  DIETARY ADVICE FORM 
IEC NO: NIS/IEC 
 
DIET ADVICE: 
 
To add in food: 
 Tender Brinjal 
 Tender country bean 
 Pepper 
 Garlic 
 Anise seed 
 Ginger 
 Onion 
  Green Peas 
  Chick pea or Bengal gram  
  Easily digestible food 
  soups  
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To avoid : 
     Tamarind 
 Tea 
 Coffee 
 Betel chewing 
 Tobacco chewing 
 Alcohol 
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FORM VIII-  DIETARY ADVICE FORM 
IEC NO: NIS/IEC 
 
§º÷ì¸ ÜÊÂ ¯½×¸û: 
 ¸ò¾Ã¢À¢ïÍ 
 «Å¨ÃÀ¢ïÍ 
 Á¢ÇÌ 
 âñÎ 
 º£Ã¸õ  
 þïº¢ 
 ¦Åí¸¡Âõ 
 Àð¼¡É¢ 
 ¦¸¡ñ¨¼¸¼¨Ä  
 ±Ç¢¾¢ø ¦ºÃ¢ìÌõ ¯½×¸û  
 Ýô Å¨¸¸û 
§º÷ì¸ Ü¼¡¾¨Å¸û: 
      
 ÒÇ¢, §¾¿£÷, ¬¸¢Â¨Å §º÷ì¸ Ü¼¡Ð. 
 
 ¦ÅüÈ¢¨Ä, À¡ìÌ §À¡¼ Ü¼¡Ð. 
 
 Ò¨¸Â¢¨Ä §À¡¼ Ü¼¡Ð. 
 
 ÁÐ «ÕóÐ¾ø Ü¼¡Ð. 
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